Eacpr: European Association For Cardiovascular Prevention and Rehabilitation

European Association for
Cardiovascular Prevention
and Rehabilitation
EACPR
A Registered Branch of the ESC
Start Time End Time Room Session Title Session Type Topic
Thursday 8 May
08:30 10:00 Brussels 2013 ESH/ESC Guidelines on Hypertension
EACPR Masterclass
Prevention & Epidemiology
11:00 12:30 Brussels Whats new in hypertension: treatment in specifc clinical conditions Prevention & Epidemiology
08:30 10:00 The Hague Innovation in design and interpretation of research: Study design
EACPR Masterclass
Prevention & Epidemiology
11:00 12:30 The Hague Innovation in design and interpretation of research: Clinical trials Prevention & Epidemiology
14:00 15:30 The Hague Innovation in design and interpretation of research: Meta-analysis Prevention & Epidemiology
16:30 18:00 The Hague Innovation in design and interpretation of research: Prediction research Prevention & Epidemiology
08:30 10:00 Ghent How to practice sports cardiology How-to Session Sports Cardiology
11:00 12:30 Amsterdam Management of cardiovascular risk in non-cardiac surgery Symposium Other
11:00 12:30 Ghent
How to train heart failure patients with cardiac devices? What should we know about the efect
of devices to exercise?
How-to Session Sports Cardiology
11:00 12:30 Utrecht The Country of the Month project: creating an interactive prevention network Symposium Other
14:00 15:30 Amsterdam Conundrums in sports cardiology Symposium Sports Cardiology
14:00 15:30 Brussels Prediction is difcult especially when its about the future Symposium Prevention & Epidemiology
14:00 15:30 Ghent Is there a scientifc basis for the vocational advice during cardiac rehabilitation? Symposium Rehabilitation & Implementation
14:00 15:30 Utrecht Erectile dysfunction: from the quality of life to the prediction of cardiovascular events Joint Session Prevention & Epidemiology
14:00 18:00 Poster Area Poster session 1 Poster Session Other
16:30 18:00 Amsterdam Exercise training: exploring new horizons Symposium Exercise & Translational Science
16:30 18:00 Brussels The year in Cardiology: The best from our prime Journals Joint Session Other
16:30 18:00 Ghent Rapid Fire Abstract I: Exercise, Rehabilitation and Other Rapid Fire Abstract Rehabilitation & Implementation
16:30 18:00 Utrecht Biomechanical factors in cardiovascular disease Joint Session Prevention & Epidemiology
18:15 19:15 Amsterdam Inaugural Session Special Event Other
Friday 9 May
08:30 10:00 Amsterdam Around the world in 90 minutes Symposium Prevention & Epidemiology
08:30 10:00 Brussels HDL: Still important in cardiovascular prevention? Symposium Prevention & Epidemiology
08:30 10:00 The Hague Emerging concepts in sports cardiology Symposium Sports Cardiology
08:30 10:00 Ghent Hot topics in hypertension Joint Session Prevention & Epidemiology
08:30 10:00 Utrecht Cardiovascular risk management in primary care: dilemmas in following the guidelines Joint Session Other
11:00 12:30 Amsterdam Global Forum on CVD Prevention in Clinical Practice Symposium Prevention & Epidemiology
11:00 12:30 Brussels Tailoring antiplatelet drugs: focus on "special" populations Joint Session Rehabilitation & Implementation
11:00 12:30 The Hague Hot debates in nutrition and globesity Debate Session Prevention & Epidemiology
11:00 12:30 Ghent Renal denervation: a novel approach to treatment of hypertension* Joint Session Rehabilitation & Implementation
11:00 12:30 Utrecht Cardiovascular Risk Management Part II: secondary prevention pitfalls Joint Session Other
08:30 12:30 Poster Area Poster Session 2 Poster Session Other
12:45 13:45 Brussels From risk control to heart failure management - Sponsored by SERVIER Satellite Symposium Rehabilitation & Implementation
12:45 13:45 The Hague
Treating ACS patients beyond the stent: current evidence & future directions
Sponsored by AstraZeneca
Satellite Symposium Prevention & Epidemiology
12:45 13:45 Ghent
The use of lipoprotein-associated phospholipase A
2
(Lp-PLA
2
) testing in risk management of
cardiovascular disease events - Sponsored by diaDexus Inc.
Satellite Symposium Prevention & Epidemiology
14:00 15:30 Amsterdam Hot topics in preventive cardiology Symposium Rehabilitation & Implementation
14:00 15:30 Brussels How to detect early cardiovascular disease? Options and pitfalls of diferent methods Symposium Prevention & Epidemiology
14:00 15:30 The Hague Latest scientifc news on exercise rehabilitation in heart failure Symposium Exercise & Translational Science
14:00 15:30 Ghent Young Investigator Award I - Cardiac Rehabilitation and EBTR Young Investigators Awards Rehabilitation & Implementation
14:00 15:30 Utrecht The Heart Lung interaction in Preventive Cardiology Symposium Prevention & Epidemiology
16:30 18:00 Amsterdam Guidelines on preventive cardiology: minor or major diferences across the Atlantic? Joint Session Other
16:30 18:00 Brussels
Imaging of subclinical atherosclerosis in cardiovascular disease prevention: show me the
evidence
Symposium Prevention & Epidemiology
16:30 18:00 The Hague Modern management of patients with diabetes: from screening to cardiac rehabilitation Joint Session Exercise & Translational Science
16:30 18:00 Ghent Young Investigator Award II - Prevention & Epidemiology and Sports Cardiology Young Investigators Awards Prevention & Epidemiology
16:30 18:00 Utrecht Joint Session with the Council on Primary Care Joint Session Other
Saturday 10 May
08:30 10:00 Amsterdam e-Health and telemedicine in cardiovascular prevention and rehabilitation Symposium Rehabilitation & Implementation
08:30 10:00 Brussels Sports cardiology in practice Symposium Sports Cardiology
08:30 10:00 The Hague Drawing on expertise from nurses and AHPs for cardiovascular prevention Joint Session Rehabilitation & Implementation
08:30 10:00 Ghent Rapid Fire Abstracts II: Diabetes, Nutrition and SES Rapid Fire Abstract Prevention & Epidemiology
08:30 10:00 Utrecht Exercise is Medicine quite some obstacles to overcome! Joint Session Rehabilitation & Implementation
10:00 11:00 Brussels EACPR General Assembly Special Session Other
11:00 12:00 Amsterdam The Fred Epstein Memorial Lecture Symposium Other
11:00 12:00 Brussels Lessons from the past Special Session Prevention & Epidemiology
11:00 12:00 The Hague Lack of individual motivation a killer of cardiovascular prevention Symposium Rehabilitation & Implementation
11:00 12:00 Ghent Exercise intensity revisited Symposium
Exercise & Translational Science
11:00 12:00 Utrecht Research after your PhD: network opportunities Symposium Other
12:15 13:00 Amsterdam Closing Ceremony Special Event Other
Programme at a Glance
Young Investigators Awards Abstracts Symposium Master class How-to-Session Poster Session Rapid Fire Abstract Special Event Joint Sesssion Special Session
*This session is supported by St. Jude Medical in a form of an unrestricted educational grant.
Inaugural Session - Join us!
Thursday 8 May
18:15 - 19:15 Room Amsterdam
Chairpersons: Stephan Gielen and Diederick E. Grobbee
Welcome from the ESC Leadership
Professor Fausto Pinto, ESC President Elect

Welcome to Amsterdam, by Local Host
Professor Diederick E. Grobbee, Local Host

Welcome from the Netherlands Society of Cardiology
Representative of the Netherlands Society of Cardiology

Welcome to Amsterdam
Alderman of the Department of Health, Education and Sport

Scientific programme: what you should not miss
Professor Johan De Sutter, Congress Programme Committee Chairperson

Youre Running out of Runway
Richard Rosendale, Guest Speaker

Welcome from the EACPR President
Associate Professor Stephan Gielen, EACPR President
EACPR General Assembly
Join your Colleagues and meet Association
Representatives: Results of the 2014 - 2016 Executive
Officers elections will be announced !
Saturday 10 May
10:00 11:00 in Room Brussels
EuroPRevent Closing Ceremony
Best Poster Acknowledgements
Saturday 10 May
12:00 13:00 in Room Amsterdam
We will announce the prestigious Young Investigator
Awards, the Best Poster Prizes and the EJPC Highly
cited award. EuroPRevent 2015s new destination and main
theme will be also presented.
1
REGISTRATION
EuroPRevent 2014
Main Entrance
AMSTERDAM
@
EXHIBITION
EXHIBITION
CONGRESS
BAGS
To
Cloakroom
To Level +1
To Level +1
Level +1
Level 0
To Level 0
To Level 0 POSTERS
POSTERS
MEMBERS
LOUNGE
GHENT
BRUSSELS
THE
HAGUE
UTRECHT
To
SPEAKER
SERVICE
CENTRE
Venue Floorplan
2
Table of Contents
Programme at a Glance....................................................................................................................................... Inside front cover
Inaugural Session ................................................................................................................................................................................... 1
EACPR General Assembly ................................................................................................................................................................. 1
Closing Ceremony ................................................................................................................................................................................. 1
Venue Floorplan ...................................................................................................................................................................................... 2
Contents ...................................................................................................................................................................................................... 3
European Association for Cardiovascular Prevention and Rehabilitation (EACPR)
Welcome Address ........................................................................................................................................................................... 4
Committees ......................................................................................................................................................................................... 5
EACPR @EuroPRevent .................................................................................................................................................................. 6
Global Forum on CVD Prevention in Clinical Practice (symposium) ......................................................... 7
Healthy Activities: EACPR joins Jump In ......................................................................................................................... 7
General Information
Amsterdam: Our Host city ........................................................................................................................................................ 8
Congress information .................................................................................................................................................................. 8
Congress hours ................................................................................................................................................................................. 9
European Certifcation ................................................................................................................................................................ 9
Transportation to the Congress Centre .......................................................................................................................... 9
Registration ......................................................................................................................................................................................... 10
Passport/Visa Requirements ................................................................................................................................................... 10
Congress Resources ....................................................................................................................................................................... 11
Healthy activities ............................................................................................................................................................................. 12
Industry at EuroPRevent 2014
TechnoPark - technology changing your practice ................................................................................................. 13
Satellite Symposia ........................................................................................................................................................................... 13
Exhibitors list and foor plan ................................................................................................................................................... 14
Scientifc Programme - Highlights ............................................................................................................................................ 20

Scientifc Programme by day

Thursday 8 May
EACPR Masterclass .......................................................................................................................................................................... 21
Morning Sessions ............................................................................................................................................................................ 23
Afternoon Sessions ........................................................................................................................................................................ 24
Poster Session 1 ................................................................................................................................................................................ 27
Friday 9 May
Lunch Time - Satellite Symposia .......................................................................................................................................... 36
Afternoon Sessions ........................................................................................................................................................................ 37
Poster Session 2 ................................................................................................................................................................................ 40
Poster Session 3 ................................................................................................................................................................................ 46
Saturday 10 May
Closing Ceremony .......................................................................................................................................................................... 54
Poster Session 4 ................................................................................................................................................................................ 55
List of Sessions ......................................................................................................................................................................................... 61
List of Chairpersons and Judges ................................................................................................................................................. 63
List of Speakers ........................................................................................................................................................................................ 64
List of Authors .......................................................................................................................................................................................... 65
3
Welcome Address
Dear Colleagues and Friends,
On behalf of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), we would
like to welcome you to Amsterdam and to EuroPRevent 2014 for a memorable few days of scientifc exchange
and discussion on preventive cardiology.
This year, we are focusing on Global Cardiovascular Health. Cardiovascular disease has long ceased to be
a problem uniquely linked to afuence and Western societies. There are more cardiovascular deaths in India
and China than in all developed countries together. The lessons learned in the West need to be blended with
the specifc cultural, social and etiologic factors that determine the steady rise of metabolic and cardiovascular
disease around the globe. The dynamics of the disease patterns, the parallel persistence of traditional diseases
of poverty, and the enormous impact on societies and health of individuals demand that we join forces to enter
a new era of fght against the burden of cardiovascular disease on an unprecedented scale. Treatment can
never provide a complete answer and prevention is the only solution. As prevention is the passion of those
gathering at the congress, EuroPRevent 2014 will expertly summarise these topics.
Over the next three days, EuroPRevent will bring the fnest international health experts together to present
their research and translate it into usable knowledge for practitioners, health care workers, researchers, and
policy makers. It is also a forum where our industry partners will network with the most infuential policy
makers and prevention experts across the globe. EuroPRevent is a congress that greatly supports young
researchers and is also a place for networking and exchange. Young investigators are selected to present
and compete for the two award sessions, and this year we will be ofering the Amsterdam Young Scientist
Award, a prestigious award generously provided by the city of Amsterdam. The winners will be announced
during the Closing Ceremony on Saturday 10 May from 12:15-13:00 in Room Amsterdam. Please join us to
congratulate our winners.
The programme is rooted in the tradition of the previous editions and will provide ample room for sharing new
research fndings, networking, education and making new friends. As this years meeting will emphasise the
global approaches to prevention, joint sessions focusing on the various existing prevention programmes
and implementation methods are organised with local, European and International Associations.
Thank you for being with us in Amsterdam, enjoy EuroPRevent!
Stephan Gielen
President,
European Association
for Cardiovascular Prevention
and Rehabilitation (EACPR)
Johan De Sutter
Chairperson,
EuroPRevent Congress
Programme Committee
Diederick Grobbee
Local Host & Co-Chairperson,
EuroPRevent Congress
Programme Committee
4
EACPR Executive Board 2012-2014
Stephan Gielen
President
Antonio Pelliccia
President-Elect
Ulf Landmesser
Treasurer
Paul Dendale
Secretary
Pantaleo Giannuzzi
Past-President
Committees
EuroPRevent 2014 Congress Programme Committee
Johan De Sutter
Chairperson
Diederick E. Grobbee
Local Host, Co-Chairperson
Members
Volker Adams
Past Chairperson
Julian Halcox
Bernhard Rauch
Sanjay Sharma
Diego Vanuzzo
Deputy Members
Alessandro Mezzani
Grethe Tell
Heinz Vller
Consultants
Ilonca Vaartjes
Jaap Deckers
Nicole Panhuyzen
Ron Peters
Katherina Schick
Luc Vanhees
5
European Association for Cardiovascular Prevention and Rehabilitation
(EACPR) @ EuroPRevent
The European Association for Cardiovascular Prevention and Rehabilitation (EACPR) is a registered branch
of the European Society of Cardiology (ESC), representing over 4000 health professionals. The EACPR aims at
promoting excellence in research, practice, education and policy in cardiovascular prevention and rehabilitation in
Europe, through the European Journal of Preventive Cardiology (EJPC), EuroPRevent congress, educational events
and professional networking.
EACPR Fast Facts
Membership
Not a member yet? Come and meet us on the ESC-EACPR stand (Exhibition Area, C1),
to join the most efcient and interactive network in preventive cardiology!
Exclusive membership benefts:

Professional development and access to continuous medical education:
Access to EACPR online courses on the ESC e-learning platform
Reduced registration fee to EuroPRevent
Reduced subscription fee to the European Journal of Preventive Cardiology (EJPC)
Contribution to the EACPR community:
Participate in the election of the Association Board
Be eligible to stand for Board and Sections positions
Receive regular, updated news via e-newsletters or topic alerts
Networking opportunities:
Access to members lounge at EuroPRevent
Access to the online membership directory
Access to ESC membership benefts
EACPR at EuroPRevent 2014
Networking opportunities
Creating an interactive prevention network (session)
Thursday 08 May l 11:00-12:30 l Room Utrecht
Research after your PhD: network opportunities (session)
Saturday 10 May - 11:00-12:00 l Room Utrecht
EACPR General Assembly: meet with the Board!
Dont miss the EACPR General Assembly to review the proposed constitution amendments, and fnd out more
about the new EACPR Board : the elections results will be announced at this occasion!
Saturday 10 May l 10:00-11:00 l Room Brussels
EACPR Sports Cardiology Section : open meeting
Meet like-minded colleagues to learn more about the Sections work and plans.
Friday 09 May l 18:00-19:00 l EACPR Meeting Room 2
EACPR Cardiac Rehabilitation Section: open meeting
Share original ideas and projects with the Cardiac Rehabilitation Section.
Friday 09 May l 17:00-18:30 l EACPR Meeting Room 1
Meet with other EACPR members in the members lounge
The EACPR Members Lounge is an exclusive area that permits members to take a break, meet up with colleagues, check
their emails or simply relax. The lounge is located next to the room THE HAGUE (Level 1) on the left hand side.
members
volunteers in the Board, Sections, Committees and Task Forces
National CVD Prevention Coordinators in ESC member countries
Educational Courses per year
E-Learning courses
issues European Journal of Preventive Cardiology issues per year
+4000
+70
59
4
8
12
J
o
in
u
s
!
6
Visit ESC - EACPR
stand C1
Global Forum on CVD Prevention in Clinical Practice (symposium)
Friday 09 May from 11:00 to 12:30 in Room Amsterdam
The United Nations and the World Health Organization have agreed to take concerted action
to reduce mortality from non-communicable diseases by 25% by 2025. In this context,
EACPR is organising the third Global Forum for Cardiovascular Disease Prevention in Clinical
Practice, to unite the voices of regional and national professional societies for cardiovascular
prevention and rehabilitation.
Chairpersons: Stephan Gielen and Shanthi Mendis
Speakers: Shanthi Mendis, Stephan Gielen, Joep Perk, Ian Graham, Lars Ryden
Did you know?
A one-year online subscription to the European Journal of Preventive Cardiology is included in the Congress
registration fee! (Standard registration fee & EACPR members only)
ESC - EACPR stand
Visit our stand to get more information on ESC and EACPR products and services, join EACPR, test your knowledge
with our CVD Prevention Tools, and get a free Health Professional Toolkit!
Learn more about EACPR
or www.escardio.org/EACPR
Healthy Activities: EACPR joins Jump In
Each year, EuroPRevent and the EACPR promote prevention through action with Thai Chi programmes, Bike
Paths, Fun Run & Fun Walks and more... Sometimes you might wonder why? Cardiovascular disease awareness and
prevention is an absolute must. The message of better and healthier lifestyle starts with the public and all partners
from policy makers to medical practitioners.
During EuroPRevent, EACPR is joining forces with Jump In, an initiative of the Department of Social Development
and Health Service of Amsterdam. The aim of the programme is to fght future obesity in primary school children
(ages 6-12) by monitoring and testing children, proposing sports and healthy food at school and informing and
educating the parents.
On Thursday 8 May, a half day will be devoted to the event in one of Amsterdams primary schools. EACPR
Leadership and City Representatives will be present to talk about the benefts of eating right, sports and healthy
lifestyles. The message will not just be for the children - it will also be for parents and teachers, because a lot of the
education starts at home and in class! Children will take part in sports classes, educational activities and a theatre
show. In addition, healthy breaks consisting of fresh fruits and water will be provided to demonstrate healthy eating.
7
Amsterdam: Our Host City
Our host is the beautiful city of Amsterdam, one of the greatest cities in the world. From its canals to world-
famous museums and historical sites, Amsterdam is one of the most romantic and beautiful cities in Europe.
Its cosy, progressive and much more of a cosmopolitan village than a busy city. Its also a magnet for
contemporary artists, thinkers and entrepreneurs, and a popular location for international festivals and
conventions.
Our two YIA winners of the prestigious Amsterdam Young Scientist Award will be provided with a stipend of
2 500 Euros for continued medical studies. Join us on Saturday 10 May at 12:15 in Room Amsterdam during the
Closing Ceremony to discover our winners!
Exchange of knowledge and interaction plays a key role in the promotion of scientifc talent in addition to
excellent facilities; this can lead to remarkable results. The Municipal Authorities of Amsterdam and their
destination partners created this grant in order to aide in the development of young talent within a scientifc
discipline.
The EACPR is very thankful to the city of Amsterdam for this generous grant.
Congress information
Dutch Regulation and Allied Health Professionals
Due to the European Medicine Directive 2001/83 (art91), only persons who are
qualifed to prescribe or supply prescription medicines are allowed to access the
commercial exhibition of EuroPRevent 2014. In respect to this directive, all local Allied
Health Professionals with grey EuroPRevent 2014 congress badges should follow the
signs indicated onsite to access the lecture rooms, poster area, congress bag area and other areas used for the
congress. These signs are located at the entrance way of Building G of the RAI Congress Centre.
Venue
Amsterdam RAI
Europaplein 22 - NL 1078 GZ
P.O. Box 77777 - NL 1070 MS Amsterdam
Tel: +31 (0) 20 549 12 12 The building is fully accessible to disabled people.

Organiser
EuroPRevent 2014 Secretariat
European Society of Cardiology
2035, Route des Colles - Les Templiers - CS 80179 Biot
06903 Sophia Antipolis Cedex - France
Tel: +33 (0)4 92 94 76 00 Fax: +33 (0)4 92 94 76 01
Email: europrevent@escardio.org
Web Site: www.escardio.org/EuroPRevent
EuroPRevent 2014 is only accessible to certifed healthcare professionals,
associated press, industry representatives and other stakeholders in the science,
management and prevention of cardiovascular disease.
By registering, you accept that non-heathcare professionals, including children,
will not be able to access the congress area.
8
ALLIED
HEALTHCARE
PROFESSIONALS
Congress hours Wednesday 7 May Thursday 8 May Friday 9 May Saturday 10 May
Registration 15:00 18:00 07:30 18:00 07:30 18:00 07:30 13:00
Speaker Service Centre 15:00 18:00 07:30 18:00 07:30 18:00 07:30 12:00
Scientifc Programme Closed 08:30 19:30 08:30 18:00 08:30 13:00
Exhibition Closed 09:00 20:00 09:00 18:00 09:00 12:00
European Certifcation
EuroPRevent 2014 is accredited by the European Board for Accreditation in Cardiology (EBAC) for
16 hours of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational
activity. EBAC works according to the quality standards of the European Accreditation Council for
Continuing Medical Education (EACCME), which is an institution of the European Union of Medical
Specialists (UEMS).
If you are a delegate attending from North America, please fnd information concerning how to validate your European
CME credits on the American Medical Association (AMA) Web Site: www.ama-assn.org
Certifcates of Attendance upon presentation of your congress badge will be available from any Badge Printing
Desk as from Friday 9 May.
Transportation to the Congress Centre
From Amsterdam Airport
The EuroPRevent 2014 venue (Amsterdam RAI) is located 15 km north of Schiphol International Airport.
Taking the train is probably your best, most cost efcient and the easiest option. There is one train
approximately every 15 minutes connecting Schiphol Airport and Amsterdam RAI station. The journey time
from the RAI station to the Congress Centre is around 10 minutes.
Journey fare: 3.70 each way for second class fare.
Journey time: 20 minutes
By bus: bus lines operate from early in the morning until late in the evening. Some lines also include a night service.
Journey fare: 4.00
From the city centre
The EuroPRevent 2014 venue (Amsterdam RAI) is located 6 km south of Amsterdam Central Station.
The local transport network of buses, trams, metros and ferries in Amsterdam is efcient, modern, reliable
and inexpensive.
Taxi: Stations are located throughout the city.
Journey fare: around 33 from Amsterdam Central station to the RAI station
By train: Metro and Trams (N4) run from the city centre to the RAI station
Journey time: around 15 minutes from Amsterdam city centre.
The journey time from the RAI station to the Congress Centre
is around 10 minutes.
9
Registration
Not registered yet?
Secure your participation now,
Register before Wednesday 10 April at www.escardio.org
After 2 May, registration will be processed on-site
Congress badges: where should I go?
You received your badge voucher by email: print your badge at the Badge Printing desk by scanning
your voucher and pick up your materials at the Congress bag desk
You received your Congress badge at home by mail and you brought it with you: pick up your material
at the Congress bag desk
You received your Congress badge at home but lost it: go to the Registration Assistance Desk
Or you can also go directly to the New Registration desks and register on the left in the main entrance
You are a Dutch Allied Health Professional with a grey badge, and have questions, please go to
the Registration Assistance Desk
Your personal Congress badge is your passport to the scientifc sessions and exhibition.
Please wear your congress badge visibly at all times. Security guards can ask you to make your badge more
visible. The second part of your badge is required to pick up your congress bag.
What colour is your badge?
White Delegate
Green Exhibitor
Grey Dutch Allied Health Professionals
Red ESC Board
Yellow Staf
When should I go to the lecture rooms?
We recommend you go to the lecture room well before the session begins.
Due to safety regulations, we are required to close the access to the session if the room flls to capacity.
If you have been contacted by the ESC Staf during the pre-congress registration period or if you are an onsite
registrant, kindly note that you must follow the indicated path to access all space used for EuroPRevent 2014
except the commercial exhibition area. In respect of the European Medicine Directive 2001/83 (art91), only
persons who are qualifed to prescribe or supply prescription medicines are allowed to access the commercial
exhibition of EuroPRevent 2014.
All signage indicates where you can obtain your congress materials, visit the posters,
attend the sessions and drop your personal belongings of at the cloakroom (Level 1).
We ask that you respect these procedures onsite.
Passport/Visa Requirements
Passports are required by all visitors to The Netherlands, except for citizens of EU countries, Switzerland and Monaco,
who may enter with a National Identity Card.
10
ALLIED
HEALTHCARE
PROFESSIONALS
Create your personal itinerary
Make your own to do list and take notes
Share with colleagues
Receive the latest news features
Search for EuroPRevent2014 in App Store/Android Market
Friday 9 May
10:00 - 11:00 and 15:30 - 16:30
Congress News will be also available online!
Congress Resources
11
NEW this year! Download the mobile app to Ask your questions and Vote during the Mobile App Interactive
Sessions! See page 20 for more details
Abstracts Online
All accepted abstracts of EuroPRevent 2014, are available for review online. Please use one of the free Internet
Corners located in the Exhibition Area or access them via the Mobile App. The abstracts will be additionally online
for consultation one week before the congress.
Congress News
Your free daily newspaper of EuroPRevent 2014!
Pick it up at the congress venue and get the key scientifc highlights of the day:
Onsite reports from the previous day
Photographs from key events
Useful information
EACPR Members Lounge
The EACPR Member Lounge is an exclusive area that permits members to take a break, meet up with colleagues,
check their mails or simply have a cup of cofee during the healthy breaks. The lounge is located next to the Poster
Area on the right hand side, it will be indicated with signage.
ESC Homepage and My ESC News
Updated frequently, it provides you with the coverage of the newspaper and the live reports
written by opinion leaders. Catch up on the sessions you did not manage to attend during the Congress and check
out scientifc highlights after the ESC Congress.
EuroPRevent 2014 Mobile application:
Make the most of EuroPRevent 2014 at your fngertips!
View the entire scientifc programme
Search for sessions, presentations, abstracts
Find exhibitors and sponsors
Navigate the foor plan
Healthy Breaks
Go on, give yourself a break! During the breaks, meet colleagues, visit exhibitors and review the posters.
3 Healthy breaks will be held during EuroPRevent 2014.
Thursday 8 May
15:30 - 16:30
Internet Corner
The Internet Corner located in the Exhibition Area is free of charge. The venue has free Wi-Fi.
Login: RAI_EACPR - Password: europrevent
Journal
Participants paying the Standard and EACPR Member fee will receive the 2015 online subscription to the European
Journal of Preventive Cardiology.
Poster Area
Consult all the posters presentation accepted for the Congress in traditional display.
Speaker Service Centre
All speakers giving a presentation in the scientifc sessions are requested to upload and validate their presentation
in the Speaker Service Centre (SSC) a minimum of 3 hours before the session starts or the day before if the session
is at 08:30. The SSC is located on Level 1 in the corridor after the lecture Room Utrecht.
SPP (Scientifc Programme Planner)
The online version of the Scientifc Programme allows you to prepare your Congress attendance and to review
abstracts online. Search the programme by topic, session or presenter.
Healthy Activities
EuroPRevent Healthy Activities Why we provide them
Throughout the years, we have tried to choose venues that can ofer our delegates healthy activities, please see
a sample of what we have done in the past:
EuroPRevent 2009 - Stockholm, Sweden: Fun Walk and Run with an entertaining early morning warm up
EuroPRevent 2010 - Prague, Czech Republic: Fun Walk and Run
EuroPRevent 2011 - Geneva, Switzerland: Pedal for your Heart, Prevention Bus and Fun Run and Walk
EuroPRevent 2012 - Dublin, Ireland : Pedal for your Heart, the Path to Health (Slai na Slainte) walking route and
a Thai Chi session
EuroPRevent 2013 - Rome, Italy: an original presentation from Magnus Scheving, CEO of Lazytown about better
health and lifestyle approaches for families and the availability of running and walking paths at the Eucalypti
Park near the congress centre
This year we only had to look as far as the RAI because a park and
adequate running or walking path already exists! During your free
time or at the end of the day when you are leaving the congress
centre, please feel free to stroll through this beautiful park.
If you dont feel like walking, ride a bike! Biking in Amsterdam is a quintessentially Dutch experience and
by far the most popular (and most efcient) form of getting around. Bike paths connect the entire country
and cyclists are well respected on the roads, making cycling an efcient as well as healthy and environmentally
friendly way to get around.
The RAI Park
12
Industry at EuroPRevent 2014
Industry Partners
Over the last years, EuroPRevent has evolved into the preeminent meeting place for European opinion leaders and
physicians in the feld of cardiovascular prevention, rehabilitation and sports medicine.
Cardiovascular diseases are still the major cause of morbidity and mortality in Europe.
In a time of shrinking healthcare budgets, prevention of cardiovascular diseases has become a top priority of the
European Union as indicated by the signing of the European Heart Health Charter in 2007.
The Committee Members wish to express their sincere appreciation to all exhibitors, industry partners and sponsors
mentioned below, who have contributed to the success of EuroPRevent 2014 in a variety of ways.
AstraZeneca
Bayer B.V.
COSMED
diaDexus
DiagnOptics Technologies B.V.
Esaote
Fukuda Denshi
Hitachi Medical Systems Europe Holding Ag
TechnoPark technology changing your practice
Devices and technical equipment have an increasingly important role to play in the feld of
cardiovascular prevention. Our industry partners are innovators in the development of new
equipment, monitors and devices, vital to the improvement of patient care.
Technological innovations will therefore have a special focus at EuroPRevent 2014 with all
companies working as innovators in the feld participating in a TechnoPark initiative.
We invite all EuroPRevent 2014 delegates to visit sponsors of the TechnoPark during the
Congress for a unique opportunity for hands-on demonstration of new devices and techniques.
The TechnoPark is an integrated part of the exhibition at EuroPRevent 2014 and sponsors will be distinguished by
the logo.
Satellite Symposia
Cooperation between clinicians, researchers and the pharmaceutical and technical industries has signifcantly
contributed to a better understanding and management of patients with cardiovascular diseases.
Delegates are cordially invited to attend the Satellite Symposia organised during EuroPRevent 2014:
Friday 9 May, 12:45 - 13:45
From risk control to heart failure management
Sponsored by SERVIER in Room Brussels
2
(Lp-PLA
2
) testing in risk management of
cardiovascular disease events
Sponsored by diaDexus Inc. in Room Ghent
Sponsored by AstraZeneca in Room The Hague
HUR Health & Fitness equipment
Russian National Society for Preventive Cardiology
SAGE
SERVIER
St Jude Medical
The Japanese Association of Cardiac Rehabilitation
TILMAN sa
Wisepress Medical Bookshop

T
e
c
h
n
oP
a
r
k
13
REGISTRATION
Main Entrance
AMSTERDAM
@
CONGRESS
BAGS
A6
A5
C8
C11
C7
A4
A3 A2
A1
C4
D2
D3
C3
C2
ESC
&
EACPR
C1
D1
Publishers Row
T
T
T
European Association for Cardiovascular Prevention and Rehabilitation
EACPR
C1
To Registration Area
& Main Entrance
To Registration Area
& Main Entrance
To Cloakroom
To Level +1
To Level +1
Exhibitors List
AstraZeneca C3
Bayer B.V. A5
COSMED A4
diaDexus A3
DiagnOptics Technologies B.V. A6
Esaote C2
European Society of Cardiology C1
European Association for Cardiovascular Prevention and Rehabilitation C1
Fukuda Denshi C7
Hitachi Medical Systems Europe Holding Ag A1
HUR Health & Fitness equipment C11
Russian National Society for Preventive Cardiology C8
SAGE D2
SERVIER C4
The Japanese Association of Cardiac Rehabilitation D3
TILMAN sa A2
Wisepress Medical Bookshop D1
Exhibition
Opening Hours
Thursday 8 May
09:00 - 20:00
Friday 9 May
09:00 - 18:00
Saturday 10 May
09:00 - 12:00
Find out more
about TechnoPark
on page 13

T
e
c
h
noPa
r
k
14
Exhibitors Description
European Society of Cardiology /
European Association for Cardiovascular Prevention and Rehabilitation C1
2035 Route des Colles
Les Templiers - CS 80179 BIOT
06903 Sophia Antipolis Cedex
France
Tel: +33 4 92 94 76 00
Fax: +33 4 92 94 86 69
Email: communications@escardio.org
Web Site: www.escardio.org
The European Society of Cardiology (ESC)
The European Society of Cardiology (or the ESC) represents over 80 000 cardiology professionals from across Europe
and the Mediterranean. The ESC comprises 56 National Cardiac Societies, 16 Working Groups, 6 Associations and 4
Councils. It also includes the distinguished community of ESC Fellows and Nurse Fellows. To fulfl its mission of reducing
the burden of cardiovascular disease in Europe, the ESC provides an array of scientifc and educational activities, such
as the production and continuous updating of Clinical Practice Guidelines, the organisation of educational courses and
initiatives, pan-European surveys on specifc disease areas and the annual ESC Congress, the largest medical meeting in
the world held this year from 30 August-3 September 2013 in Barcelona, Spain .The ESC is proud to hold, in conjunction
with its constituent bodies, several sub-specialty congresses, which are becoming increasingly popular within the
profession. These are Acute Cardiac Care, EHRA EUROPACE, EuroEcho-Imaging, EuroHeartCare, EuroPRevent, Frontiers
of CardioVascular Biology (FCVB), Heart Failure, and International Conference of Nuclear Cardiology (ICNC).
About EACPR
The European Association for Cardiovascular Prevention and Rehabilitation (EACPR) is a registered branch of the European
Society of Cardiology (ESC), representing over 4000 health professionals. The EACPR aims at promoting excellence in
research, practice, education and policy in cardiovascular prevention and rehabilitation in Europe, through the European
Journal of Preventive Cardiology (EJPC), EuroPRevent congress, educational events and professional networking.
________________________________________________________________________________________
AstraZeneca C3
Rue Egide Van ophem 110
1180 Uccle (Brussels)
Belgium
Tel: +32 479 508 164
Email: tim.dejaegere@astrazeneca.com
Web Site: www.astrazeneca.com
AstraZeneca is a global innovation-driven biopharmaceutical company specialising in the discovery, development,
manufacturing and marketing of prescription medicines that make a meaningful diference in healthcare.
BRILIQUE, co-administered with acetylsalicylic acid, is indicated for the prevention of atherothrombotic events in
adult patients with Acute Coronary Syndromes (unstable angina, non ST elevation Myocardial Infarction (NSTEMI) or
ST elevation Myocardial Infarction (STEMI).
Bayer B.V. A5
Bayer HealthCare, Science for a better life
3641 RT Mijdrecht
The Netherlands
Tel: +31 297 280 449
Fax: +31 297 280 415
Email: remco.maaskant@bayer.com
Web Site: www.bayer.com
Bayer aims to improve peoples quality of life with our products. To achieve this, we concentrate on the research and
development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving
established products. Bayer HealthCare Pharmaceuticals uses the experience it has gained from over a century in the
business.
15
COSMED A4
Via dei Piani di Monte Savello, 37
00041 Albano Laziale (Rome)
Italy
Tel: +39 069 315 492
Fax: +39 069 314 580
Email: info@cosmed.com
Web Site: www.cosmed.com
COSMED is a leading manufacturer of cardiopulmonary solutions for the assessment of exercise capacity in healthy
subjects or clinical population (cardiovascular diseases, pre-op assessment, cardiac rehabilitation).
COSMED solutions include: fully-featured metabolic carts, desktop CPET solutions, full-disclosure stress PC-ECGs,
advanced 6MWT, spirometers and an extensive range of ergometers for clinical applications.
diaDexus A3
349 Oyster Point Blvd.
San Francisco, CA 94080
United States of America
Tel: +1 650 246 6524
Fax: +1 650 246 6503
Email: ajansen@diadexus.com
Web Site: www.plactest.com
diaDexus, Inc., based in South San Francisco California, USA develops and commercializes proprietary cardiovascular
diagnostic products addressing unmet needs in cardiovascular disease. The diaDexus PLAC Test is a simple blood test
that measures Lp-PLA
2
, a vascular-specifc infammatory marker critical in the formation of rupture-prone plaque. Visit
www.plactest.com for more information.
DiagnOptics Technologies B.V. A6
Aarhusweg 4-9
9723 JJ Groningen
The Netherlands
Tel: +31 505 890 612
Fax: +31 505 890 613
Email: r.heikens@diagnoptics.com
Web Site: www.diagnoptics.com
DiagnOptics develops and markets a non-invasive diagnostic technology, which can assess the tissue accumulation of
AGEs. Recently we introduced AGE Reader mu, a non-invasive test to identify people at risk for (pre)diabetes without
overnight fasting, blood being drawn, or waiting hours for lab results. The detection is superior to FPG and at least as
good as HbA1c.
Esaote C2
Via di Caciolle 15
50127 Florence
Italy
Tel: +39 055 422 91
Fax: +39 055 422 9208
Email: international.sales@esaote.com
Web Site: www.esaote.com
Esaote is internationally recognized as one of the worlds leading diagnostic imaging companies. Esaote product
portfolio includes a wide range of clinical solutions from prevention to therapy for evaluating cardiovascular diseases
providing complete reports and early staging. Come to the Esaote stand to get to know our innovative ultrasound
solutions for cardiovascular imaging and preventative medicine.

T
e
c
h
noP
a
r
k
16
Fukuda Denshi C7
13 Westminster Court
Hipley Street, Surrey
GU22 9LG Old Woking
United Kingdom
Tel: +44 148 372 8065
Fax: +44 148 372 8066
Email: info@fukuda.co.uk
Web Site: www.fukuda.co.uk
Fukuda Denshi are one of Japans most successful medical device manufacturers with over 75 years experience in the
feld. The VaSera machine measures arterial stifness using the novel CAVI index and is trusted by over 12,000 sites
across the world for assessing the risk of cardiovascular disease.
Hitachi Medical Systems Europe Holding Ag A1
Sumpfstrasse 13
6300 Zug
Switzerland
Tel: +41 417 486 333
Fax: +41 417 486 332
Email: welcome@hitachi-medical-systems.com
Web Site: www.hitachi-medical-systems.com
Increase your expectation of life
Innovative Technologies for Prevention
Highly specialized analysis capabilities for early detection of atherosclerosis and global analysis of the cardiovascular
system including:
Evaluation of arterial stifness
Wave Intensity & Flow Mediated Dilatation
Evaluation of thickening of the vessel wall
We welcome you at Booth A1 to experience our innovative technologies
HUR Health & Fitness equipment C11
Patamentie 4
67100 Kokkola
Finland
Tel: +358 683 255 00
Email: sales@hur.f
Web Site: www.hur.f/en
HUR Health and Fitness Equipment, the technology leader with 20 years of experience in strength training equipment
for rehabilitation, active ageing and ftness. HUR equipment provide safe and efective exercise for people of all ages
and abilities.
Russian National Society for Preventive Cardiology C8
10, Petroverigski per.
101990 Moscow
Russian Federation
Tel: +7 499 553 6932
Fax: +7 499 553 6932
Email: cardioprevent@gnicpm.ru
Web Site: www.cardioprevent.ru
The Russian National Society for Preventive Medicine has been established in 2007 (before 2013 - the Russian National
Society for Cardiovascular Prevention and Rehabilitation). The Society put forward the initiative of development of the
frst Russian National Guidelines on CVD Prevention. Under the aegis of the Society a big number of large-scale studies
(international as well) have been conducted. The annual conferences of the Society with international participation
have been held since 2008. The Society is working closely with the European Society for Cardiovascular Prevention and
Rehabilitation.

T
e
c
h
noP
a
r
k

T
e
c
h
noP
a
r
k
17
SAGE D2
1 Olivers Yard
55 City Road
EC1Y 1SP London
United Kingdom
Tel: +44 (0)207 324 8500
Fax: +44 (0)207 324 8600
Email: market@sagepub.co.uk
Web Site: www.sagepub.co.uk
SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional
markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and
students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology and
medicine. An independent company, SAGE has principal ofces in Los Angeles, London, New Delhi, Singapore and Washington
DC. www.sagepub.co.uk.
SERVIER C4
50 rue Carnot
92284 Suresnes Cedex
France
Tel: +33 55 72 73 43
Fax: +33 55 72 58 77
Email: sophie.nisse-durgeat@fr.netgrs.com
Web Site: www.servier.fr
Servier is involved in research and development, and the manufacture and marketing of ethical pharmaceuticals. It is a private,
independent pharmaceutical company, led by its founder Dr Jacques Servier.
Cardiovascular diseases represent the most important therapeutic area for Servier, which has developed various drugs for the
treatment of hypertension, heart failure, and cardiac ischemia, such as Procoralan (ivabradine), Coversyl (perindopril), Natrilix
SR (indapamide), and Vastarel MR (trimetazidine), as well as fxed-combination antihypertensives such as Preterax (perindopril/
indapamide) and Coveram (perindopril/amlodipine).
Procoralan (ivabradine), the frst If inhibitor, is indicated for heart failure and the symptomatic treatment of chronic stable angina.
Procoralan is included in the 2012 ESC guidelines for the management of heart failure and also in the new guidelines for stable
coronary artery disease.
The Japanese Association of Cardiac Rehabilitation D3
2-23-1-260 Yoyogi, Shibuya-ku
1530053 Tokyo
Japan
Tel: +81 363 007 977
Fax: +81 363 007 966
Email: jacr-master@umin.ac.jp
Web Site: square.umin.ac.jp/jacr/en/index.html
The JACR aims to promote implementation of cardiac rehabilitation and to improve its quality as an advanced cardiovascular
therapy. JACR will also promote mutual collaboration with related organizations both in Japan and overseas, and will distribute
information and make recommendations on cardiac rehabilitation to the citizens, professionals and general public.
18
TILMAN sa A2
Zoning Industriel Sud 15
5377 Baillonville
Belgium
Tel: +32 843 203 41
Fax: +32 843 203 75
Email: ed@tilman.be
Web Site: www.cholesfytol.be
Cholesfytol, an innovative product to control cholesterol nevel.
Cholesfytol has a unique composition: the dosages in monacolin K 10 mg (80% hydroxy-acid form) and in hydroxytyrosol 5
mg correspond to the recommendations of EFSA. Cholesfytol helps to control the cholesterol level with fewer adverse efects.
Cholesfytol is a great alternative in frst intention but also for the intolerants to statins.
Cholesfytol is produced by Tilman - the belgian specialist of phytotherapy.
Wisepress Medical Bookshop D1
25 High Path
Merton Abbey
SW19 2JL London
United Kingdom
Tel: +44 208 715 181
Fax: +44 208 715 172
Email: bookshop@wisepress.com
Web Site: www.wisepress.com
Wisepress are Europes principal conference bookseller. We exhibit the leading books, sample journals and digital content
relevant to this meeting. Books may be purchased at the booth, and we ofer a postal service. Visit our online bookshop for
special ofers and follow us on Twitter for the latest news @WisepressBooks.
19
Highlight on the Scientifc Programme
At the heart of every congress is the scientifc programme, the main reason why people get together to meet, exchange
ideas and learn. This years theme is Global Cardiovascular Health and will emphasise the global approaches to
prevention all the while reminding us that we need to join forces to enter a new era of fght against the burden of
cardiovascular disease because treatment can never provide a complete answer and prevention is the only solution.
NEW! Two Educational EACPR Master Class Sessions on Thursday 8 May, one being dedicated to scientifc methods
for conducting studies in preventive cardiology and the second relating to hypertension.
Innovation in Design and interpretation of Research: These four subsequent sessions will be held in held in
Room The Hague and are organised with the aim to provide researchers/physicians with innovative information about
research design and appropriate interpretation of research
Hypertension: These two subsequent sessions will be held in Room Brussels and will review the pieces of novelty in
the 2013 ESH-ESC Guidelines on Hypertension and the treatment of hypertension in specifc clinical conditions
NEW! Special tracks for general practitioners geared towards Benelux residents and general attendees, nurses and
cardiologists in training, focusing on diabetes, telemonitoring, hypertension and renal denervation.
NEW! The integration of a selection of abstracts into the ofcial scientifc content.
Look for the special logo in the programme, it will indicate that the presentation is an accepted abstract.
NEW! Dr Bernd Hewing and Dr Kentaro Kamiya, winners from last years YIA Sessions will be chairing this years YIA
sessions! The EACPR puts great emphasis on presentations by young investigators as they are the future of the feld. This
is just one more additional way of supporting young PhDs, peers and researchers from all continents. Dont miss the
YIA sessions, see pages 37 and 39.
NEW! Download the EuroPRevent 2014 Mobile Application to Ask your questions and Vote during the Mobile App
Interactive Sessions! More faculty interaction and exchange! The sessions will both be held on Friday 9 May in Room
Brussels, see the below details.
HDL: Still important in cardiovascular prevention? 08:30 to 10:00
How to detect early cardiovascular disease? Options and pitfalls of diferent methods. 14:00 to 15:30
DONT MISS:
EACPR Masterclass on Hypertension - see page 21
EACPR Masterclass on Innovation in design and interpretation of research - see page 22
The Global Forum on CVD Prevention in Clinical Practice! See page 34
The Global Track - see pages 33, 34 and 37
The Fred Epstein Memorial Lecture - see page 53
Our Joint sessions with our Local, European and International Partners in Prevention
A special session dedicated to the Heart - Lung Interaction in Preventive Cardiology with a special
presentation by Dr. G Bothius, Associate Professor and Chairman of the European Heart Network (EHN)
Tobacco Expert Group - see page 38
A Special Joint Session with the Japanese Society of Cardiac Rehabilitation - see page 39
An innovative presentation on the Horus Study in the session entitled Lessons from the Past - see page 53
20
Special logo joint session
Thursday 8 May
EUROPR E VE NT 2014 - FI NAL PROGR AMME
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
EACPR MASTERCLASS EDUCATIONAL COURSE - HYPERTENSION BRUSSELS
08:30 - 10:00
This interactive EACPR Masterclass will review the pieces of novelty in the 2013 ESH-ESC Guidelines on Hypertension including the
diagnosis of hypertension, search for organ damage, and total cardiovascular risk assessment; principles of treatment of hypertension
including anti-platelet and lipid-lowering drugs will be presented.
The second session of the Masterclass in Hypertension will focus on treatment of hypertension in specic clinical conditions.
2013 ESH/ESC Guidelines on Hypertension
EACPR Masterclass Educational Course - Hypertension
Chairpersons: G. Mancia (Milan, IT); T. Kahan (Stockholm, SE)
08:30 Diagnosis of hypertension: ofce blood pressure or out-of-ofce blood pressure? 1
G. Parati (Milan, IT)
08:52 Diagnosis of hypertension: organ damage and total cardiovascular risk. 2
K.L. Christensen (Hojbjerg, DK)
09:15 General treatment recommendations. 3
G. Mancia (Milan, IT)
09:37 Antiplatelet and lipid-lowering drugs in hypertension. 4
R. Cifkova (Prague, CZ)
11:00 - 12:30
This Masterclass in Hypertension will focus on treatment of hypertension in specic clinical conditions.
At the end of this session, the participants will be able to:
Know the principles of treatment of hypertension in diabetes, chronic kidney disease, atrial brillation, and heart failure.
Learn the goal blood pressure in diabetes and chronic kidney disease.
Learn the principles of anti-coagulation in atrial brillation.
Learn the principles of heart failure management in patients with hypertension.
Whats new in hypertension: treatment in specic clinical conditions
EACPR Masterclass Educational Course - Hypertension
Chairpersons: D. Lovic (Nis, RS); J. Brguljan (Ljubljana, SI)
11:00 Diabetes. 14
P.M. Nilsson (Dalby, SE)
11:22 Chronic kidney disease. 15
G. Wuerzner (Lausanne, CH)
11:45 Atrial brillation. 16
S.E. Kjeldsen (Oslo, NO)
12:07 Heart failure. 17
T. Kahan (Stockholm, SE)

21
Thursday 8 May
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
EACPR MASTERCLASS EDUCATIONAL COURSE - INNOVATION IN DESIGN AND INTERPRETATION OF RESEARCH THE HAGUE
These four subsequent sessions will be held in held in Room The Hague and are organised with the aim to provide researchers/
physicians with innovative information about research design and appropriate interpretation of research.
Epidemiology is a scientic discipline increasingly asked for in clinical research, industry and policy making.
With evidence based medicine setting new standards, specialists are needed in design, data collection, analysis and interpretation
of epidemiological and health research. In this Educational Master Class Course we will offer a high level of education and the most
updated information. Each session is comprised of an introductory lecture and an interactive discussion of worked out examples.
The EACPR Masterclass has been organised by the EACPRs Epidemiology Section and is sponsored by MSc-Epidemiology EU.
Participants are expected to have basic epidemiological knowledge.
08:30 - 10:00
Innovation in design and interpretation of research: study design
08:30 Study design 5
C.S. Uiterwaal (Utrecht, NL); O.H. Franco Duran (Rotterdam, NL)
11:00 - 12:30
Innovation in design and interpretation of research: Clinical trials
11:00 Clinical trials 18
R. Groenwold (Utrecht, NL); J.C. Jacobsen (Copenhagen, DK)
14:00 - 15:30
Innovation in design and interpretation of research: Meta-analysis
14:00 Meta-analysis 40
J.B. Reitsma (Utrecht, NL); R. Chowdhury (Cambridge, GB)
16:30 - 18:00
Innovation in design and interpretation of research: Prediction research
16:30 Prediction research. 61
K.G.M. Moons (Utrecht, NL); M. Kavousi (Rotterdam, NL)
22
Thursday 8 May - Morning
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
08:30 - 10:00 HOW-TO SESSION GHENT
How to practice sports cardiology
Chairpersons: S. Sharma (London, GB); F. van Buuren (Bad Oeynhausen, DE)
08:30 How to assess a young athlete with echocardiography. 6
N. Sheikh (London, GB)
08:48 How to interpret an exercise stress test in an athlete? 7
H.K. Rasmusen (Copenhagen, DK)
09:06 How should we set up a registry for sudden cardiac death in athletes? 8
E.E. Solberg (Oslo, NO)
09:24 Preventing sudden cardiac death in the young: Results from a population-based screening programme in the UK. 9
R. Narain, H. Dhutia, A. Merghani, J. Myers, A. Malhotra, L. Millar, N. Sheikh, S. Sharma, M. Papadakis (London, GB)
09:42 Negative predictive inuence of higher blood pressure on functional aerobic capacity in professional male athletes. 10
M. Zdravkovic, S. Mazic, M. Djelic, M. Antic, I. Nedeljkovic, M. Dekleva, T. Acimovic (Belgrade, RS)
11:00 - 12:30 SYMPOSIUM AMSTERDAM
Management of cardiovascular risk in non-cardiac surgery
Chairpersons: D.E. Grobbee (Utrecht, NL); H.M. Nathoe (Soest, NL)
Recent research showed that non-cardiac surgery is a major stress test for the heart. The risk of perioperative myocardial injury in adult patients
varies from 15% to 30%. This symposium will highlight the current controversies in the management of patients undergoing non-cardiac surgery.
11:00 Is there a role for beta-blockers in the prevention of peri-operative cardiovascular events? 11
S. Beattie (Toronto, CA)
11:30 New endovascular techniques for aortic aneurysm repair with potential benets in high risk patients. 12
J. Van Herwaarden (Utrecht, NL)
12:00 Post-operative management of patients with myocardial injury. 13
H.M. Nathoe (Soest, NL)
11:00 - 12:30 HOW-TO SESSION GHENT
How to train heart failure patients with cardiac devices?
What should we know about the effect of devices to exercise?
Chairpersons: M.F. Piepoli (Piacenza, IT); W. Benzer (Feldkirch, AT)
11:00 Ventricular assist devices. 19
M. Pistono (Veruno, IT)
11:18 Cardiac resynchronisation therapy, cardiac resynchronisation therapy-drop. 20
M.F. Piepoli (Piacenza, IT)
11:36 Cardiac contractility modulation. 21
F. Giallauria (Naples, IT)
11:54 Cardiac contractility modulation effects on exercise capacity and quality of life: meta-analysis of randomised controlled trials. 22
F. Giallauria, C. Vigorito, M.F. Piepoli, A.J.S. Coats (Naples and Piacenza, IT; Melbourne, AU)
12:12 Exercise based cardiac rehabilitation in end stage chronic heart failure patients after axial-ow left ventricular assist
device implantation: a single centre experience. 23
N. Russo, L. Compostella, T. Setzu, V. Tursi, T. Bottio, A. Loforte, G. Sani, U. Livi, G. Gerosa, F. Bellotto (Padua,
Cortina D'ampezzo, Udine, Bologna and Siena, IT)
11:00 - 12:30 SYMPOSIUM UTRECHT
The Country of the Month project: creating an interactive prevention network
Chairpersons: A. Abreu (Lisbon, PT); L. Tokgozoglu (Ankara, TR)
Modelling an overview of cardiovascular prevention in Europe
11:00 Introduction to the Country of the Month Project. 24
J. Perk (Oskarshamn, SE)
11:05 Structure of health care and risk factor statistics: what are the core components? 25
H. Gohlke (Ballrechten-Dottingen, DE); S. Jennings (Dublin, IE)
11:25 Prevention and rehabilitation methods, how can models be compared? 26
M. Viigimaa (Tallinn, EE); A. Kiessling (Stockholm, SE)
11:45 Main prevention activities: learning from campaigns and educational efforts. 27
K. Andersen (Reykjavik, IS); D. Ural (Kocaeli, TR)
12:05 Plans for the future: the country of the month, a support for national prevention coordinators. 28
Y. Henkin (Beer-Sheva, IL); R. Kraaijenhagen (Amstelveen, NL)
12:25 Summary of the country of the month project. 29
I.M. Graham (Dublin, IE)
23
Thursday 8 May - Afternoon
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Conundrums in sports cardiology
Chairpersons: N.M. Panhuyzen-Goedkoop (Rozendaal, NL); D. Corrado (Padova, IT)
14:00 Can we improve current ESC recommendations for interpretation of the athlete's ECG? 30
S. Sharma (London, GB)
14:18 Differentiating athletes heart from arrhythmogenic right ventricular cardiomyopathy. 31
S.T.A. Zaidi (Miskin, GB)
14:36 Is there a role for genetic testing in sports cardiology? 32
L. Monserrat (Oleiros, ES)
14:54 Abnormal electrocardiographic ndings in athletes: correlation with sport type and intensity of training. 33
H. Dores, A. Malhotra, N. Sheikh, L. Millar, H. Dhutia, R. Narain, A. Merghani, M. Papadakis, S. Sharma (Lisbon, PT; London, GB)
15:12 The electrocardiographic phenotype in athletes with hypertrophic cardiomyopathy: implications for pre-participation
cardiovascular evaluation using electrocardiography. 34
N. Sheikh, M. Papadakis, A. Malhotra, L. Millar, H. Dhutia, A. Merghani, R. Narain, H. Dores, S. Sharma (London, GB)
14:00 - 15:30 SYMPOSIUM BRUSSELS
Prediction is difcult especially when its about the future
Chairpersons: S. Sans Menendez (Barcelona, ES); K.G.M. Moons (Utrecht, NL)
14:00 Whats a high risk country? 35
G. De Backer (St Martens Latem, BE)
14:18 Cardiovascular disease risk in the young and old: we got it wrong! 36
D. Vanuzzo (Udine, IT)
14:36 Predicting the future of risk estimation. 37
M. Kavousi (Rotterdam, NL)
14:54 Sex differences in predictors of ischaemic stroke: Cohort Norway and Cardiovascular Disease in Norway (CVDNOR) Study. 38
G. Egeland, M. Ebbing, J. Igland, S. Sulo, G.S. Tell (Bergen, NO)
15:12 Cardiovascular risk assessment at the pharmacy may identify the population at risk 39
M. Norelius, J. Perk (Stockholm and Kalmar, SE)
14:00 - 15:30 SYMPOSIUM GHENT
Is there a scientic basis for the vocational advice during cardiac rehabilitation?
Chairpersons: C. Vigorito (Naples, IT); C.H. Davos (Athens, GR)
14:00 Return to work after acute myocardial infarction and the role of cardiac rehabilitation an European overview. 41
M. Mendes (Carnaxide, PT)
14:30 How to overcome individual psychological barriers to return to work? A major task of cardiac rehabilitation. 42
M. Dempster (Belfast, GB)
15:00 Return to heavy and/or dangerous work after myocardial infarction or unemployment? The social point of view. 43
W.J. Mayer-Berger (Leichlingen, DE)
Erectile dysfunction: From the quality of life to the prediction of cardiovascular events
Joint Session with the ESC Working Group on Peripheral Circulation
Chairpersons: C. Vlachopoulos (Athens, GR); M. Viigimaa (Tallinn, EE)
14:00 Endothelial dysfunction: linking erectile dysfunction with cardiovascular disease. 45
L. Ghiadoni (Pisa, IT)
14:18 Erectile dysfunction: The ignored prognostic indicator in cardiovascular disease. 46
C. Vlachopoulos (Athens, GR)
14:36 Erectile dysfunction: When to advise, when to avoid PDE-5 inhibitors? 47
A. Lazaridis (Thessaloniki, GR)
14:54 Functional capacity predicts the presence of erectile dysfunction in patients with recent acute coronary syndrome. 48
M. Fernandez Anguita, A. Castro, R. Dalmau, S. Del Prado, I. Ponz, G. Alonso, M.D. Hernandez, A. Araujo, H. Arranz,
J.L. Lopez Sendon (Albacete, Madrid and madrid, ES)
15:12 Erectile dysfunction: a harbinger of coronary artery disease? 49
I. Campos Moreira De Almeida, F. Caetano, J. Silva, H. Coelho, P. Mota, A. Leitao-Marques (Coimbra, PT)
ESC Working Group
Peripheral Circulat ion
24
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Exercise training: exploring new horizons
Chairpersons: To be announced; M.F. Piepoli (Piacenza, IT)
Exercise training is considered one of the most efcient ways to improve physical capacity of debilitated patients. Whereas its implementation has long
been restricted to low risk patients, there is now a strong impetus to test and use tailored exercise training in other, often therapy-resistant patients. This
session will deal with recent data on the initial successes in patients with HFPEF and will cover the rst steps that are being taken in high-risk patients with
pulmonary hypertension and VAD patients. Heart failure patients with depression are a particularly difcult group and therefore a special challenge
16:30 Heart failure with preserved ejection fraction. 50
M. Halle (Munich, DE)
17:06 VAD patients. 51
U. Corra (Veruno, IT)
17:24 Resistance training in patients with an intracorporal ventricular assist device (VAD) of the third generation during
phase II cardiac rehabilitation (CR). 52
A. Workowski, P. Bartsch, H. Stuhr, D. Willemsen, B. Bjarnason-Wehrens (Bad Rothenfelde and Cologne, DE)
16:48 Importance of exercise training characteristics in the rehabilitation of cardiac patients 53
L.E.M. Vanhees (Leuven, BE)
17:42 Comparison of aerobic interval training with moderate endurance training in patients with coronary artery disease.
Results from the SAINTEX-CAD study. 54
V. Conraads, C. De Maeyer, N. Pattyn, P.J. Beckers, E. Coeckelberghs, V.A. Cornelissen, K. Goetschalckx, N. Possemiers,
E.M. Van Craenenbroeck, L. Vanhees (Edegem and Leuven, BE)
16:30 - 18:00 SYMPOSIUM BRUSSEL
The year in Cardiology: The best from our prime Journals.
Joint Session between the European Heart Journal and the European Journal of Preventive Cardiology.
Chairpersons: U. Landmesser (Zurich, CH); D.E. Grobbee (Utrecht, NL)
16:30 Introduction. 55
U. Landmesser (Zurich, CH)
16:35 The year in diabetes. 56
F. Cosentino (Stockholm, SE)
16:55 The year in hypertension. 57
S. Taddei (Pisa, IT)
17:15 The year in lipids. 58
To be announced
17:35 The year in sports cardiology. 59
C. Schmied (Zurich, CH)
17:55 Summary. 60
D.E. Grobbee (Utrecht, NL)
16:30 - 18:00 RAPID FIRE ABSTRACT GHENT
Rapid Fire Abstract Session I: Exercise, Rehabilitation and Other
Chairpersons: P. Doherty (York, GB); M. Guazzi (San Donato Milanese, IT)
16:30 Effects of 8 and 12 weeks of high-intensity aerobic interval training vs. moderate exercise on blood pressure and
cardiorespiratory condition in hypertensive patients: a randomized controlled trial. 62
S. Maldonado-Martin, B. Jurio-Iriarte, I. Camacho-Azkargorta (Vitoria-Gasteiz, Arabavalava (Basque country)
and Vitoria-Gasteiz, ES)
16:39 Long term exercise performance in patients with implanted left ventricular assist devices: are there limits? 63
C. Marko, E. Xhelili, T. Lackner, J. Riebandt, D. Zimpfer, H. Schima, R. Mueller, F. Moscato (Muthmannsdorf and Vienna, AT)
16:48 Changes in physical activity (PA) and physical functioning (PF) as risk factors for cardiovascular disease. The HAPIEE
Krakow Study. 64
A. Dorynska, M. Kozela, K. Szafraniec, R. Topor-Madry, R. Wolfshaut-Wolak, W. Misiowiec, A. Pajak (Krakow, PL)
16:57 Patterns of Systolic and Diastolic Left Ventricular Deformation in Olympic Athletes 65
S. Caselli, D. Montesanti, F. Di Paolo, C. Pisicchio, L. Verdile, B. Musumeci, C. Autore, A. Spataro, N.G. Pandian, A. Pelliccia
(Rome, IT; Boston, US)
17:06 Cardiac rehabilitation (CR) in transcatheter aortic valve implantation patients (TAVI): comparison to surgical aortic valve
replacement patients (AVR) and assessment of mortality predictors 66
F. Tarro Genta, M. Tidu, Z. Bouslenko, C. Taglieri, F. Comazzi, F. Bertolin, P. Giannuzzi (Turin and Veruno, IT)
17:15 Potential inuence of the low education level on cardiac rehabilitation or prognosis after myocardial infarction or CABG surgery 67
A. Simon, I. Tiringer, I. Berenyi, E. Gelesz, G. Veress (Balatonfured and Pcs, HU)
17:24 Health status, readmission and mortality 6-12 months after heart valve surgery 68
K. Laerum Sibilitz, S.K. Berg, L.C. Thygesen, T.B. Hansen, L. Kober, C. Hassager, A.D. Zwisler (Copenhagen and Roskilde, DK)
25
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
17:33 Prevalence of atrial brillation from a large-scale screening population: results from the Belgian heart rhythm week. 69
G.H. Mairesse, C. Scavee, N. Claes, P. Goethals, Y. Vandekerckhove, J. Vijgen, I. Blankoff, M. Goethals (Arlon, Woluwe-Saint
Lambert, Hasselt, Brussels, Bruges, Charleroi and Overpelt, BE)
17:42 Validation of a European hospital performance model for acute coronary syndrome using in-hospital death as
outcome: the EURHOBOP project. 70
I. Roman Degano, I. Subirana, M. Torre, J. Ferrieres, A. Azevedo, C. Meisinger, D. Farmakis, M. Davoli, U. Hakkinen,
J. Marrugat (Barcelona, ES; Rome, IT; Toulouse, FR; Porto, PT; Neuherberg, DE; Athens, GR; Helsinki, FI)
17:51 Is nighttime blood pressure important in cardiovascular risk assessment in coronary atherosclerosis? 71
M. Wirtwein, W. Sobiczewski, M. Gruchala (Gdansk (Poland), PL)
Biomechanical factors in cardiovascular disease
Joint Session with the ESC Working Group on Atherosclerosis and Vascular Biology
Chairpersons: P. Evans (Shefeld, GB); I. Hoefer (Utrecht, NL)
Summary: Blood vessels are exposed to multiple mechanical forces that are exerted on the vessel wall and at the endothelial surface.
The stresses and strains experienced by arteries have profound effects on vascular physiology and disease. They are major determinants
of the localisation, progression and fate of atherosclerotic lesions. This proposed session entitled biomechanical factors in cardiovascular
disease will highlight the interface between mechanical forces and vascular biology by including talks from leading engineers and vascular
biologists in the eld.
16:30 MicroRNAs in ow-dependent vascular remodelling. 72
C. Weber (Munich, DE)
16:52 Biomechanical factors as triggers of vascular growth. 73
I. Hoefer (Utrecht, NL)
17:15 Biomechanical factors in the biology of aortic wall and aortic valve diseases. 74
M. Back (Stockholm, SE)
17:37 Drug interactions and shear stress in the vasculature 75
P. Evans (Shefeld, GB)
ESC Working Group
At herosclerosis
& Vascular Biology
26
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
14:00 - 18:00 POSTER SESSION POSTER AREA
Poster session 1
Posters to be on display from 14:00 to 18:00
Set up time is between 13:30 and 14:00
Presenter must be by the poster between 15:30 - 16:30 for posters viewing time and discussant interventions.
Your poster must be removed between 18:00- 18:30
To nd your poster location, look for its Final Programme Number on the boards in the Poster Area -
Posters are on display from 14:00 - 18:00
Poster Viewing Tour is scheduled from 15:30 -16:30
Presenters will be by their poster during the coffee break from 15:30 and 16:30 for posters viewing time and discussant interventions.
At the end of their tour, the Poster Host will select a Best Poster from his/her group
The nal Four Best Posters (one from each main topic) will be on display in a dedicated area for the entire duration of the congress.
Diploma will be presented at Awards Ceremony on Saturday in room Amsterdam.
Group 1 Prevention and Epidemiology hosted by O. Barna (Kyiv, UA) P76
Prevalence of abdominal obesity among secondary school teachers P77
V. Serebryakova, M. Khamedova, V. Kaveshnikov, I. Trubacheva (Tomsk, RU)
Nonphamacological approach to weight reduction in adults with high normal blood pressure and overweight or obesity for
prevention of hyperension P78
O. Molchanova, G.F. Andreeva (Moscow, RU)
Obesity and eating behaviors among a sample of Romanian adolescents P79
C.C. Diaconu, L.A. Balaceanu, E. Diaconu, B. Balaceanu, B. Paraschiv (Bucharest, RO)
Metabolic syndrome predicts cardio- and cerebrovascular events in a twenty years follow-up. a prospective study. P80
S. Novo, F. Guarneri, A. Peritore, E. Corrado, F. Macaione, G. Novo (Palermo, IT)
The impact of weight loss after laparoscopic adjustable gastric banding surgery on the cardiac structure and the diastolic function P81
L. Abaraviciute, V. Dzenkeviciute, Z. Petrulioniene, S. Aidietiene, V. Sapoka, J.-A. Abaravicius (VIlnius and Vilnius, LT)
Waist-to-height ratio is a better predictor of cardiorespiratory tness in children than body mass index P82
H. Weberruss, H. Netz, R. Dalla Pozza, R. Oberhoffer (Munich, DE)
The impact of body mass index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity
paradox exist? P83
F. Witassek, M. Schwenkglenks, P. Erne, D. Radovanovic (Zurich, CH)
Ten-year old dynamics of cardiovascular risk factors and morbidity in healthy individuals with different levels of blood pressure P84
Y. Khovaeva, B. Golovskoy, N. Moiseenko, L. Ermachkova (Perm, RU)
The cardiac adaptations in acute pressure overload during pregnancy hypertension. P85
S. Bele, A. Rrugia, A. Doko, M. Cafka, A. Abazaj, E. Petrela, L. Cakerri (Tirana, AL)
Early ECG alterations of the left atrium and ventricle caused by beginning arterial hypertension in the context of primary
prevention P86
M.E. Moellenberg, S. Hossain, J. Gilis-Januszewski, F. Van Buuren, A. Fruend, D. Horstkotte, K.P. Mellwig (Bad Oeynhausen, DE)
Group 2 Prevention and Epidemiology hosted by S. Capewell (Liverpool, GB) P87
Autonomic nervous system activity and inammatory cytokines level during glucose tolerance test in individuals with optimal
and high normal blood pressure P88
T. Manhylova (Simferopol, UA)
Epidemiological study aiming to extract data on the prevalence of dyslipidemia among hypertensive patients. The EXIST study. P89
D. Richter, C. Varounis, G. Rombopoulos, D. Georgiopoulos (Athens, GR)
Association between total fat intake and hypertension among urban high school adolescents in Mexico City P90
M. Gomez Martinez, A. Vergara Castaneda, L. Castillo Martinez, C. Velasquez Aguilar, A. Espinoza Castillo, J.C. Avila Lopez,
J. Alvarez Gomez, P. Rodriguez Cordoba, Y. Soto Martinez, P. Mike Garcia (Mexico City, MX)
The predictive role of cardiovascular risk factors among elderly persons: the CUORE project P91
L. Palmieri, C. Donfrancesco, D. Vanuzzo, M.M. Ferrario, S. Panico, G. Cesana, F. Dima, L. Pilotto, G. Veronesi, S. Giampaoli
(Rome, Udine, Varese, Naples and Monza, IT)
Amplied arterial stiffness in youth- Pulse wave velocity is inuenced by traditional risk factors P92
J. Elmenhorst, R. Oberhoffer (Mnchen, DE)
Copeptin in patients with acute myocardial infarction and healthy controls with or without glucose abnormalities - a report
from the GAMI trial P93
M.I. Smaradottir, L.G. Mellbin, V. Ritsinger, K. Malmberg, A. Norhammar, P. Nasman, L. Ryden (Stockholm, SE)
Compound heterozygous familial lipoprotein lipase deciency due to a known and a new mutation in the lipoprotein lipase
gene (A Case Report) P94
U. Kassner, M. Wuehle-Demuth, L. Steimann, W. Maerz, E. Steinhagen-Thiessen, I. Demuth (Berlin and Mannheim, DE)
Lipid prole of a young student population P95
J.F. Kerr Saraiva, A. Avezum, A. Timerman, D.J.B. Saraiva, J.R.Z. Mendes, C.C. Magalhaes, L.A.M. Cesar (Sao Paulo, BR)
27
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Relationship between serum adipocyte fatty acid-binding protein and endothelial / hemostatic markers in asymptomatic
dyslipidemic subjects P96
D. Karasek, H. Vaverkova, J. Orsag, D. Novotny, Z. Frysak, L. Slavik (Olomouc, CZ)
The prevalence and pattern of dyslipidemia among middle-aged men in Lithuania: results from the LitHiR study P97
R. Jakaite, E. Rinkuniene, V. Dzenkeviciute, A. Laucevicius, Z. Petrulioniene, V. Kasiulevicius, R. Puronaite (VIlnius and Vilnius, LT)
Group 3 Prevention and Epidemiology hosted by I.M. Graham (Dublin, IE) P98
Racial differences in total cholesterol levels of adolescent blood donors P99
S. Eason, S. Fernando, M. Sayers (Bedford and Fort Worth, US)
Sympathetic nervous system activity and lipid metabolism: the NEO study P100
S. Hillebrand, C.A. Swenne, A.C. Maan, E. De Koning, A. De Roos, J.W. Jukema, F.R. Rosendaal, M. Den Heijer, P.C.N. Rensen,
R. De Mutsert (Leiden and Amsterdam, NL)
Additional tool to improve adherence to lifestyle modication and medications P101
Z. Gasimov (Baku, AZ)
Nicotine replacement therapy was more effective in elderly people of a cardiovascular hospital. P102
N.H. Lopes, C.G. Buzo, P.C.J. Lima Santos, A.C. Pereira, F. Paulitch, T.M.O. Abe, L.P. Huck, J.S. Issa, H. Pierri (Sao Paulo, BR)
Sedentarism as a stress generator in a young population of a metropolitan school P103
D.J.B. Saraiva, A. Avezum, A. Timerman, L.A.M. Cesar, J.R.Z. Mendes, C.C. Magalhaes, J.F. Kerr Saraiva (Sao Paulo, BR)
Social network characteristics and body mass index in an elderly Korean population P104
H.C. Kim, W.J. Lee, Y.S. Youm, Y. Rhee, S.H. Chu, Y.R. Park (Seoul and Yongin, KR)
Stratifying cardiovascular risk with Cardio-Ankle Vascular Index (CAVI): a novel instrument to detect arterial stiffness P105
L. Gianturco, C. Colombo, D. Stella, V. Gianturco, B.D. Bodini, M. Turiel (Milan and Rome, IT)
The association between lipoprotein associated phospholipase A2 (Lp-PLA2) and cardiovascular disease risk in an Irish
population. P106
K. Hutchinson, E. Dunleavy, M. Louw, J. Mason, Y. Rochev (Galway and Dublin, IE)
Acute myocardial infarction in the absence of classical risk factors P107
E.P. Garcia Martin, R. Dalmau Gonzalez-Gallarza, A. Castro Conde, A. Jurado Roman, A. Miguel Gutierrez, E. Gomez Mariscal,
S. Mayordomo Gomez, J. Molina Martin De Nicolas, B. Diaz Anton, B. Rubio Alonso (Madrid, ES)
Associations of body composition, adipokines levels and cardiovascular risk (SCORE). P108
P.A. Alyasova, I.A. Skripnikova, E.S. Abirova, V.E. Novikov, N.G. Gumanova (Moscow, RU)
Group 4 Prevention and Epidemiology hosted by To be announced P109
Alcohol consumption is the main cause of the excessive premature CVD mortality and explains the regional differences in CVD
mortality in Kazakhstan. P110
K. Davletov, S. Berkinbaev, Z. Battakova (Almaty, KZ)
Glycosylated hemoglobin as an integral marker of progression of atherogenic metabolic disorders in patients with stable
coronary heart disease and nondibetic chronic kidney disease P111
K.H. Semegen-Bodak, T. Solomenchuk, V. Bodak (Lviv, UA)
Improved cardiovascular risk stratication in asymptomatic healthy individuals a of the general population P112
P.L. Graversen, L. Jespersen, E. Prescott, S. Abildstroem, A. Borglykke (Copenhagen and Glostrup, DK)
Serum transferrin, CTF and serum iron are predictive of MS in men and premenopausal women P113
N. Kilani, G. Waeber, P. Vollenweider, P. Marques-Vidal (Lausanne, CH)
Cardiovascular risk in nonalcoholic fatty liver disease patients P114
R. Ivanova, M. Gospodinova, J. Petrova, A. Alexiev, S. Denchev, L. Mateva (Soa, BG)
Effect of occupational noxious work on lipid exchange in patients with myocardial infarction up to 50 years of age P115
T. Solomenchuk (Lviv, UA)
Assesment of risk factors in women from city population in Bulgaria P116
S. Naydenov, S.V. Tsonev, T. Donova, N. Runev, K. Vitlianova, M. Milanova (Soa, BG)
"Lipid school" as method of prevention of cardiovascular diseases P117
O.G. Cherkasova, I.V. Tyshchenko, E.P. Finkova, I.A. Esaulenko, A.V. Danylova, T.S. Turlyun (Dnipropetrovsk, UA)
The association of chronotropic response to exercise with carotid atherosclerosis in apparently healthy individuals P118
C. Liontou, J. Skoumas, C. Chrysohoou, C. Pitsavos, C. Stefanadis (Athens, GR)
Diagnostic value of quantication of myocardial deformation in the assessment of patients with suspected coronary artery disease P119
D. Teferici, S. Qirko, E. Petrela, A. Dibra, E. Pavli, P. Bara (Tirana, AL)
High Sensitivity C Reactive Protein (hsCRP) post-infarction : a cross-sectional study in 50 patients
P. Pimentel, J. Leivas, C. Zucchetti, A. Galvao, A. Stein, B. Beskow (Porto Alegre, BR)
Multimarker scale for accessing the effectiveness of secondary prevention in patients with unstable angina W122
I. Markava, A. Miadzvedzeva, V. Shyshko, L. Helis (Minsk, BY)
A randomized controlled trial measuring the effectiveness of screening for cardiovascular disease using classic risk assessment
and coronary artery calcium: the ROBINSCA study P123
R. Ijkema, M.A. Van Aerde, C.M. Van Der Aalst, M. Van Ballegooijen, M. Oudkerk, H.J. De Koning (Rotterdam and Groningen, NL)
28
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Ethnic differences in the impact of population versus high-risk approaches to primary prevention of cardiovascular disease P124
J. Baker, R. Mitchell, J.P. Pell (Glasgow, GB)
The changes in secondary coronary heart disease prevention in the Czech Republic, 1995 - 2013. EUROASPIRE I - IV studies. P125
J. Bruthans, 0. Mayer Jr, M. Galovcova, J. Seidlerova, J. Belohoubek, K. Timoracka, P. Vagovicova, J. Vanek, J. Filipovsky, R. Cifkova
(Prague and Pilsen, CZ)
Use of different look-back periods in dening incident acute myocardial infarction (AMI) have an impact on observed rates and
time trends: a CVDNOR project P126
G. Sulo, O. Nygard, S.E. Vollset, J. Igland, M. Ebbing, G. Egeland, E. Sulo, G.S. Tell (Bergen, NO)
Universally accessible cardiovascular risk screening programme and therapeutic lifestyle change interventions - a decade of
continuous signicant decline of cardiovascular mortality in Slovenia P127
Z. Fras, J. Maucec Zakotnik, J. Govc Erzen, B.L. Leskosek, S. Vrbovsek, B. Jug (Ljubljana and Celje, SI)
Implementation of cardiovascular prevention guidelines in clinical practice in Europe: a comparison of three EUROASPIRE
surveys 1999-2013 P128
K. Kotseva, D. De Bacquer, C. Jennings, V. Gyberg, G. De Backer, L. Ryden, D. Wood (London, GB; Ghent, BE; Stockholm, SE)
Sex sifferences in adverse outcomes of younger adults with obstructive coronary artery disease- the role of angina P129
M. Izadnegahdar, M.K. Lee, T. Sedlak, M. Gao, N. Bairey Merz, M. Grubisic, K.H. Humphries (Vancouver, CA; Los Angeles,
California, US)
Country of the month, European networking in preventive cardiology P130
J. Perk, I. Graham, Y. Henkin, T. Karlsen (Kalmar, SE; Dublin, IE; Beer Sheva, IL; Trondheim, NO)
Group 6 Prevention and Epidemiology hosted by U. Nixdorff (Duesseldorf, DE) P131
Importance of early physical activity in the prevention of heart failure after surgical myocardial revascularization P132
M. Krstic, M. Deljanin - Ilic, I. Nikolic - Pavlovic, V. Ilic (Niska Banja, RS)
Health status and prognosis of patients with type 2 diabetes with or without previously unknown heart failure; a survey with
one year follow-up. P133
L.J.M. Boonman-De Winter, H.F. Van Stel, F.H. Rutten, M.J. Cramer, G.E.H.M. Rutten, A.W. Hoes (Etten-Leur and Utrecht, NL)
Predictors of low Medication Adherence Scale in a population of acutely decompensated chronic heart failure patients P134
I. Sharka, A. Quka, L. Gjyli, M. Xhafaj, S. Myftiu (Tirana, AL)
Inamation , left ventricle hypertrophy and mortality in chronic renal disease. P135
M. Cafka, M. Rroji, S. Seferi, G. Burazeri, J. Seiti, J. Lazaj, A. Goda (Tirana, AL)
Enhancement of viability-related myocardial signaling pathways is induced by single chest irradiation of rats. P136
C. Viczenczova, B. Bacova, B. Benova, B. Kura, C. Yin, R. Kukreja, J. Slezak, N. Tribulova (Bratislava, SK; Richmond, US)
Narrow pulse pressure in severe aortic stenosis: a myth? P137
G. Doolub (Milton Keynes, GB)
Evaluation pilot integrated lifestyle intervention program julius t P138
K. Van Den Brekel, M. Stigter, N. De Wit (Utrecht, NL)
Screening method for initial clinical forms of chronic cerebrovascular disease detection in primary health care P139
I.V. Kim, E.V. Bochkareva, Y.Y. Varakin, E.V. Kokurina (Moscow, RU)
Gender and carotid intima-media thickness in young children P140
T. Aluma, G.W. Dalmeijer, Y.T. Van Der Schouw, C.S.P.M. Uiterwaal (Utrecht, NL)
Regional differences regarding prevalence and mortality from cardiorespiratory diseases in Russian Arctic P141
M.H. Gambaryan, A.M. Kalinina, S.A. Shalnova, A.D. Deev (Moscow, RU)
Group 7 Prevention and Epidemiology hosted by E. Prescott (Copenhagen, DK) P142
Participation rate of an integrated cardio vascular risk management program in primary care P143
M. Hollander, F.H. Rutten, N.J. De Wit (Utrecht, NL)
Associations of air pollution and ambient temperature with the risk of stroke:a systematic review and meta-analysis P144
G. Topi, R. Chowdhury, E. Harsheld, S.K.L. Darweesh, P.K. Bautista, T. Voortman, E.M. Moreira, W.M. Bramer,
E.H. Van Den Hooven, O.H. Franco (Rotterdam, NL; Cambridge, GB)
QT interval variability as a pointer to sympathetic drive to ventricles under hypobaric hypoxia P145
R.M. Negoescu, S. Dinca-Panaitescu, F. Boanta, V. Filcescu (Bucharest, RO; Toronto, CA)
VCO2 changes during therapeutic hypothermia P146
F. Franchi, S. Scolletta, M. Nocci, L. Cubattoli (Siena, IT)
Associations between controlling nutritional status score and inammation markers in acute heart failure P147
K. Kida, N. Suzuki, K. Teramoto, K. Ashikaga, Y.J. Akashi (Kawasaki, JP)
Preventive programme results: trend of salt consumption in Italy from 2009 to 2012 P148
C. Donfrancesco, P. Strazzullo, D. Galeone, L. Palmieri, C. Lo Noce, R. Ippolito, O. Russo, D. Vanuzzo, S. Giampaoli (Rome, Naples
and Udine, IT)
Dietary prevention of cardiovascular risk factors in Switzerland: still a long way to go P149
M. Grange, A. Mayen-Chacon, P. Marques-Vidal, G. Waeber, P. Vollenweider, I. Guessous (Lausanne, lausanne and Geneva, CH)
Effect of a 12-month employer-sponsored after-work exercise program on cardiovascular tness and risk factors? P150
M. Langenbeck, B. Langenbeck, J. Pukrop, S. Herget-Rosenthal (Bremen and Essen, DE)
29
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 8 Rehabilitation & Implementation hosted by A. Abreu (Lisbon, PT) P151
Effect of cardiac rehabilitation on subjective health status after primary percutaneous coronary intervention in obese patients P152
R.T. Van Domburg, N. Ter Hoeve, A. Spronk, K. Dulfer, E.M.W.J. Utens, M. Sunamura (Rotterdam, NL)
Complex inuence of metabolic syndrome and OSA on the vascular remodeling in patients with hypertension P153
V. Oleinikov, N. Sergatskaya, L. Gusakovskaya (Penza, RU)
High intensity interval training and lifestyle intervention in patients with abdominal obesity: effect on submaximal and
maximal BP P154
D. Hayami, M. Gayda, G. Marquis-Gravel, V. Guilbeault, E. Latour, M. Juneau, A. Nigam (Montreal, CA)
Impact of diabetes on phase II in-hospital rehabilitation after cardiac surgery P155
U.C. Corra', C. Marcassa, A. Giordano, F. Comazzi, M. Ossola, M. Gattone, V. Bolzani, P. Giannuzzi (Veruno, IT)
Proinammatory T-helper-17 in patients with impaired glucose tolerance and diabetes mellitus type 2 P156
I. Kologrivova, T. Suslova, O. Koshelskaya, R. Karpov (Tomsk, RU)
Disproportional increase in systolic blood pressure and twenty four hour pulse pressure for the risk assessment in hypertensive
diabetic patients P157
O.A. Koshelskaya, R.S. Karpov (Tomsk, RU)
Improvements in physical tness and depression are related to improvements in social participation during and after cardiac
rehabilitation. P158
N. Ter Hoeve, R.T. Van Domburg, H.J. Stam, M.E. Van Geffen, M. Sunamura, H.J.G. Van Den Berg-Emons (Rotterdam, NL)
Educational intervention in patients with coronary artery disease: psycho-emotional achievements P159
M.A. Ruescas-Nicolau, E. Marques-Sule, F. Querol-Fuentes (Valencia, ES)
The impact of cross-sectional cardiac rehabilitation with a hospital nurse as case manager on perception of received Chronic
Illness Care. The GoHeart follow-up study. P160
V.B. Hansen, V.P. Haslev, H.T. Maindal (Vejle and aarhus, DK)
Type D personality as determinant of health-related quality of life in coronary artery disease patients with heart failure: effects
of depressive symptoms and social support P161
M. Staniute, J. Brozaitiene, R. Bunevicius (Palanga, LT)
ACEIs removal in intolerant patients with coronary but not hypertensive disease increases their exercise training capacity
during the cardiac rehabilitation program P162
J.A. De La Chica, J. Mora-Robles, M.A. Roldan Jimenez, M. De Mora (Malaga, ES)
Group 9 Rehabilitation & Implementation hosted by B. Hewing (Berlin, DE) P163
Multiple risk factor analysis, eye fundus modications and long-term prognosis after myocardial infarction P164
I. Albert, A. Albert (Sf. Gheorghe, RO)
Reproducibility of peripheral arterial tonometry measurements in cardiovascular patients P165
M. Nil, D. Schaefer, T. Radtke, M. Wilhelm, H. Saner, P. Eser (Bern, CH)
A comparative analysis of predictors for 1-year recurrent Acute Coronary Syndromes events, between middle aged and elderly
patients: the Greek Study of ACS (GREECS). P166
D. Panagiotakos, V. Notara, C. Pitsavos, Y. Kogias, P. Stavropodis, A. Antonoulas, S. Zombolos, Y. Mantas, C. Stefanadis (Athens,
Karditsa, Zakynthos, Lamia, Kalamata and Halkida, GR)
Clinical case management improves cardiac rehabilitation program participation of patients after PCI P167
W. Benzer, P. Zauner, C. Grimm Blenk, A. Philippi, T. Banerjee (Feldkirch and Schruns, AT)
The effect of a 12-week exercise or weight loss program on glucose metabolism and abdominal fat in overweight patients with
coronary artery disease: Results from the controlled randomized CUT IT trial P168
L.R. Pedersen, R.H. Olsen, A. Jurs, S.B. Haugaard, E. Prescott (Copenhagen, DK)
Evaluation of functional capacity improvement in patients treated with ranolazine in a cardiac rehabilitation program P169
S. Prado Diaz, F. De-Torres Alba, I. Ponz De Antonio, M. Fernandez Anguita, G. Alonso Deniz, R. Dalmau Gonzalez-Gallarza,
A. Castro Conde, D. Gemma, S. Rosillo Rodriguez, J.L. Lopez-Sendon (Madrid and Albacete, ES)
Short-term functional improvement in cardiac rehabilitation outpatients depends on baseline functional capacity P170
F. Cesana, S. Riccobono, F. Posca, L. Frigerio, M. Molteni, F. Panzeri, P. Meani, L. Giupponi, M. Alloni, C. Giannattasio (Milan, IT)
Tai chi chuan improves functional capacity after myocardial infarction: a randomized clinical trial P171
R. Stein, R.M. Nery, M. Zanini, R.P. Buhler, J.B. De Lima, A.D. Silveira (Porto Alegre, BR)
Which patients with severe ventricular dysfunction after an acute coronary syndrome normalize left ventricular ejection fraction? P172
J. Caro Codon, F. De Torres Alba, I. Ponz De Antonio, Z. Blazquez Bermejo, A. Castro Conde, R. Dalmau Gonzalez-Gallarza,
S. Del Prado Diaz, S.O. Rosillo Rodriguez, D. Gemma, J.L. Lopez Sendon (Madrid, ES)
Does care sharing early after acute coronary syndrome between hospital, general practice and municipality improve
attendance and outcome? P173
J.B. Bertelsen, H. Kanstrup, I. Qvist, J. Refsgaard, S.P. Johnsen, B. Christensen, K.L. Christensen (Aarhus, Silkeborg and Viborg, DK)
Completely revascularized patients present lower rates of rehospitalizations due to new acute coronary syndromes than culprit
vessel-only ones during cardiac rehabilitation program. P174
J.A. De La Chica, J. Mora-Robles, M.A. Roldan Jimenez, M.A. De Mora (Malaga, ES)
30
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 10 Rehabilitation & Implementation hosted by J.-P. Schmid (Bern, CH) P175
The impact of a traditional dance program on lower extremity muscle performance in cardiac rehabilitation programs P176
Z. Vordos, E. Kouidi, F. Mavrovouniotis, T.H. Metaxas, E. Dimitros, A. Kaltsatou, A. Deligiannis (Thessaloniki and Thessalonik, GR)
Hemodynamic prole in heart failure patients assessed with real time impedance cardiography submitted to 6 minutes walking test P177
R. Stein, R. Cechet, R.I. Da Silva, A.D. Silveira (Porto Alegre, BR)
Long-term results of the use of edge-to-edge method without annuloplasty ring in patients with surgical correction of
hypertrophic obstructive cardiomyopathy P178
K. Smyshlyaev, V. Evtushenko, K. Petlin (Tomsk, RU)
Benecial effects of Cardiac Rehabilitation on endothelial dysfunction in patients after myocardial infarction P179
P. Rio, M. Nogueira, A. Abreu, T. Pereira-Da-Silva, P. Teixeira, G. Portugal, N. Santos, C. Fondinho, S. Silva, R. Cruz Ferreira (Lisbon, PT)
Coronary ow reserve is an independent predictor of exercise capacity in non-diabetic overweight patients with coronary
artery disease W180
A. Jurs, L.R. Pedersen, R.H. Olsen, S.B. Haugaard, E. Prescott (Copenhagen, DK)
Impact of continuous exercise intensity versus high intensity interval exercise training on endurance capacity in coronary
artery disease patients with preserved left ventricular function P181
R. Hofmann, C. Gogol, M. Karoff, B. Bjarnason-Wehrens (Cologne and Ennepetal, DE)
Methods for assessing exercise training intensity in Dutch Cardiac Rehabilitation centres P182
T. Vromen, N. Peek, H.M. Kemps (Amsterdam and Veldhoven, NL)
Burden of ischemic mitral regurgitation on functional recovery after a myocardial infarction in patients following a cardiac
rehabilitation program P183
I. Ponz De Antonio, S. Del Prado Diaz, J.M. Fernandez Anguita, A. Castro Conde, R. Dalmau Gonzalez-Gallarza, J.L. Lopez Sendon
(Madrid and Albacete, ES)
Predictors of functional capacity recovery after a cardiac rehabilitation program P184
D. Iglesias Del Valle, A. Garcia, E. Martinez, I. Hortelano, M. Larrondo, A. Berjillos, A. Martin-Penato, J. De Juan, E. Prieto, I. Plaza
(San Sebastian de los Reyes, ES)
Determinants of early exercise capacity improvement in patients after acute myocardial infarction P185
J. Brozaitiene, I. Duoneliene, M. Staniute, V. Jakumaite, N. Kazukauskiene, V. Gelziniene, N. Mickuviene (Palanga, LT)
Double product break point as indicator of metabolic transition during incremental exercise test in coronary patients P186
M.I.G.U.E.L. Resnik, G. De Roia, S. Taurozzi, D. Maggio, R.M. Ruffa, G. Moreno, R. Vizcarra, D. Roitenburd (Ciudad Autonoma de
Buenos Aires and Buenos Aires, AR)
Exercise intensity guidelines for cancer survivors: are we heading in the right direction? P187
S. Maldonado-Martin, E. Gil-Rey, K. Quevedo, F. Herrero (VITORIA-GASTEIZ, ARABA/ALAVA (BASQUE COUNTRY)
and MIRANDA DE EBRO (BURGOS), ES)
Cardiac rehabilitation for acute phase using restricted blood ow method in intensive care unit P188
Y. Matsuo, Y.M. Morino, M.K. Kurabayashi, T.N. Nakajima, K.F. Fukumura, T.S. Yasuda, Y.S. Sato, R.F. Funada, N.K. Koitabashi,
N.T. Takama (Maebashi and Tokyo, JP; Battaramulla, LK)
Group 11 Sports Cardiology hosted by J. Niebauer (Salzburg, AT) P189
Unexpected large prevalence hypercholesterolemia in elite athletes P190
B. Di Giacinto, A. Franco, P.E. Adami, G. Berlutti, E. De Blasiis, C. Briganti, L. Torrisi, F. Culasso, C. Tranquilli, A. Pelliccia (Rome, IT)
The inuence of regular walking at different times of day on blood lipids and inammatory markers in sedentary patients with
coronary artery disease W191
L.S. Wang, X.Q. Lian (Nanjing, CN)
Cardiovascular risk and aerobic tness in paralympic athletes with locomotor impairments P192
M.R. Squeo, L. Corsi, P.E. Adami, R. Lanzano, C. Marini, C. Gallozzi, C. Tranquilli, A. Spataro, A. Pelliccia, M. Bernardi (Rome, IT)
Pulse wave velocity measurement for cardiovascular risk stratication in an asymptomatic athletic population: reproducibility
and impact of ct-scanning P193
T.L. Braber, N.H.J. Prakken, A. Mosterd, P.A.F.M. Doevendans, W.P.T.M. Mali, H.M. Nathoe, R. Rienks, F.J.G. Backx, B.K. Velthuis
(Utrecht and Amersfoort, NL)
Reversible left ventricular trabeculation associated with increased cardiac preload in a pregnancy model: where do we stand
with adult left ventricular non-compaction in low risk populations? P194
S. Gati, M. Papadakis, A. Zaidi, N. Papamichael, N. Sheikh, M. Reed, R. Sharma, B. Thilaganathan, S. Sharma (London, GB)
Reassessment of morphologic criteria for the diagnosis of ARVC in elite athletes P195
P.E. Adami, F. Di Paolo, C. Pisicchio, M.E. Tundidor, M.R. Squeo, F. Federico, L. Verdile, F.M. Quattrini, A. Pelliccia (Rome, IT)
T wave morphology analysis in Danish elite athletes P196
S. Glasius Tischer, E. Prescott, J. Kanters, H.K. Rasmusen (Copenhagen, DK)
Echocardiographic ndings in elderly men by cardiovascular screening before exercise training P197
U. Koepp, G.E. Eivindson, S. Berntsen, G. Paulsenn, F.T. Gjestvang (Kristiansand and Oslo, NO)
High interindividual variability in the acute dose-response of the right ventricular performance in cross-running participants P198
M. Sanz, G. Grazioli, B. Bijnens, C. Pajuelo, E. Guasch, E. Subirats, D. Brotons, R. Brugada, E. Rocca, M. Sitges (Barcelona
and Girona, ES)
Impaired arterial stiffness in children and adolescence with higher peak oxygen uptake P199
J. Mueller, J. Elmenhorst, B. Boehm, R. Oberhoffer (Munich, DE)
31
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 12 Exercise & Translational Science hosted by J.P.J. Halcox (Swansea, GB) P200
Effect of electrical stimulation on selected left ventricular parameters among hypertensive over-weight middle aged men P201
A. Abdelhameed (Sharjah, AE)
Relationship between aerobic tness and cardiac autonomic modulation in hypertensive patients P202
J. Suzic Lazic, I. Nedeljkovic, S. Mazic, A. Majstorovic, M. Kleut, A. Sljivic, M. Djelic, I. Pantic, S. Suzic, V. Celic (Belgrade, RS)
Effectiveness of physical exercise on sexual dysfunction in cardiovascular patients P203
P.P. Johansen, S.K. Berg, P.U. Pedersen (Copenhagen and Aalborg, DK)
Various subsets of proangiogenic circulating mononuclear cells in asymptomatic coronary artery disease P204
A. Berezin, A. Kremzer (Zaporozhye, UA)
Stress echocardiography tests in detection of silent myocardial ischemia P205
I. Nedeljkovic, J. Stepanovic, A. Djordjevic-Dikic, V. Giga, M. Banovic, B. Beleslin, M. Nedeljkovic, M. Dobric, V. Stojanov, M.C. Ostojic
(Belgrade, RS)
The steep ramp test in youth: reliability, validity and norm values P206
T. Takken, B.C. Bongers, S.I. De Vries, J. Obeid, P.J.M. Helders, S. Van Buuren (Utrecht, The Hague and Leiden, NL; Hamilton, CA)
Bioelectrical impedance and soccer performance in professional soccer players. P207
G. Mascherini, L. Stefani, H. Gatterer, A. Cattozzo, G. Galanti (Florence, IT)
32
Friday 9 May - Morning
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Around the world in 90 minutes
Global Track
Chairpersons: D.E. Grobbee (Utrecht, NL); I.M. Graham (Dublin, IE)
08:30 The double burden: prevention challenges in Africa. 208
A.P. Kengne (Cap Town, ZA)
08:52 Cardiovascular prevention in Asia Pacic. 209
H. Sone (Niigata, JP)
09:15 Why are disease rates in Russia worse than the rest in Europe? 210
N. Pogosova (Moscow, RU)
09:37 Burden of cardiometabolic risk factors, clinical and cost-effectiveness interventions to counter CVD in Latin America. 211
A. Rubinstein (Buenos Aires, AR)
HDL: Still important in cardiovascular prevention?
Chairpersons: P. Leeson (Oxford, GB); M. Halle (Munich, DE)
NEW! Mobile App Interactive Session
Make sure you have downloaded the EuroPrevent 2014 Mobile App to interact in this session
08:30 Introduction by chairperson 212
P. Leeson (Oxford, GB)
08:45 HDL: a heterogeneous lipoprotein class. 213
09:15 HDL function: a parameter to be inuenced by exercise training or weight loss? 214
V. Adams (Leipzig, DE)
09:45 Discussions and conclusion 215
08:30 - 10:00 SYMPOSIUM THE HAGUE
Emerging concepts in sports cardiology
Chairpersons: A. Pelliccia (Rome, IT); F. Carre (Rennes, FR)
This session will cover relatively novel papers in sports cardiology. The symposium will commence with a talk on the incidence and
prognosis of exercise related sudden cardiac arrest during exercise in the general population and will be followed by another talk on how
to assess the signicance of ambiguous autopsy results in athletes and subsequent assessment of rst-degree relatives. The third talk will
provide a detailed study of the right ventricle in young athletes and the overlap with the arrhythmogenic right ventricular cardiomyopathy
phenotype. The session will end with an overview on performance enhancing agents and the heart.
08:30 Incidence and prognosis of exercise related sudden cardiac death in the general population? 216
A. Mosterd (Amersfoort, NL)
08:48 Sudden cardiac death in young competitive athletes: The beginning, not the end! 217
M. Papadakis (London, GB)
09:06 Performance enhancing agents and the heart? 218
J. Niebauer (Salzburg, AT)
09:24 The impact of current ECG criteria in cardiac screening of young individuals: Relevance to short-QT syndrome. 219
H. Dhutia, S. Parpia, R. Narain, S. Ghani, N. Chandra, A. Malhotra, L. Miller, A. Merghani, M. Papadakis, S. Sharma
(London, GB; Hamilton, CA)
09:42 The diagnostic accuracy of exercise electrocardiography in asymptomatic recreational and competitive athletes. 220
D.A.J.P. Van De Sande, A. Hoogeveen, J. Hoogsteen, H.M.C. Kemps (Veldhoven, NL)
33
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Hot topics in hypertension
Joint Session with the ESC Working Group on Hypertension
Chairpersons: R. Fagard (Korbeek-Lo, BE); R. Cifkova (Prague, CZ)
08:30 Global burden of hypertension. 221
R. Fagard (Korbeek-Lo, BE)
08:48 Why it is important to search for target organ damage in hypertension. 222
M. Volpe (Rome, IT)
09:06 Primary and secondary prevention of stroke. 223
A. Coca (Barcelona, ES)
09:24 Non-pharmacological interventions protect from malignant arrhythmias partially by targeting myocardial Cx43
channels in experimental model of hypertension. 224
N. Tribulova, T. Benova, J. Radosinska, B. Bacova, C. Viczenczova, V. Knezl, M. Zeman (Bratislava, SK)
09:42 Famine in early life can be associated with adult hypertension but not with vascular aging: data from Leningrad Siege
population. 225
A.O. Konradi, O.P. Rotar, E.V. Moguchaya, E.P. Kolesova, A.M. Erina, M.A. Boyarinova, E.V. Shlyakhto (Saint-Petersburg, RU)
Cardiovascular risk management in primary care: dilemmas in following the guidelines
Joint session with the Dutch and Belgian Working Group on Primary Care
Chairpersons: J. Perk (Oskarshamn, SE); K. Konings (Maastricht, NL)
08:30 Should identical CVD risks in young and old patients be managed identically? 226
M. Hollander (Utrecht, NL)
09:00 Promoting lifestyle changes according to the guidelines: is it feasible? 227
K. Van den Brekel (Utrecht, NL)
09:30 The treatment goals according to the standard. What can be achieved? 228
E. Huijbers (Geldrop, NL)
Global Forum on CVD Prevention in Clinical Practice
Global Track
Chairpersons: S. Gielen (Halle, DE); S. Mendis (Geneva, CH)
11:00 The WHO Action Plan 2013 2020. 229
S. Mendis (Geneva, CH)
11:18 Global alliance for cardiovascular disease prevention in clinical practice. 230
S. Gielen (Halle, DE)
11:36 Guidelines for cardiovascular disease prevention: does what works for the rich also work for the poor? 231
J. Perk (Oskarshamn, SE)
11:54 Cardiovascular disease risk scoring around the world: Uniformity or diversity? 232
12:12 Obesity and diabetes as global challenges. 233
L. Ryden (Stockholm, SE)
Tailoring antiplatelet drugs: focus on "special" populations
Joint Session with the ESC Working Group on Thrombosis
Chairpersons: B. Rocca (Rome, IT); S. Husted (Herning, DK)
11:00 Balancing antiplatelet drugs and bleeding risk in the elderly. 234
G. Gambassi (Roma, IT)
11:22 Antiplatelet drugs and obesity. 235
A. Siegbahn (Uppsala, SE)
11:45 Antiplatelet and anticoagulants. 236
S. Husted (Herning, DK)
12:07 Antiplatelet drugs and diabetes. 237
B. Rocca (Rome, IT)
ESC Working Group
Hypert ension
and t he Heart
ESC Working Group
Thrombosis
34
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
11:00 - 12:30 DEBATE SESSION THE HAGUE
Hot debates in nutrition and globesity
Chairpersons: S. Gupta (London, GB); O. Barna (Kyiv, UA)
11:00 The role of food industry in cardiovascular disease prevention at the population level: good vector? 238
S. Capewell (Liverpool, GB)
11:22 The role of food industry in cardiovascular disease prevention at the population level: bad vector? 239
T. Joergensen (Glostrup, DK)
11:45 Globesity from prevention to treatment, are there easy and lasting solutions? Global impact on and prevention of
obesity through lifestyle. 240
T. Marsh (London, GB)
12:07 Globesity: from prevention to treatment, are there easy and lasting solutions? The role of obesity treatment in CVD
prevention. 241
J. Seidell (Amsterdam, NL)
Renal denervation: a novel approach to treatment of hypertension
Joint Session with the ESC Working Group on Hypertension.
This session is supported by St. Jude Medical in a form of an unrestricted educational grant.
Chairpersons: A. Coca (Barcelona, ES); S.E. Kjeldsen (Oslo, NO)
11:00 Denition and epidemiology of resistant hypertension. 242
R. Cifkova (Prague, CZ)
11:22 How to assess a patient referred for resistant hypertension. 243
T. Kahan (Stockholm, SE)
11:45 Sympathetic nervous system in resistant hypertension. 244
G. Parati (Milan, IT)
12:07 Renal denervation: introduction of the technique and a critical review of results. 245
C. Tsious (Athens, GR)
Cardiovascular risk management part II: secondary prevention pitfalls
Joint session with the Dutch and Belgian Working Groups on Preventive Cardiology.
Chairpersons: J. Wittekoek (Utrecht, NL); I. Elegeert (Kortrijk, BE)
11:00 The days after Guidelines for the management of acute coronary syndromes 246
J.E.A. Appelman (Amsterdam, NL)
11:30 Treatment targets in secondary prevention: How low can you go? 247
I. Elegeert (Kortrijk, BE)
12:00 The life style specialist: all-inclusive: a package deal for cardiovascular prevention: a new trend? 248
J. Wittekoek (Utrecht, NL)
ESC Working Group
Hypert ension
and t he Heart
35
Learn more about your Association!
Dont miss the EACPR General Assembly on Saturday 10 May
from 10:00 - 11:00 in Room Brussels
Friday 9 May - Lunchtime
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
12:45 - 13:45 SATELLITE SYMPOSIUM BRUSSELS
Sponsored by SERVIER
Chairpersons: A.A. Voors (Groningen, NL); S. Gielen (Halle, DE)
Risk evaluation is important in the management of heart failure patients. Correct understanding of likely outcomes improves disease
control and treatment adjustment. In addition, physicians will have to deal with a variety of patient proles and comorbidities. Good
inter-departmental collaboration and a global approach to patients by each specialist should ensure a continuum of care and slow disease
progression. Each step of the heart failure patients management can yield short-term and also long-term benets. So, it is essential to
optimize patients treatment quickly, to educate them, and to get them involved in the management of their disease.
12:45 Introduction. 249
12:51 Risk evaluation in heart failure. 250
13:07 Multiple facets of the heart failure patient. 251
A.A. Voors (Groningen, NL)
13:23 Heart failure management: timing matters. 252
P. Jourdain (Pontoise, FR)
13:39 Conclusion. 253
A.A. Voors (Groningen, NL)
12:45 - 13:45 SATELLITE SYMPOSIUM THE HAGUE
Sponsored by AstraZeneca
Chairpersons: P.R. Sinnaeve (Leuven, BE)
- Insight in long term cardiovascular mortality after ACS
- The importance of duration and treatment complaince of antiplatelet therapy
- The importance of cardiac rehalibilitation after ACS
12:45 The important and underrecognized burden of long-term cardiovascular mortality after ACS. 254
P.R. Sinnaeve (Leuven, BE)
13:05 How long should we treat ACS patients with antiplatelet therapy after an ACS? 255
F.W.A. Verheugt (Amsterdam, NL)
13:25 The importance of cardiac rehabilitation after ACS. 256
J.-P. Schmid (Bern, CH)
12:45 - 13:45 SATELLITE SYMPOSIUM GHENT
2
(Lp-PLA
2
) testing in risk management of cardiovascular disease events
Sponsored by diaDexus Inc.
Chairpersons: U. Nixdorff (Duesseldorf, DE)
The session will provide an overview of the role inammation plays in the pathogenesis of atherosclerosis and how Lp-PLA
2
expression
is up-regulated in unstable and rupture-prone plaques what can lead to cardiovascular events. Epidemiological and genetic data will be
presented to support the concept that Lp-PLA
2
is a vascular-specic inammatory risk factor for the progression of atherosclerotic disease
and can be measured with a simple blood test. Further results of the recently published LIPID-Study will be presented showing that the
reduction of Lp-PLA
2
with statin therapy, independent of baseline Lp-PLA
2
levels, can help predict the reduction in cardiovascular disease
events.
12:45 Overview of lipoprotein-associated phospholipase A
2
as a vascular specic inammatory risk factor critical in the
formation of rupture-prone plaque. 257
U. Nixdorff (Duesseldorf, DE)
13:10 The use of lipoprotein-associated phospholipase A
2
testing in prevention of cardiovascular disease events. 258
W. Fache (Ghent, BE)
13:35 Questions and answers. 259

36
Friday 9 May - Afternoon
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Hot topics in preventive cardiology
Global Track
Chairpersons: P. Giannuzzi (Veruno, IT); S. Gielen (Halle, DE)
14:00 Lessons from EUROASPIRE. 260
V. Gyberg (Stockholm, SE)
14:22 Guidelines on hypertension: what is new? 261
R. Fagard (Korbeek-Lo, BE)
14:45 Guidelines on diabetes: what is new? 262
R. Ajjan (Leeds, GB)
15:07 How to translate science to politics? 263
Z. Reiner (Zagreb, HR)
How to detect early cardiovascular disease? Options and pitfalls of different methods
Chairpersons: M. Bots (Utrecht, NL); M. Halle (Munich, DE)
NEW! Mobile App Interactive Session
Make sure you have downloaded the EuroPrevent 2014 Mobile App to interact in this session
Large epidemiological as well as smaller studies use measures to detect early cardiovascular disease. These diagnostic methods are partly
well established, but not ubiquitously applied. In order to implement these measures into studies or routine application the benets but
also pitfalls of these methods will have to be described
14:00 Pulse wave velocity and augmentation index. 264
H. Hanssen (Basel, CH)
14:22 Endothelial function. 265
C.D.A. Stehouwer (Maastricht, NL)
14:45 Carotid artery disease - IMT. 266
R. Meijer (Voorschoten, NL)
15:07 Coronary artery calcium. 267
P. Leeson (Oxford, GB)
Latest scientic news on exercise rehabilitation in heart failure
Chairpersons: L.E.M. Vanhees (Leuven, BE); R. Hambrecht (Bremen, DE)
14:00 Latest results from clinical trials. 268
S. Adamopoulos (Athens, GR)
14:18 Modes of exercise. 269
14:36 Heart failure with preserved systolic LV-function. 270
H.D. Duengen (Berlin, DE)
14:54 Exercise-based rehabilitation for heart failure: Cochrane Review 2013 update. 271
R.S. Taylor, V. Sugar, H. Daal (Exeter, GB)
15:12 Impact of beta-blockers in heart rate and oxygen uptake response to exercise and recovery in older patients with heart
failure with preserved ejection fraction. 272
S. Maldonado-Martin, P.H. Brubaker, C. Ozemek, J.A. Jayo-Montoya (Vitoria-Gasteiz, Araba/Alava (Basque Country),
ES; Winston-Salem and Muncie, US)
14:00 - 15:30 YOUNG INVESTIGATORS AWARDS ABSTRACTS GHENT
Young Investigator Award I - Cardiac Rehabilitation and EBTR
Chairpersons: B. Hewing (Berlin, DE); A. Pelliccia (Rome, IT)
Judges: J.-P. Schmid (Bern, CH); G.S. Tell (Bergen, NO); J. De Sutter (Gent, BE); V. Adams (Leipzig, DE);
J.P.J. Halcox (Swansea, GB)
Winners will be announced at the Closing Ceremony in Room Amsterdam on Saturday 10 May between 12:15 - 13:00
14:00 Reduction of functional decline in the rst year after cardiac rehabilitation in a large cohort of very old coronary patients 273
A. Pratesi, S. Baldasseroni, C. Burgisser, S. Francini, R. Pallante, R. Barucci, F. Fattirolli (Florence, IT)
37
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
14:15 Physical capacity and resistant hypertension: a sub analysis of the heated water based exercise training trial (HEX trial) 274
L.G.B. Cruz, E.A. Bocchi, M.M. Fernades-Silva, E.L. Dorea, G.V. Guimaraes (Sao Paulo, BR)
14:30 The effect of a 12-week interval training or weight loss program on coronary ow reserve in overweight patients with
coronary artery disease: Primary outcome of the randomised controlled CUT-IT trial 275
R.H. Olsen, L.R. Pedersen, M. Snoer, A. Jurs, S.B. Haugaard, E. Prescott (Copenhagen, DK)
14:45 Reference values for the oxygen uptake efciency slope in healthy men and women aged 20-60 years 276
R. Buys, V. Cornelissen, E. Coeckelberghs, R. Peeters, L. Vanhees (Leuven, BE; Utrecht, NL)
15:00 The effects of diet and exercise training on microvascular endothelial dysfunction in severe childhood obesity 277
L. Bruyndonckx, A. De Guchtenaere, E.R. Bassle, A.R. Tanghe, M. Van Helvoirt, V.Y. Hoymans, D.K. Vissers, C.J. Vrints,
J. Ramet, V.M. Conraads (Edegem, De Haan and Antwerp, BE)
15:15 Aortic stenosis pathogenesis: a potential role for epicardial fat tissue 278
V. Parisi, V.D.esposito, F. Passaretti, A. Caruso, T. Lonobile, G. Grimaldi, C. De Lucia, P. Formisano, D. Leosco, G. Rengo
(Naples, Maddaloni and Telese Terme, IT)
The Heart Lung interaction in Preventive Cardiology
Session supported by the Dutch Heart Foundation
Chairpersons: A. Urhausen (Luxembourg, LU); S. Logstrup (Brussels, BE)
A brief overview is given of the disastrous effects of tobacco smoking on health, the environment and the economy. Obstacles for
prevention are exemplied by the strong addictive property of nicotine, the ruthlessness and greed of the tobacco industry, and
the ambivalence still demonstrated by the political and the health professional community in the ght against tobacco. A successful
comprehensive tobacco control strategy is recognized and promoted by the rst global health convention, the World Health Organization
(WHO) Framework Convention on Tobacco Control. WHO has great expectations of the health community to support the implementation
of the convention: who else has a greater responsibility. At the end of the session, join the Dutch Heart Foundation for a reception and
symbolic handing over of the petition.
14:00 COPD and heart failure: tricky diagnoses in primary care. 279
F.H. Rutten (Utrecht, NL)
14:30 Smoking cessation in 2014: update on (non)-pharmacological strategies. 280
H. Boudrez (Laarne, BE)
15:00 Smoking prevention: obstacles and possibilities. 281
G. Boethius (Stockholm, SE)
Guidelines on preventive cardiology: minor or major differences across the Atlantic?
Joint session with the American Heart Association
Chairpersons: H. Gohlke (Ballrechten-Dottingen, DE); J. Perk (Oskarshamn, SE)
16:30 What is the population at CVD risk: risk assessment using SCORE. 282
16:52 What is the population at CVD risk: using the US risk calculator. 283
T.A. Gaziano (Boston, US)
17:15 No guidance without targets. 284
G. De Backer (St Martens Latem, BE)
17:37 Conclusion. 285
H. Gohlke (Ballrechten-Dottingen, DE)
Imaging of subclinical atherosclerosis in cardiovascular disease prevention: show me the evidence
Chairpersons: U. Nixdorff (Duesseldorf, DE); E. Greco (Fuscaldo, IT)
16:30 Has carotid intima-media thickness (IMT) fullled its promise? 286
M. Bots (Utrecht, NL)
16:48 Should we be looking at progression of subclinical atherosclerosis? 287
M. Lorenz (Frankfurt Am Main, DE)
17:06 Weighing the evidence in guideline formation: do we really need clinical trials? 288
H.J. de Koning (Rotterdam, NL)
17:24 ICEBERG, cardiovascular outcomes data according to a baseline carotid ultrasound in 1,449 patients. 289
D.W. Armstrong, A.M. Johri, U. Jurt, D. Brouillard, M. Matangi (Kingston, CA)
17:42 The contribution of cardiorespiratory tness relative to traditional risk factors on subclinical atherosclerosis. 290
J. Scholl, M.L. Bots, S.A.E. Peters (Rdesheim am Rhein, DE; Utrecht, NL)
38
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Modern management of patients with diabetes: from screening to cardiac rehabilitation
Joint Session with the Japanese Society of Cardiac Rehabilation
Chairpersons: Y. Kimura (Hirakata, JP); V. Adams (Leipzig, DE)
16:30 Screening for diabetes: how and when? 291
J. Tuomilehto (Helsinki, FI)
16:52 Diabetes in CAD patients: lessons from the EUROASPIRE Surveys. 292
L. Ryden (Stockholm, SE)
17:15 Potential effects and possibilities of exercise in diabetes management and care. 293
H. Sone (Niigata, JP)
17:37 Effect of cardiac rehabilitation programme on dysglycemia in patients with heart disease. 294
H. Adachi (Gunma, JP)
16:30 - 18:00 YOUNG INVESTIGATORS AWARDS ABSTRACTS GHENT
Young Investigator Award II - Prevention & Epidemiology and Sports Cardiology
Chairpersons: P. Giannuzzi (Veruno, IT); K. Kamiya (Sagamihara, JP)
Judges: D. Vanuzzo (Udine, IT); E. Prescott (Copenhagen, DK); M. Guazzi (San Donato Milanese, IT); U. Corra (Veruno, IT)
Winners will be announced at the Closing Ceremony in Room Amsterdam on Saturday 10 May between 12:15 - 13:00
16:30 The impact of adopting new ECG interpretation criteria when screening an ethnically diverse cohort of athletes 295
N.R. Riding, C. Adamuz, M.G. Wilson (Doha, QA)
16:45 Differentiating physiological left ventricular hypertrophy from hypertrophic cardiomyopathy in athletes: Proposed
echocardiographic protocol 296
A. Malhotra, N. Sheikh, A. Siva, H. Dhutia, H. Dores, L. Millar, A. Merghani, R. Narain, S. Sharma, M. Papadakis (London, GB)
17:00 How does the right ventricle adapt to high intensity endurance exercise? Insights from segmental myocardial
deformation imaging 297
M. Sanz, G. Grazioli, B. Bijnens, C. Pajuelo, E. Guasch, E. Subirats, B. Brotons, R. Brugada, E. Rocca, M. Sitges
(Barcelona and Girona, ES)
17:15 Quantifying the impact of maintenance and changes of lifestyles on risk of cardiovascular disease and all-cause
mortality: the doetinchem cohort study 298
G. Hulsegge, H.A. Smit, Y.T. Van Der Schouw, M.L. Daviglus, W.M.M. Verschuren (Bilthoven and Utrecht, NL; Chicago, US)
17:30 The european obese model: the shape of things to come 299
L. Webber, D. Divajeva, T.I.M. Marsh, M. Brown, T. Wijnhoven, J. Breda (London, GB)
17:45 Seasonality of cardiovascular mortality: a worldwide analysis of 61 million deaths 300
C. Gubelmann, S. Gonseth, H. Marti-Soler, S. Stringhini, P. Bovet, P.-C. Chen, B. Wojtyniak, D. Tsai, T. Zdrojewski,
P. Marques-Vidal (Lausanne, CH; Taipei, TW; Warsaw and Gdansk, PL)
Joint Session with the Council on Primary Care
Chairpersons: D.E. Grobbee (Utrecht, NL); F.D.R. Hobbs (Oxford, GB)
16:30 Welcome by the Chairpersons. 301
16:35 Can physicians help with lifestyle behaviour change? 302
P. Aveyard (Oxford, GB)
17:00 Motivational interviewing how and why. 303
C. Taylor (Birmingham, UK)
17:25 Poly-pill or high risk strategy whats best for patients? 304
J.W. Mant (Cambridge, GB)
17:50 Panel discussion. 305

39
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Poster Session 2
Posters to be on display from 08:30 to12:30
Presenter must be by the poster between10:00 - 11:00 for posters viewing time and discussant interventions.
Your poster must be removed between 12:30 - 13:00
To nd your poster location, look for its Final Programme Number on the boards in the Poster Area
Group 1 Prevention and Epidemiology hosted by U. Nixdorff (Dusseldorf, DE) P306
Inuence of Metabolic syndrome on left ventricular dimensions, mass and diastolic function after laparoscopic adjustable
gastric banding surgery P307
J. Gureckyte, V. Dzenkeviciute, Z. Petrulioniene, S. Aidietiene, G. Brimas (VIlnius and Vilnius, LT)
Assessment of left ventricular geometry patterns in morbidly obese patients who undergo bariatric surgery. P308
V. Hernandez Jimenez, J. Saavedra Falero, A. Gonzalez Gomez, P. Iglesias Bolanos, S. Civantos, G. Guijarros, S. Monereo Megias
(Ciudad Real and Madrid, ES)
Impact of body mass index on clinical outcome in patients undergoing percutaneous coronary intervention P309
L. Simoni, E. Shirka, S. Kabili, A. Goda (Tirana, AL)
Ultrasound lipometric indicators of subcutaneous and abdominal fat: distribution and metabolic predictors in a population
sample P310
A. Ryabikov, Z. Guliev, S. Malyutina, S. Schakhmatov, E. Veryovkin (Novosibirsk, RU)
IQ, serum cholesterol and all-cause mortality in Swedish men: a study of IQ at conscription, total serum cholesterol (TC) at age
40 and all-cause mortality after age 40 P311
G. Nilsson, J. Leppert, A. Rosenblad (Vasteras, SE)
Preliminary ndings from a systematic review of the prevalence of childhood overweight and obesity in the republic of ireland
(roi) from 2002-2012 W312
E. Keane, P.M. Kearney, I.J. Perry, C.C. Kelleher, J.M. Harrington (Cork and Dublin, IE)
The effect of lifestyle advice program in hypertensive patients P313
N. Pogosova, A. Ausheva, A. Karpova (Moscow, RU)
Sensitivity to salt masked hypertension men P314
A. Miroshnichenko, I. Osipova, V. Kulikov, O. Antropova, A. Aleksentseva (Barnaul, RU)
Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010 P315
P. Tuppin, P. Ricci-Renaud, C. De Peretti, A. Fagot-Campagna, N. Danchin (Paris, FR)
B-type natriuretic peptide (BNP) as a novel bio-marker for left ventricular hypertrophy in asymptomatic, uncontrolled
hypertensive subjects P316
O. El Shahawy, M. Entcheva, M. El Shahawy (Richmond and Sarasota, US)
Group 2 Prevention and Epidemiology hosted by G.S. Tell (Bergen, NO) P317
Echocardiographic evaluation with Strain and Strain-rate in patients with type 2 diabetes with paroxysmal or persistent atrial
brillation W318
A.A. Aleksandrov, S. Kukharenko, M. Yadrikhinskaya, E. Drozdova, O. Shatskaya, O. Kulieva, I. Martyanova, Y. Solyanik (Moscow, RU)
Prevalence of diabetes mellitus in patients with acute coronary syndrome admitted in National Institute of cardiovascular
diseases, Dhaka, Bangladesh. P319
M.T. Rahman (DHAKA, BD)
Impact of glycemic status on left ventricular systolic functions in patients with acute coronary syndrome W320
A.E.H. Amin, W.A.A. Ammar, A.A.F. Farrag, M.Z.R. Elramly (Cairo, EG)
Adherence to the mediterranean diet is associated with reduced overall mortality in subjects with diabetes. Prospective results
from the Moli-sani study P321
M. Bonaccio, A. Di Castelnuovo, S. Costanzo, M. Persichillo, M.B. Donati, G. De Gaetano, L. Iacoviello (Pozzilli, IT)
The predictive role of blood glucose versus presence of diabetes for the cardiovascular risk assessment: the CUORE project P322
C. Donfrancesco, L. Palmieri, M.M. Ferrario, D. Vanuzzo, S. Panico, G. Cesana, S. Vannucchi, G. Veronesi, A. Mattiello, S. Giampaoli
(Rome, Varese, Udine, Naples and Monza, IT)
Association between hypertriglyceridemia and erectile dysfunction in men younger than 55 years with ischemic heart disease. P323
M. Fernandez Anguita, R. Dalmau, A. Castro, S. Del Prado, I. Ponz, G. Alonso, M.D. Hernandez, A. Araujo, H. Arranz,
J.L. Lopez Sendon (Albacete, Madrid and madrid, ES)
The role of gender factor in the delopment of CVD in naive HIV - infected patiets. W324
I. Komarova, I. Chukaeva, A. Kravthenko, T. Kushakova (Moscow, RU)
40
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Physical activity and the correlation with hdl levels in a young population from a metropolitan school P325
D.J.B. Saraiva, A. Avezum, A. Timerman, L.A.M. Cesar, J.R.Z. Mendes, C.C. Magalhaes, J.F. Kerr Saraiva (Sao Paulo, BR)
Psychosocial and behavioral determinants of lipid disorders in teenagers. Results of SOPKARD Junior Project P326
J. Marczulin, M. Krawczyk, T. Zdrojewski (Gdansk, PL)
Longitudinal trends in lipids among Moscow population from 1975 to 2001 P327
Y. Balanova, S. Shalnova, A. Deev, A. Kapustina (Moscow, RU)
Group 3 Prevention and Epidemiology hosted by D. Vanuzzo (Udine, IT) P328
Examining the gap between evidence based guidelines and clinical practice in lipid modication in adults at high risk of
cardiovascular disease mortality: evidence from an Irish cohort P329
C. Murphy, K. Bennett, E. Shelley, I. Graham, T. Fahey, R.A. Kenny (Dublin, IE)
Smoke-free laws and trends in tobacco quit rates: Perspective from a single centre inpatient smoking cessation programme P330
J.H.J. See, Y.C. Lum (Singapore, SG)
Health-related quality of life does not always improve after coronary artery bypass graft surgery: The inuence of
Psychological distress and personality. W331
L.J. Middel, N. El Baz, S.S. Pedersen, J.P. Van Dijk, K. Wynia (Groningen and Tilburg, NL)
Arterial stiffness evaluation by measuring cardio-ankle vascular index and its correlation with SCORE risk chart P332
D.S. Komkov, R.M. Linchak (Moscow, RU)
Are the classic risk estimation system reliable in persons with spinal cord lesions ? P333
M. Zen Jurancic, T. Erjavec (Ljubljana, SI)
Age-related changes in left ventricular structure and function and their relationship to the cellular senescence P334
E.V. Plokhova, D. Akasheva, O. Tkacheva, I. Strazhesko, A. Kruglikova, V. Pikhtina, E. Dudinskaya, N. Brailova, I. Ozerova, S. Boytsov
(Moscow, RU)
The association between statin therapy and circulating and urinary levels of one-carbon metabolites and B vitamers among
patients with suspected angina pectoris P335
G.F.T. Svingen, H. Schartum-Hansen, P.M. Ueland, R. Seifert, E.K.R. Pedersen, O. Midttun, O.K. Nygaard (Bergen, NO)
Risk factors for cardiovascular disease: is the public aware? P336
E.J. Caruana, A.M. Vassallo, M.M. Boffa, S. Micallef, G. Maresca, G. Pace-Moore, J. Borg, P. Schembri-Wismayer (Msida, MT)
Occurrence of epicardial fat in patients with severe obstructive sleep apnea and its correlation with anthropometric and
clinical parameters P337
M. Sova, E. Sovova, M. Hobzova, M. Kamasova, J. Zapletalova, M. Sovova, V. Kolek (Olomouc, CZ)
(Dis)-agreement among cardiovascular risk calculators in clinical practice P338
D. Santovito, C. Paganelli, M. Pagnottella, P. Marcantonio, G. Giammichele, D. De Marco, E. Vitale, A. Mezzetti, F. Cipollone,
M. Bucci (Chieti, IT)
Group 4 Prevention and Epidemiology hosted by. K. Kamiya (Sagamihara, JP) P339
Breast arterial calcications: a systematic review and meta-analysis of their determinants and risk P340
E.J.E. Hendriks, P.A. De Jong, W.P.T.M. Mali, Y. Van Der Graaf, Y.T. Van Der Schouw, J.W.J. Beulens (Utrecht, NL)
D-dimer levels and risk of acute coronary syndrome in men and women: ndings from the EPICOR study P341
A.F. Di Castelnuovo, C. Agnoli, A. De Curtis, G. Matullo, S. Panico, C. Sacerdote, R. Tumino, G. De Gaetano, M.B. Donati,
L. Iacoviello (Pozzilli, Milan, Turin, Naples, turin and Ragusa, IT)
Activity of rheumatoid arthritis is a novel atherosclerotic risk factor P342
M.A.K. Abdel Wahab, A.F. Darweesh (El Minya, EG)
Risk factor assessment of young myocardial infarction in Turkish population W343
I. Caglar, I.F. Akturk, F.N. Turhan Caglar, I. Ungan, M. Erturk, E. Oaz, O. Karakaya (Istanbul, TR)
Cardiovascular risk assessment using the hypertriglyceridemic waist phenotype and common carotid artery intima-media
thickness P344
I. Tilea, T.O. Szakacs Xantus, R. Tatar, A.E. Bocicor (Tirgu Mures, RO)
Vitamin D association with myocardial revascularization in peripheral artery disease: a cross sectional study. P345
G. Di Stolfo, S. Mastroianno, G. De Luca, T. Santoro, M. Fanelli, A. Facciorusso, A. Russo, R. Fanelli (San Giovanni Rotondo
and Foggia, IT)
Coronary artery atherosclerosis and nephroprotective statins effect in patients with nondiabetic chronic kidney disease P346
K.H. Semegen-Bodak, T. Solomenchuk, V. Bodak, P. Bodak (Lviv, UA)
Prevalence of peripheral arterial disease in high-risk patients in Bulgaria P347
M. Panikian-Latifyan, M.D.S. Stankev (Soa, BG)
Baseline mean platelet volume is associated with residual platelet reactivity in patients with unstable angina W348
I. Markava, A. Miadzvedzeva, L. Helis, V. Shyshko (Minsk, BY)
Priorities of the secondary prevention of the coronary heart disease in the Ingush Republic P349
R. Didigova, E. Akhmedova, F. Dumanova, M. Mamedov, Y. Balanova, Z. Ugurchieva (Moscow, RU)
Predictive value of the corrected TIMI frame count in patients with stable angina pectoris symptoms but no obstructive
coronary artery disease at angiography P350
L. Jespersen, S.Z. Abildstrom, A. Pena, P.R. Hansen, E. Prescott (Copenhagen, DK)
41
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 5 Prevention and Epidemiology hosted by E. Prescott (Copenhagen, DK) P351
Risk factors control in female patients treated with primary pci P352
D.B. Dragana Bacic, J.K. Jelena Kostic, A.D.D. Ana Djordjevic Dikic, V.G. Vojislav Giga, J.S. Jelena Stepanovic, B.B. Branko Beleslin,
I.P. Ivana Paunovic (Belgrade, RS)
Trends in rates of revascularization procedures after an acute myocardial infarction (AMI) during 1994-2009 in Norway: a
CVDNOR project P353
E. Sulo, O. Nygard, S.E. Vollset, J. Igland, G. Sulo, M. Ebbing, G. Egland, G.S. Tell (Bergen, NO)
ICEBERG, poor management of dyslipidemia in the elderly. Is carotid ultrasound an alternative to conventional risk scores? P354
M. Matangi, D.W. Armstrong, D. Brouillard, U. Jurt, A.M. Johri (Kingston, CA)
Diagnostic yield of coronary computed tomographic angiography in women versus men: A single-center study P355
B. Jug, D. Kosuta, Z. Fras (Ljubljana, SI)
The impact of cardiovascular disease in the decrease of total mortality in men in France and Belgium during 2 decades
1990-2009) P356
E. Schroeder, L. Gabriel, L. Galanti, P. Laloux, G. Hourrier, J.L. Loison, H. Lewalle, P. Majerus (Yvoir, BE; Charleville-Mzires, FR)
The presence of carotid arteries atherosclerosis and intima-media thickness increase in patients from different categories of
cardiovascular risk P357
A.E. Semenova, D.N. Nozadze, T.V. Balakhonova, I.V. Sergienko, O.A. Pogorelova, S.Z. Urazalina, V.V. Kukharchuk, Y.A. Karpov,
S.A. Boytsov (Moscow, RU)
Detection of early left ventricular systolic and diastolic dysfunction in patients with maternal placental syndrome by tissue
Doppler and strain rate Imaging P358
R. Gaber, S. Bayomi, W. Attalah (Tanta, EG)
Emergence of diastolic dysfunction in south east asia W359
J. Ismail, Z. Ibrahim, K. Arshad, E. Abd Rahman, A. Zainal Abidin, C.W. Lim, C. Nicholas, R. Khir, S. Kasim (Selangor, MY)
Importance of prediction and prevention of severe valve prosthesis- patient mismatch P360
L. Olivencia, M.D. Fernandez, I. Macias, R. Rivera (Granada and Malaga, ES)
Angiotensin II receptor blockers in prevention of valve myxomatous progression and left ventricular dysfunction in mitral valve prolapse P361
E. Malev, G. Kim, M. Omelchenko, E. Zemtsovsky (Saint Petersburg and Krasnodar, RU)
Group 6 Prevention and Epidemiology hosted by P. Dendale (Hasselt, BE) P362
Training and peripheral arterial disease P363
A.D.P. Antonio Di Patria (Maddaloni, IT)
Body composition in patients with peripheral arterial disease (PAD): Lean body mass (LBM) and bone marrow density (BMD)
correlate signicantly with leg perfusion P364
A. Horina, B. Arefnia, G. Wimmer, H. Mangge, F. Hafner, G. Hackl, M. Brodmann, G. Seinost (Graz, AT)
Implications of ankle-brachial index measurement in a primary prevention study of a Central-European town P365
L.Z. Kiss, Z. Bagyura, P. Soos, R. Vadas, L. Polgar, O. Szenczi, Z. Szelid, B. Merkely (Budapest, HU)
Integrated preventive services in primary care: pilot implementation of an online cvd risk assessment and lifestyle intervention
program P366
K. Van Den Brekel, A. Rengers, N. De Wit, R. Kraaijenhagen (Utrecht and Amsterdam, NL)
Obsered changes in cardiovascular disease risk in high risk middle-aged men after lifestyle counselling P367
R. Siren, J. Eriksson, H. Vanhanen (Helsinki, FI)
Lifestyle intervention clinical trial in a labour population with high cardiovascular risk: 24 months follow-up preliminary results P368
M. Cabrera Sierra, A. Fernandez-Meseguer, M.V. Cortes Arcas, M.T. Garcia-Margallo, R.I. Navarro Valle, C. Sanz Martin,
L.A. Diez Alonso, F. Gutierrez Gonzalez, M.A. Zamora Ramirez, E. Calvo Bonacho (Madrid, ES)
Genetic predictor of atrioventricular block P369
A. Chernova, S.Y.U. Nikulina, V.A. Shulman (Krasnoyarsk, RU)
Stimulating the healthy eating on the workplace: results of the project realized in the nancial organization in Russia P370
A. Kontsevaya, N. Karamnova (Moscow, RU)
Vitamins supplement use among adults in Warsaw: is there any nutritional benet? P371
A. Waskiewicz, E. Sygnowska (Warsaw, PL)
Group 7 Prevention and Epidemiology hosted by E. Greco (Fuscaldo, IT) P372
Public health nutrition actions across 14 European countries: a qualitative study to elicit the views of policy makers and
thought-leaders P373
F. Lloyd Williams, H. Bromley, L. Orton, C. Hawkes, D. Taylor Robinson, M.O.aherty, M. Rayner, S. Capewell (Liverpool, London
and Oxford, GB)
A survey on personal health behaviors and attitudes towards physical activity of the staff in a teaching hospital in China P374
W. Zhao, W. Gao (Beijing, CN)
A 16 year review of deaths due to cardiovascular disease in the United Kingdom Armed Forces P375
A.T. Cox, G. Pratt, E. Byrne, L. Baird, K. Harrison, D. Wilson, S. Sharma (London, Bristol and Birmingham, GB)
Athletic CardioClub. A Romanian original experience in promoting physical activity as a way of cardiovascular disease primary
prevention P376
G.P. Tatu-Chitoiu, R. Tecuceanu, F. Mitu, A. Petris, C. Marinescu, D. Deleanu, D. Gaita, I. Coman (Bucharest, Iasi and Timisoara, RO)
42
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
A 17 year review of discharges on medical grounds due to cardiovascular disease in the United Kingdom Armed Forces. P377
A.T. Cox, B. Backholer, E. Byrne, G. Pratt, K. Harrison, D. Wilson, S. Sharma (London, Bristol and Birmingham, GB)
The combined relation of occupational and leisure time physical activity with all-cause mortality accounting for physical tness
among men P378
E. Clays, M. Lidegaard, D. De Bacquer, K. Van Herck, G. De Backer, F. Kittel, P. De Smet, A. Holtermann (Ghent and Brussels, BE;
Copenhagen, DK)
Gender differences in physical activity - Longitudinal results of a comprehensive school-based intervention study (JuvenTUM 3)
over 4 years P379
M. Siegrist, H. Hanssen, C. Lammel, M. Halle (Munich, DE; Basel, CH)
Group 8 Rehabilitation & Implementation hosted by C. Vigorito (Naples, IT) P380
Does isocaloric diet decrease muscle mass loss in patients with obstructive sleep apnea and severe obesity? P381
D. Shamsheva (Moscow, RU)
The relationship between pulse wave velocity and chronic obstructive pulmonary disease in patients with arterial hypertension P382
T. Aksenova, V. Gorbunov, S. Tsarenok, S. Lukyanov (Chita, RU)
Glucometabolic status after acute myocardial infarction in high risk patients: impact on exercise capacity and prognosis. P383
N. Russo, L. Compostella, E. Vettore, T. Setzu, S. Ferretto, A. Zito, F. Devito, C. Bilato, A. Avogaro, F. Bellotto
(Padua, Cortina D'ampezzo and Bari, IT)
Impact of short-term exercise training on QT dispersion and double product in diabetic patients after coronary artery bypass
graft surgery P384
V. Stoickov, S. Ilic, M. Deljanin Ilic, M. Stoickov, D. Petrovic, S. Andonov, V. Ilic, M. Golubovic, P. Babovic, S. Saric (Nis and Niska
Banja, RS)
Cardiac patients with and without type-2 diabetes; body weight, tness and response to rehabilitation P385
H. Kristjansson, S. Jonsdottir, R. Lydsdottir, M.R. Jonasson, K. Kristjansson (Mosfellsbaer, IS)
Dislipidemia management in university vs. general practice setting: compraison of Euroaspire III and DYSlipidemia International
Study (DYSIS) in Slovenia P386
B. Jug, Z. Fras (Ljubljana, SI)
Efcacy of tobacco cessation program in a cardiac rehabilitation unit P387
J.A. Alarcon, X. Arrazola, M. Lavado, A. Perez, M. Rocandio, J. Reparaz, F. Madruga, J. Barrera, J. San Vicente, P. De La Cuesta
(Donostia, ES)
Evaluation of quality of life in hypertensive patients at out-patient treatment: results of 6-month observation P388
G. Radchenko, I. Marzovenko (Kyiv and Summy, UA)
Improved physical tness leads to reduced fatigue during and after cardiac rehabilitation P389
M.E. Van Geffen, N. Ter Hoeve, M. Sunamura, R.T. Van Domburg, H.J.G. Van Den Berg-Emons (Rotterdam, NL)
Self-care management in sleep-activity in patients with coronary artery disease - a randomized intervention study P390
A. Johansson, A. Adamson, J. Ejdeback, U. Edell-Gustafsson (Skvde and Linkping, SE)
Group 9 Rehabilitation & Implementation hosted by To be announced P391
Marital status and health status of patients with cardiac rehabilitation after percutaneous coronary intervention for
myocardial infarction P392
R.T. Van Domburg, N. Ter Hoeve, P.R. Obbens, K. Dulfer, E.M.W.J. Utens, M. Sunamura (Rotterdam, NL)
Information needs and patients attitude towards decision making in cardiac rehabilitation P393
S.C.J. Traa, H.M.C. Kemps, N.B. Peek (Veldhoven and Amsterdam, NL)
RETICARD sub-study: control of cardiovascular risk factors in a cohort of patients with chronic coronary heart disease after
1 year follow-up P394
M. Marina Breysse, J. Piqueras Flores, M.T. Lopez Lluva, N. Pinilla Echeverri, A. Gonzalez Garcia, H. Estero Serrano De La Cruz,
I. Lopez Mesa, I. Sanchez Perez, J. Benezet, F. Lozano Ruiz Poveda (Ciudad Real and Madrid, ES)
Uptake of an online questionnaire system for cardiac rehabilitation patients: preliminairy results P395
J.M.R. Wiggers, S. Vosbergen, R. Kraaijenhagen, M. Jaspers, N. Peek (Amsterdam, NL)
Ambulatory cardiac rehabilitation after coronary revascularization: a gender analysis P396
S. Doimo, A. Della Mattia, K. Salame, P. Maras, G. Sinagra (Trieste, IT)
Benecial effect of cardiac rehabilitation on chronotropic response and associated factors in coronary artery disease P397
P. Rio, T. Pereira-Da-Silva, A. Abreu, M. Nogueira, N. Santos, J. Labandeiro, S. Silva, T. Alves, E. Oliveira, R. Cruz Ferreira (Lisbon, PT)
Functional characteristics of circulating microparticles in patients with coronary artery disease: impact of an exercise training
rehabilitation programme P398
N. Kraenkel, S. Briand, M. Uhlemann, E. Straessler, S. Moebius-Winkler, M. Grunze, G.C. Schuler, T.F. Luescher, V. Adams,
U. Landmesser (Zurich, CH; Leipzig and Trassenheide, DE)
Cost-effectiveness of 2-year comprehensive cardiac rehabilitation program after coronary bypass surgery P399
E. Lubinskaya, O. Nikolaeva (Saint Petersburg, RU)
Predictors of rehospitalization in chronic heart failure patients P400
C.C. Diaconu, L.A. Balaceanu, B. Paraschiv, D. Bartos (Bucharest, RO)
43
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Trimetazidine in cardiac rehabilitation after conventional valve replacement: results from a randomized, open-label, case
control 1-year study P401
I.R. Gaisin, A.S. Gazimzyanova, T.V. Sokolova, A.A. Galimova, M.A. Voronova, E.A. Chernikch, N.I. Maksimov (Izhevsk, RU)
B-Blockers substitution by ivabradine in intolerant patients improves their functional exercise capacity during the cardiac
rehabilitation program without modifying optimal training heart rate. P402
J. Mora-Robles, J.A. De La Chica, M.A. Roldan Jimenez, M. De Mora (Malaga, ES)
Group 10 Rehabilitation & Implementation hosted by A. Abreu (Lisbon, PT) P403
The new concept of the division of physical exercises on the physiological phases for compiling the individual programs of
physical rehabilitation P404
T. Lelyavina, M.Y.U. Sitnikova, E.V. Shlyakhto (Saint Petersburg, RU)
Impact of short-term aerobic training program on long-term cardiovascular mortality in patients with systolic heart failure P405
A.V. Brand, D.A. Andreev, I.Y.U. Giverts, A.A. Gnedina, O.N. Dikur, A.A. Doletsky, E.R. Kuzmina, M.G. Poltavskaya, A.V. Svet,
A.L. Syrkin (Moscow, RU)
Usefulness of rate of perceived exertion for prescribing and self-regulating water- and land-based exercise in heart transplant
recipients P406
R.E. Castro, G.V. Guimaraes, A.C. Tavares, J. Greve, E. Bocchi, F. Bacal, M. Fernandes-Silva, E.G. Ciolac (Sao Paulo and Bauru, BR)
Effectiveness of exercise rehabilitation after lower limb arterial blood ow surgery P407
E. Jakubseviciene, R. Kubilius, L. Velicka, D. Vasiliauskas, E. Milinaviciene, D. Zigmantiene (Kaunas and Virsuziglis, LT)
Primary care , an opportunity to perform cardiac rehabilitation for patients at low risk. P408
M.R. Fernandez Olmo, S. Isaza-Arana, J. Torres-Llergo, J. Vallejo-Carmona, F. Guerrero-Marquez, A. Lopez-Lozano, J.A. Exposito-
Tirado, A. Martinez-Martinez (Seville and Jaen, ES)
Patient-related clinical and sociodemographic determinants of in-patient cardiac rehabilitation outcome in elderly patients P409
A. Salzwedel, K. Wegscheider, L. Herich, G. Strandt, H. Voller (Potsdam and Hamburg, DE)
Is it possible to individualize intensity of eccentric cycling exercise from perceived exertion on concentric test? P410
V. Gremeaux, C. Joussain, C. Espagnac, C. Morisset, N. Tordi, J.M. Casillas, D. Laroche (Dijon and Besanon, FR)
Perceived barriers to exercise in a cardiovascular primary prevention programme P411
S. Tuohy, G. Flaherty, F. Sharif, P. Nash, B. Macneill, K. Daly, J. Crowley (Galway, IE)
Effects of exercise training in patients with type 2-diabetes and coronary artery disease W412
R. Byrkjeland, I.U. Njerve, H. Arnesen, S. Anderssen, I. Seljeot, S. Solheim (Oslo, NO)
Physical tness improvement after cardiac rehabilitation program depends on PWV P413
D. Agnoletti, S. Millasseau, G. Amah, C. Guiti, S. Gagey, J. Peroz, M. Duval, K. Abdennbi (Bobigny, Saint Leu La Foret and Paris, FR)
Telerehabilitation in coronary artery disease (TRIC-study), 3 months data P414
K. Wallner, J. Altenberger, U. Haller, S. Klausriegler, B. Kogler, I. Mairinger, R. Mueller, R. Rieder, H. Zauner (Grossgmain, AT)
Community-based maintenance exercise training following cardiac, pulmonary and heart failure rehabilitation: feasibility,
attendance predictors and scalability W415
J. Adsett, A. Hickey, A. Nagle, A.M. Mudge (Brisbane and Armidale, AU)
Group 11 "Sports Cardiology" hosted by F. van Buuren (Bad Oeynhausen, DE) P416
Prevalence ventricular tachyarrhythmia in young elite athletes P417
V. Komoliatova, L. Makarov, N. Fedina, I. Kiseleva, D. Besportochny (Moscow, RU)
T wave alternans in the young elite athletes P418
V. Komoliatova, L. Makarov, N. Fedina, I. Kiseleva, D. Besportochny (Moscow, RU)
Cardiovascular disease and symptoms in veteran endurance athletes: a purely ageing phenomenon? P419
A. Merghani, M. Walker, R. Narain, A. Cox, L. Millar, H. Dhutia, A. Malhotra, N. Sheikh, M. Papadakis, S. Sharma (London, GB)
Role of arteriosclerotic plaque burden by carotid duplex imaging in cardiovascular screening before exercise training in elderly,
assumed healthy men P420
U. Koepp, G. Eivindson, S. Berntsen, G. Paulsen, F.T. Gjestvang (Kristiansand and Oslo, NO)
Autonomic nervous system activity and markers of arterial stiffness in amateur endurance athletes P421
C. Graeni, D. Schaefer, L. Trachsel, A. Schmidt-Trucksaess, T. Radtke, M. Wilhelm (Bern and Basel, CH)
Early repolarisation is not related to cardiac structure and function in an ethnically diverse cohort of athletes P422
M.C. Adamuz Ruiz, N. Riding, M. Wilson, S. Targett (Doha, QA)
What predicts atrial brillation in veteran endurance athletes P423
A. Merghani, M. Walker, R. Narain, G. Mellor, L. Millar, H. Dhutia, A. Malhotra, N. Sheikh, M. Papadakis, S. Sharma (London, GB)
On site assessment of cardiac function and neural regulation in amateur half marathon runners. P424
L. Dalla Vecchia, E. Traversi, D. Lucini, M. Pagani (Milan and Montescano (Pavia), IT)
Left atrial stiffness is reduced in competitive athletes: a non-invasive estimation by tissue Doppler and speckle-tracking
echocardiography P425
F.D.ascenzi, B.M. Natali, F. Alvino, E. Incampo, V. Andrei, M. Bonifazi, S. Mondillo (Siena, IT)
44
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 12 "Exercise & Translational Science" hosted by M. Guazzi (San Donato Milanese, IT) P426
the peculiarities of the immune status of patients suffered from essential hypertension received different treatment methods W427
O. Molchko (Lviv, UA)
Blood pressure response to cardiopulmonary stress test in primary hyperaldosteronism P428
V. Tuka, J. Widimsky, M. Matoulek, E. Chytilova, T. Zelinka (Prague, CZ)
Rate of oxidative DNA damage in patients with hypertension working under conditions of ultrahigh range radiation exposure P429
V.S. Potaskalova, M.N. Seliuk, A.P. Burlaka, N.V. Khaitovych, M.M. Kozachok, O.V. Seliuk (Kiev, UA)
Acute effects of water- and land-based exercise on ambulatory blood pressure and heart rate variability in heart transplant
recipients P430
E. Ciolac, R. Castro, A. Tavares, S. Ayub, V. Issa, E. Bocchi, F. Bacal, G. Guimaraes (Bauru and Sao Paulo, BR)
prevalence of hypertension in China: a systematic review into trends and regional differences P431
X. Wang, M.L. Bots, F. Yang, A.W. Hoes, C.H. Vaartjes (Utrecht, NL; Changchun, CN)
Myocardial jeopady score as a bridge from pathophysiology of coronary stenosis to myocardial ischemia P432
I. Nedeljkovic, J. Stepanovic, A. Djordjevic-Dikic, V. Giga, M. Banovic, B. Beleslin, M. Nedeljkovic, M. Dobric, M. Tesic, M. Ostojic
(Belgrade, RS)
Assessment of LV function response to incremental dynamic exercise in healthy children and adolescents using 2-D speckle
tracking echocardiography P433
G.E. Pieles, J. Forsey, P. Ramanujam, F. Miller, R.M.R. Tulloh, A.G. Stuart, C.A. Williams (Bristol and Exeter, GB)
The OUES, not the anaerobic threshold, discriminates between patients with cardiovascular disease over COPD P434
A.J. Barron, D.P. Francis, J. Mayet, S. Elkin, A.D. Hughes, R. Wensel (London, GB)
45
Dont Miss
Saturday 10 May
EACPR General Assembly
10:00 - 11:00 in Room Brussels

and
Closing Ceremony
12:15 - 13:00 in Room Amsterdam
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Poster Session 3
Posters to be on display from 14:00 to 18:00
Presenter must be by the poster between 15:30 - 16:30 for posters viewing time and discussant interventions.
Your poster must be removed between 18:00- 18:30
Group 1 Prevention and Epidemiology hosted by. T. Joergensen (Glostrup, DK) P435
Early left ventricular systolic and diastolic dysfunctions in patients with newly diagnosed obstructive sleep apnoea and normal
left ventricular ejection fraction P436
D. Lisulov-Popovic, M. Zdravkovic, M. Krotin, M. Vukcevic, R. Pokrajac, J. Saric, V. Galijan, M. Brajkovic (Belgrade, RS)
Obesity and cardiovascular risk: the role of epicardial fat measured by echocardiography P437
L. Arvigo, G. Novo, M. Guglielmo, M. Lo Presti, S. Giambanco, M.R. Sutera, S. Verga, S. Novo (Palermo, IT)
Body fat mass and arterial stiffness in patients with abdominal obesity P438
O. Listopad, E. Bazhenova, E. Baranova (Saint-Petersburg, RU)
Efcacy of an intensive cardiovascular primary prevention program: 6 and 12 months follow up. P439
S.E. Masnaghetti, S. Sarzi Braga, M. Peraro, T. Marinoni, R. Brugnera, F. Maslowsky, R.F.E. Pedretti (Tradate, IT)
Hypertension and psychological distress in the indigenous population of suriname P440
I.S.K.K. Krishnadath, C.C.F. Antonius, A. Hofman, J. Toelsie (Paramaribo, SR; Rotterdam, NL)
Effect of Heated water-based Exercise training on blood pressure in resistant arterial hypertension: a randomized controlled
Trial (HEx trial) P441
G.V. Guimaraes, L.G.B. Cruz, M.M. Fernandes-Silva, E.L. Dorea, E.A. Bocchi (Sao Paulo, BR)
The metabolomic of hypertension: a powerful tool for early diagnosis and prevention. P442
M. Biagioli, L. Tenori, X. Hu, P. Pantaleo, B. Alterini, C. Luchinat, I. Bertini, A. Montereggi, A. Leone, G.F. Gensini (Florence, IT)
National trends in risk factors for cardiovascular disease P443
C. Koopman, A. Blokstra, I. Vaartjes, M.L. Bots, W.M.M. Verschuren, I. Van Dis (Utrecht, Bilthoven and The Hague, NL)
Lower omega-3 index can be a marker of increased propensity of hypertensive rat heart to malignant arrhythmias. P444
B. Bacova, C. Viczenczova, T. Benova, P. Sec, M. Certik, N. Tribulova (Bratislava, SK)
Metabolic syndrome and target-organs damage in relatively healthy population of bank employers P445
O.P. Rotar, E.G. Malev, E.V. Moguchaya, O.B. Dubrovskaya, M.A. Boyarinova, E.P. Kolesova, V.N. Solntsev, A.O. Konradi,
E.V. Shlyakhto (Saint-Petersburg, RU)
Group 2 Prevention and Epidemiology hosted by P. Marques-Vidal (Lausanne, CH) P446
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta
analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events P447
S.A.E. Peters, R. Huxley, M. Woodward (Utrecht, NL; Brisbane and Sydney, AU)
Copeptin, IGFBP-1 and cardiovascular prognosis in patients with type 2 diabetes during and after acute myocardial infarction P448
M.I. Smaradottir, S.B. Catrina, K. Brismar, V. Gyberg, K. Malmberg, L. Ryden, L.G. Mellbin (Stockholm, SE)
LDL particle size and distribution in children with type 1 diabetes P449
S. Alabakovska, D. Labudovic, K. Tosheska Trajkovska (Skopje, MK)
Risk assessment of diabetes in men with different cardiovascular risk P450
M. Mamedov, M. Kovrigina, Z. Toguzova, E. Akhmedova, Y. Balanova (Moscow, RU)
Physical activity among T2DM patients and its inuence on HbA1c P451
V. Bralic Lang, B. Bergman Markovic (Zagreb, HR)
Left ventricle myocardial remodeling at hypertensive patients with type 2 diabetes or impaired glucose tolerance P452
I. Sapozhnikova, E.I. Tarlovskaya, A.K. Tarlovski (Kirov, RU)
Preventing dyslipidemia in chronic viral B hepatitis patients treated with nucleozidic analogous. Are statins safe? A 2-year study
in Constanta County, Romania P453
A.I. Suceveanu, I.R. Parepa, A. Suceveanu, L. Mazilu, D. Catrinoiu (CONSTANTA, RO)
Familial hypercholesterolemia in Polish population - clinical and molecular diagnosis. P454
A. Wegrzyn, M. Fijalkowski, M. Taszner, M. Chmara, B. Wasag, J. Limon, A. Rynkiewicz, M. Gruchala (Gdansk, PL)
Hdl blood levels and frequency of sh consumption in a young student population P455
A. Avezum, L.A.M. Cesar, D.J.B. Saraiva, J.R.Z. Mendes, C.C. Magalhaes, J.F. Kerr Saraiva (Sao Paulo, BR)
12-weeks of lipid-lowering therapy decrease exercise tolerance without affecting endothelial function or arterial stiffness
among subjects with primary untreated hypercholesterolemia P456
P. Sosner, M. Gayda, G. Mitchell, J. Lalonge, S. Lacroix, M. Juneau, J.-C. Tardif, A. Nigam (Poitiers, FR; Montreal, CA; Norwood, US)
46
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 3 Prevention and Epidemiology hosted by P. Dendale (Hasselt, BE) P457
Non HDLc and cardio-metabolic risk P458
D.E. Baibata, S.G. Ionescu, O.C. Iancu, S. Mancas (Timisoara, RO)
Does use of gul (smokeless tobacco) increase the risk of coronary heart disease in Bangladesh? W459
M.A. Rahman, N. Spurrier, M.A. Mahmood, M. Rahman, S.R. Choudhury, S. Leeder (Melbourne, Adelaide and Sydney, AU;
Dhaka, BD)
Depression and cardiorespiratory tness: A meta-analysis. P460
T. Papasavvas, M. Al-Hashemi, D. Micklewright (Colchester, GB; Doha, QA)
Coronary artery disease and arrhythmia in relation to depressive symptoms P461
J. Piwonski, A. Piwonska, E. Sygnowska, T. Zdrojewski (Warsaw and Gdansk, PL)
External validation of the CAMUNI score, a long-term cardiovascolar disease risk prediction equation for low-incidence
populations P462
G. Veronesi, C. Donfrancesco, L.E. Chambless, F. Gianfagna, L. Palmieri, G. Mancia, G. Cesana, S. Giampaoli, M.M. Ferrario
(Varese, Rome and Monza, IT; Chapel Hill, US)
Echocardiographic features in relation to alcohol in a population with diverse alcohol consumption P463
S.K. Malyutina, A. Ryabikov, S. Shakhmatov, E. Voronina, N. Yasyukevich, Y.U. Nikitin (Novosibirsk, RU)
Chronic Kidney Disease and Metabolic Syndrome in Korean middle-aged Adults from 1998 through 2009 P464
S.Y. Jang, E.Y. Ju, S.W. Park, D.K. Kim (Seoul, KR)
Bariatric surgery improves metabolic prole and diastolic left ventricular function in morbid obesity P465
V. Hernandez Jimenez, J. Saavedra, A. Gonzalez, P. Iglesias, S. Civantos, G. Guijarro, C. Toran, S. Monereo
(Ciudad Real and Madrid, ES)
The relationship between obstructive sleep apnea and reactive hyperemia by peripheral arterial tonometry W466
J. Oh, S. Park, J.C. Youn, G.R. Hong, S.H. Lee, S.M. Kang, D. Choi (Seoul, KR)
Erectile dysfunction in men with high cardiovascular risk and metabolic disorders P467
G. Sharvadze, Y. Balanova, A. Yevdokimova, E. Akhmedova, M. Mamedov (Moscow, RU)
Group 4 Prevention and Epidemiology hosted by H. Saner (Bern, CH) P468
A study of lipoprotein associated phospholipase A2 (LpPLA2) as a better marker than highly sensitive C Reactive protein
(hs CRP) and lipoprotein(a) in Indians with coronary artery disease W469
S. Das, S.K. Gupta, G. Mp, P.C. Ray (New Delhi, IN)
Beyond Framingham Risk Factors and Coronary Calcication: Does Aortic Valve Calcication improve Risk Prediction?
The Heinz Nixdorf Recall Study P470
H. Kaelsch, N. Lehmann, A.A. Mahabadi, M. Bauer, K. Kara, P. Hueppe, S. Moebus, S. Moehlenkamp, K.-H. Joeckel, R. Erbel
(Essen, DE)
Implementation of cardiovascular prevention by evaluation of practice, the Swedish experience P471
A. Kiessling, K. Hambraeus, L. Nilsson, L. Svennberg, J. Perk (Stockholm, Falun, Linkoping, Gvle and Kalmar, SE)
An immunomodelating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma
cholesterol-lowering activity in apoE-/- mice P472
R. Vik, B.B. Bjorndal, M. Musnelli, C. Parolini, S. Holm, P. Bohov, B.B. Halvorsen, T. Brattelid, S. Manzini, G.S. Ganzetti
(Bergen and Oslo, NO; Milano, IT)
The impact of social deprivation on cardiac revascularization outcomes within the National Health Service in England and Wales P473
B. Matata, M. Shaw, J. Mcshane, J. Lucy, T. Grayson, M. Jackson (Liverpool and Swansea, GB)
Percentiles for oscillometric pulse wave velocity in childhood and adolescence P474
J. Elmenhorst, R. Oberhoffer (Mnchen, DE)
Acute atherogenic effect of single fatty meal on healthy volunteer P475
M.A.K. Abdel Wahab, A.M. Ibrahim, T.M. Abdel Rahman (El Minya, EG)
Clinical prole of acute coronary syndrome in elderly patients P476
M.T. Lopez Lluva, V. Hernandez Jimenez, V. Mazoteras Munoz, M. Marina Breysse, N. Pinilla Echeverri, J. Piqueras Flores,
A.L. Moreno Reig (Ciudad Real, ES)
Carotid artery ultrasound dopplerography for detection of coronary artery disease severity estimated by Gensini score P477
N. Gavrilova, V. Metelskaya, E. Yarovaya, S. Boytsov (Moscow, RU)
Signicance of circulating endothelial cells and CD4+CD28null T-lymphocytes for cardiovascular risk stratication in primary
ischemic heart disease prevention P478
A. Iakovleva, O. Mirolyubova, Y.U. Vakhrusheva (Arkhangelsk, RU)
A new state health screening program: rst results P480
N. Pogosova, A. Ausheva, A. Kursakov, A. Karpova (Moscow, RU)
Evaluation of lipid control in patients undergoing percutaneous coronary intervention. Why don't we reach the recommended
target levels? P481
E. Bosch Peligero, M. Bonet Alvarez, R. Flores Clotet, D. Valcarcel Paz, M. Diaz Nuila Alcazar, M. Santalo Corcoy, J.C. Oliva Morera,
J. Guindo Soldevila, A. Martinez Rubio (Sabadell, ES)
Premature rehospitalization after acute coronary syndrome P482
M.T. Rodriguez Esteban, P. Couto Comba, R. Pimienta, R. Llorens Leon, S. Nunez, A. Cabrera De Leon, J.J. Aleman Sanchez,
J.S. Hernandez Afonso (Santa Cruz de Tenerife, ES)
47
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Modiable cardiovascular risk factors and erectile dysfunction - an analysis of the patients awareness of such factors in males
suffering from ischemic heart disease P483
D. Kalka, Z.A. Domagala, A. Rakowska, K. Womperski, R. Franke, E. Sylwina-Krauz, J. Stanisz, M. Pilot, J. Gebala, W. Pilecki
(Wroclaw, Glucholazy and Karpacz, PL)
Pre-hypertension or pre-diabetes: which is better for predicting cardiovascular conditions? P484
A. Khosravi, M. Gharipour, A. Balouchi, Z. Khosravi, M. Talaie, M. Sadeghi, N. Sarrafzadegan (Isfahan, IR)
Changes in cardiovascular and non-cardiovascular comorbidities in 24,878 ambulatory outpatients with cardiac dysfunction
1999-2012 P485
J.M.O. Arnold, A. Ignaszewski, P. Liu, J. Howlett, M.-H. Leblanc, A. Kaan, G. Marchiori (London, Vancouver, Ottawa, Calgary
and Quebec, CA)
Prevention of heart failure in patients after regression of chronic B-cell lymphoid leukemia: response to zofenopril P486
B. Samura (Zaporozhye, UA)
Essential echocardiographic predictors of positive response to cardiac resynchronization therapy P487
M. Zlobina, A. Sokolov, E. Kaygorodova, S. Popov (Tomsk, RU)
Toxic metal barium in children heart tissue P488
O. Koval, N. Nagorna, I. Mokryk, G. Dubova, O. Novack, O. Muzichin, S. Gaida, O. Shvedka, A. Bilyk, N. Usenko (Donetsk, UA)
Exercise testing in patients with a normal ABI and an abnormal lowest ABI. P489
D. Armstrong, D. Brouillard, U. Jurt, C. Tobin, M. Matangi (Kingston, CA)
Group 6 Prevention and Epidemiology hosted by O. Barna (Kyiv, UA) P490
The role of ankle-brachial index for predicting peripheral arterial disease and guiding the antiagregant regimen after acute
coronary syndrome P491
L. Iliuta, E. Panaitescu, M. Rac Albu (Bucharest, RO)
Vascular risk factors of mild cognitive impairment and alzheimers disease P492
J.A. Gonzalez Caceres, O.F.C. Otman Fernandez Concepcion (La Habana, CU)
NT-pro-BNP serum level is an independent predictor of intima-media thickness of the common carotid artery in asymptomatic
patients of a primary prevention study P493
Z. Bagyura, L. Kiss, Z.S. Szelid, R. Vadas, P. Soos, O. Szenczi, B. Merkely (Budapest, HU)
Reference values of aortic pulse wave velocity in adults using oscillometric method (Arteriograph) P494
B. Benczur, R. Bocskei, M. Illyes (Szolnok, Budapest and Pecs, HU)
The role of mitochondrial targeted anti-oxidants in the modulation of reactive oxygen species mediated signalling in human
endothelial cells P495
A. Sanyal, K. Herbert (Leicester, GB)
Treadmill test in identifying preclinical electrical instability of myocardium in healthy subjects. P496
M. Krestjyaninov, V.I. Ruzov, R.H. Gimaev, V.A. Razin, H. Khalaf (Ulyanovsk, RU)
The prevalence of early repolarisation pattern in young Indian population P497
R. Narain, G. Mellor, H. Dhutia, A. Merghani, N. Kumar, L. Millar, A. Malhotra, M. Papadakis, E. Behr, S. Sharma (London and
Birimingham, GB)
Low dose dietary sh oil increases omega-3 index, reduces sub-maximal heart rate and improves heart rate recovery after
intense exercise in t and healthy males P498
G. Peoples, M. Macartney, L. Hingley, M. Brown, P. Mclennan (Wollongong, AU)
Phylloquinone concentrations and the risk of vascular calcication in healthy women P499
G.W. Dalmeijer, Y.T. Van Der Schouw, S. Booth, P.A. De Jong, J.W.J. Beulens (Utrecht, NL; Boston, US)
Vitamin D and components of the metabolic syndrome: the Rotterdam Study P500
A. Vitezova, M.C. Zillikens, A. Hofman, A.G. Uitterlinden, O.H. Franco, J.C. Kiefte-De Jong (Rotterdam, NL)
The management of patients with multiple risk factors through strategic planning improves the success rate of medium term
goals. P502
V.D. Martire, E.R. Pis Diez, D.O. Portillo (La Plata, Buenos Aires., AR)
Exercise capacity and muscle strength in late adolescence and subsequent risk of arrhythmias - a cohort study of 1,4 million men P503
K. Andersen, C. Held, M. Neovius, P. Tynelius, F. Rasmussen, J. Sundstrom (Uppsala, Stocholm and Stockholm, SE)
The association between exercise and non-exercise steps with cardio-metabolic risk factors in healthy adults P504
I. Heinonen, M. Hirvensalo, C.G. Magnussen, T. Tammelin, R. Huupponen, A. Jula, M. Kahonen, T. Lehtimaki, J.S.A. Viikari,
O.T. Raitakari (Turku, Jyvskyl and Tampere, FI)
How much is physical activity decit in men with metabolic syndrome - a pilot accelerometric study P505
A. Kisko, L. Dernarova, N. Kishko, G. Skreckova (Presov, SK; Uzhgorod, UA)
Determinants of attaining and maintaining a low cardiovascular risk prole: the doetinchem cohort study P506
G. Hulsegge, H.A. Smit, Y.T. Van Der Schouw, M.L. Daviglus, W.M.M. Verschuren (Bilthoven and Utrecht, NL; Chicago, US)
Associations between physical activity and palpitations P507
B. Morseth, M.L. Lochen (Tromso, NO)
Identifying solutions, to increase participation in physical activity interventions within a socio-economically disadvantaged
community: a qualitative study P508
M.E. Cupples, C.L. Cleland, R.F. Hunter, M.A. Tully, D. Scott, F. Kee, L. Prior, M. Donnelly (Belfast and Newcastle upon Tyne, GB)
48
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Daily values of central pressure and arterial stiffness in patients older than 60 years with systolic-diastolic, and isolated systolic
hypertension P510
V. Oleinikov, L. Gusakovskaya, N. Sergatskaya, Y. Tomashevskaya (Penza, RU)
Effects of cardiovascular rehabilitation on endothelial function in diabetic patients P511
M. Deljanin Ilic, S. Ilic, D. Simonovic, G. Kocic, R. Pavlovic (Niska Banja and Nis, RS)
Information needs in patients attending cardiac rehabilitation: the role of demographics P512
J. Gallagher, R. Buckmaster, F. Doyle, B. Hannon, N. Pender, B. Mcadam (Dublin, IE)
Young age and ethnicity are risk markers for developing psychological distress after cardiac revascularisation in patients
with ischemic heart disease P513
A. Holdgaard, R. Poulsen, M. Frederiksen, E. Prescott, H. Kruuse Rasmusen (Copenhagen, DK)
Social participation during and after cardiac rehabilitation: frequency, perceived restrictions and satisfaction P514
N. Ter Hoeve, R.T. Van Domburg, H.J. Stam, M.E. Van Geffen, M. Sunamura, H.J.G. Van Den Berg-Emons (Rotterdam, NL)
Importance of psychological intervention during cardiac rehabilitation programs P515
D. Iglesias Del Valle, B. Arbulo, A. Garcia, E. Martinez, I. Soler, N.E. Martinez, C. Casanova, R. Cano, C. Tejero, I. Plaza
Efcient correction of depressive disorders in patients with coronary heart disease P516
A.N. Repin, T.G. Nonka, T.N. Sergienko, E.V. Lebedeva (Tomsk, RU)
Low referral rate to cardiac rehabilitation after primary percutaneous coronary intervention predicted by clinical variables P517
M. Sunamura, N. Ter Hoeve, R. Steenaard, H.J. Van Den Berg, M.L. Geleijnse, H.J. Stam, E. Boersma, R.T. Van Domburg
(Rotterdam, NL)
High levels of risk factors but lack of follow up and poor secondary prevention for people treated for coronary heart disease
(CHD) in Jordan P518
A. Ashour, D. Fitzsimons, P.A.U.L. Slater, B. O.neill, M. Al Nemri, M. Jarrah,
H. Amrat (Jordanstown, GB; Amman and Irbid, JO)
Changes in cardiorespiratory data and quality of life with two different types of exercise: Moderate continuous exercise versus
high intensity interval training. P519
K. Villelabeitia, I. Diaz Buschmann, C. Hernandez De La Pena, C. Lazaro Gomez, A. Garcia Romero, A. Nunez Cortes,
J. Castillo Martin, M. Abeytua Jimenez (Madrid, ES)
Group 9 Rehabilitation & Implementation hosted by C. Vigorito (Naples, IT) P520
Cost reduction by an internet-based telerehabilitation program in coronary artery disease patients after the acute rehabilitation
phase P521
I. Frederix, N. Van Driessche, D. Hansen, J. Berger, K. Bonne, T. Alders, P. Dendale (Leuven and Hasselt, BE)
Compliance to a cardiac rehabilitation program provides benets and prognosis impact P522
A. Ramirez Moreno, J.R. Siles-Rubio, M. Noureddine-Lopez, J. Munoz-Bellido, C. Pera-Rojas, L. Fernandez-Lopez, L. Inigo-Garcia,
F.J. Bravo-Marques, F. Martinez-Garcia (Estepona and Marbella, ES)
Exercise capacity after myocardial infarction in patients with preserved left ventricular ejection fraction P523
M. Dekleva, J. Suzic Lazic, A. Stevanovic, S. Mazic, A. Arandjelovic (Belgrade, RS)
Early inpatient engagement improves cardiac rehabilitation enrollment of patients with coronary artery disease P524
P. Ting, T. Chong, S.L. Ho, S.C. Tan, F. Dawood, F.Y. Yip, G.H. Low, J. Jumari, L.J. Fu, S.W. Tan (Singapore, SG)
Eccentric training in chronic heart failure: feasibility and functional effects - results of a comparative study P525
V.G. Gremeaux, D. Besson, C. Joussain, C. Morisset, Y. Laurent, J.M. Casillas, D. Laroche (Dijon, FR)
Distance walked in eld tests correlates with peak oxygen uptake in chagasic patients and identies patients with low
functional capacity P526
H. Silveira Costa, R. Leite Alves, M. Noman De Alencar, M.C. Pereira Nunes, M.M. Oliveira Lima, M.O.C. Rocha (Belo Horizonte
and Diamantina, BR)
Factors predicting changes in the cardio-respiratory tness of the cardiac rehabilitation patients P527
M. Almodhy, G. Sandercock, G. Pepera (Colchester, GB; Lamia, GR)
Cardiovascular risk factors and return-to work after cerebrovascular disease P528
M. Cabrera Sierra, C. Catalina-Romero, C. Fernandez-Labandera, M. Ruiz-Moraga, L.M. Ruilope, M.A. Sanchez-Chaparro,
P. Valdivielso, A. Gonzalez-Quintela, E. Calvo-Bonacho (Madrid, Mlaga and Santiago de Compostela, ES)
Effects of transcutaneous electrical nerve stimulation on walking distance in patients with peripheral artery disease P529
M. Labrunee, T. Guiraud, J.M. Senard, A. Pathak (Toulouse, FR)
Group 10 Rehabilitation & Implementation hosted by C.H. Davos (Athens, GR) P530
Effect of myocardial ischemia on heart rate response during incremental exercise P531
S. Yoshida, H. Adachi, J. Tomono, S. Oshima (Maebashi, JP)
Origins and development of cardiovascular prevention and rehabilitation in Spain. P532
M.A. Ruescas-Nicolau, M. Guardiola-Sabater, P.C. Aguirre-Marco (Valencia and valencia, ES)
Prognostic value of submaximal measures of exercise capacity in patients with coronary artery disease: a preliminary analysis P533
E. Coeckelberghs, R. Buys, D. Schepers, V.A. Cornelissen, L. Vanhees (Leuven, BE)
49
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Gender differences in cardiac rehabilitation patient characteristics and treatment results across Europe P534
W. Benzer, B. Rauch, J.-P. Schmid, A.-D. Zwisler, P. Dendale, A. Abreu, C. Davos, A. Simon, D. Gaita, H. Mc Gee (Feldkirch, AT;
Ludwigshafen, DE; Bern, CH; Copenhagen, DK; Hasselt, BE; Lisboa, PT; Athens, GR; Balatonfred, HU; Timisoara, RO; Dublin, IE)
Reproducibility of kinetics of skeletal muscle deoxygenation during onset of submaximal exercise in patients with chronic heart failure P535
G. Buskermolen, V.M. Niemeijer, R.F. Spee, P.F.F. Wijn, H.M.C. Kemps (Eindhoven and Veldhoven, NL)
Are ventilatory treshold and 6-minute walk test heart rates interchangeable ? P536
M.D. Morard, L. Bosquet, D. Besson, G. Deley, J.M. Casillas, V. Gremeaux (Dijon and Poitiers, FR; Montreal, CA)
Physical exercise and compliance with nonpharmacologic treatment of patients with coronary artery disease undergoing
coronary artery bypass grafting P537
S. Pomeshkina, E.B. Loktionova, N.V. Arkhipova, O.L. Barbarash (Kemerovo, RU)
Physical exercise for late life Major Depression: the SEEDS study P538
G. Toni, M. Belvederi Murri, S. Zanetidou, M. Menchetti, G. Ermini, F. Tripi, A. Piras, C. Mussi, M. Piepoli, M. Amore
(Correggio, Genova, Bologna, Modena and Piacenza, IT)
The Impact of structured exercise on heart rate recovery in patients with ischemic heart disease P539
M.R. Fernandez Olmo, S. Isaza-Arana, J. Torres-Llergo, J. Vallejo-Carmona, A. Lopez-Lozano, J.A. Exposito-Tirado,
A. Martinez-Martinez (Seville and Jaen, ES)
Heidelberg competence training as a mental training for lifestyle changes in cardiac rehabilitation (HECTALIS-Study) P540
R.M. Nechwatal, L. Glatz, A. Dillenburg, W. Knoerzer (Heidelberg, DE)
The factors that inuence improvements in physical activity in cardiac patients P541
G. Mckee, M. Mooney, S.O.donnell, F.O.brien, D.K. Moser (Dublin, IE; Lexington, US)
Walking tests: a possible assessment tool to predict maximal heart rate for coronary heart disease patients ? P542
V. Gremeaux, J.M. Casillas, C. Joussain, C. Moreau, A. Hannequin, A. Rapin, Y. Laurent, C. Benaim (Dijon and Reims, FR)
Group 11 Sports Cardiology hosted by A. Bif (Rome, IT) P543
The impact of work and intensity-matched aerobic interval vs continuous training on left ventricular morphology and function
in healthy obese women P544
A. Khalil, D. Oxborough, K. Birch (Leeds and Liverpool, GB)
Blood pressure response to exercise in moderate static sports P545
N.M. Panhuyzen-Goedkoop, J.L.R.M. Smeets (Nijmegen, NL)
Are exercise induced premature ventricular beats related to a high risk of sports related cardiac events? P546
N.M. Panhuyzen-Goedkoop, J.L.R.M. Smeets (Nijmegen, NL)
High incidence of arteriosclerosis in assumed healthy, elderly men detected by cardiovascular screening before exercise training P547
U. Koepp, G. Eivindson, S. Berntsen, G. Paulsen, F.T. Gjestvang (Kristiansand and Oslo, NO)
Patterns of left ventricular diastolic function in Olympic athletes. P548
S. Caselli, F. Di Paolo, B. Di Giacinto, C. Pisicchio, F. Quattrini, R. Assorgi, A. Spataro, N.G. Pandian, A. Pelliccia (Rome, IT; Boston, US)
Prevalence and signicance of anterior T wave inversion in females. P549
A. Malhotra, H. Dhutia, S. Ghati, H. Dores, N. Sheikh, L. Millar, R. Narain, A. Merghani, M. Papadakis, S. Sharma (London, GB)
Cardiac benets of endurance training: 40 years old is not too late to start P550
D. Matelot, F. Schnell, C. Ridard, G. Kervio, N. Ville, F. Carre (Rennes, FR)
Cardiovascular ndings in assumpted healthy elderly men by screening before vigorous exercise training P551
U. Koepp, G.E. Eivindson, S. Berntsen, G. Paulsen, F.T.G. Gjestvang (Kristiansand and Oslo, NO)
Palpitations are the most frequent symptom in a physically active population referred to a clinic in sports cardiology P552
L.V. Kaiser-Nielsen, S. Glasius Tischer, E. Prescott, H. Kruuse Rasmusen (Copenhagen, DK)
Group 12 Exercise & Translational Science hosted by A. Mezzani (Veruno (No), IT) P553
Addition of yoga therapy to standard lifestyle modication improve cardiovascular autonomic function and metabolic
derangement in prehypertensive subjects: a randomized controlled study P554
T. Ramkumar, S. Senthil Kumar, P. Pravati, P. Gopal Krushna, T. Madanmohan, Z. Bobby, D. Ashok Kumar (Pondicherry, IN)
Cardiovascular tness assessment in renal organ transplants P555
G. Galanti, L. Stefani, G. Mascherini, M. Gianassi, E. Minetti, A. Pacini (Florence, IT)
Safety of the CO-rebreathing blood volume method in patients with coronary artery disease P556
T. Karlsen, I.M. Leinan, I.L. Aamot, A. Stoylen (Trondheim, NO)
Myocardial infarction rapidly induces diaphragm muscle weakness P557
N. Mangner, T.S. Bowen, S. Werner, S. Glaser, A. Schrepper, T. Doenst, A. Linke, G. Schuler, V. Adams (Leipzig and Jena, DE)
Acute Effects of a Submaximal Endurance Training on Arterial Stiffness in Healthy Middle- and Long-Distance Runners P558
J. Mueller, M. Wilms, R. Oberhoffer (Munich, DE)
Exercise training reduces high mobility group box-1 levels in women with breast cancer: the DIANA (diet and androgens)-5
project P559
F. Giallauria, M. Gentile, P. Chiodini, A. Mattiello, L. Maresca, A. Vitelli, M. Mancini, F. Berrino, S. Panico, C. Vigorito
(Naples and Milan, IT)
50
Saturday 10 May - Morning
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
e-Health and telemedicine in cardiovascular prevention and rehabilitation
Chairpersons: P. Dendale (Hasselt, BE); H. Saner (Bern, CH)
08:30 Into results from the heart coach programme 560
R.J.G. Peters (Amsterdam, NL)
08:52 Telemonitoring in heart failure patients. 561
F. Koehler (Berlin, DE)
09:15 Telerehabilitation-state of the art. 562
I. Frederix (Rotselaar, BE)
09:37 Telemonitoring in cardiovascular prevention: actual situation and future challenges. 563
D. Willemsen (Bad Rothenfelde, DE)
Sports cardiology in practice
Chairpersons: A. Bif (Rome, IT); J. Niebauer (Salzburg, AT)
This symposium will discuss day to day clinical practice in sports cardiology and will cover important aspects of athlete management using
clinical scenarios. The session will commence with an overview for current exercise recommendations in athletes diagnosed with cardiac
disease. The second speaker will discuss advanced imaging techniques (CMR and CT) and their role sports cardiology. The nal speaker
will provide an overview of the signicance and management of repolarisation changes in athletes
08:30 Overview of exercise guidelines in athletes with cardiovascular disease. 564
A. Bif (Rome, IT)
08:48 Indications for advanced imaging techniques in sport cardiology. 565
B.K. Velthuis (Utrecht, NL)
09:06 Assessment of the athlete with repolarisation anomalies. 566
D. Corrado (Padova, IT)
09:24 Left ventricular hypertrophy in athletes: the gray-zone revisited. 567
S. Caselli, M. Maron, J.A. Urbano Moral, N.G. Pandian, A. Spataro, B.J. Maron, A. Pelliccia (Rome, IT; Boston and
Minneapolis, US)
09:42 Right ventricular morphological and functional adaptations in top-level athletes during the season: a speckle-tracking,
prospective, longitudinal study. 568
F.D.ascenzi, V. Curci, F. Alvino, M. Cameli, M. Lisi, M. Focardi, C. Meniconi, M. Bonifazi, S. Mondillo (Siena, IT)
Drawing on expertise from nurses and AHPs for cardiovascular prevention
Joint Session with the Council on Cardiovascular Nursing and Allied Professions
Chairpersons: D. Fitzsimons (Belfast, GB); S. Gielen (Halle, DE)
08:30 Dynamics for lifestyle change in married and cohabiting couples. A review of the literature. 569
C.S. Jennings (London, GB)
08:52 The RESPONSE trial of hospital based nurse coordinated secondary prevention. 570
W.J.M. Scholte Op Reimer (Amsterdam, NL)
09:15 The effect of psychological co-morbidities on the potential of coronary patients to achieve lifestyle changes following a
coronary event. 571
G. McKee (Dublin, IE)
09:37 The COACH trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban
community health centres. 572
C. Dennison (Baltimore, US)
51
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Rapid Fire Abstracts Session II: Diabetes, Nutrition and SES
Chairpersons: D.E. Grobbee (Utrecht, NL); E. Prescott (Copenhagen, DK)
08:30 Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 58 cohorts
including 773,379 individuals and 12,253 strokes 573
S.A.E. Peters, R. Huxley, M. Woodward (Utrecht, NL; Brisbane and Sydney, AU)
08:39 Telomere biology and vascular aging in patients with T2DM 574
E.N. Dudinskaya, N.V. Brailova, I.D. Strazhesko, D.U. Akasheva, O.Y. Isaykina, N.V. Sharashkina, O.N. Tkacheva, S.A. Boytsov
(Moscow, RU)
08:48 Oral glucose tolerance test superior to HbA1c when screening for undiagnosed diabetes in patients with coronary
artery disease. A report from EuroAspire IV 575
V. Gyberg, D. De Bacquer, K. Kotseva, G. De Backer, L. Mellbin, C. Jennings, O. Schnell, J. Tuhomiletho, L. Ryden
(Stockholm, SE; Ghent, BE; London, GB; Munich, DE; Helsinki, FI)
08:57 Using a novel framework to categorise public health nutrition actions in 30 European countries 576
H. Bromley, F. Lloyd Williams, L. Orton, R. Mcgill, E. Anwar, D. Taylor Robinson, M.O.aherty, M. Guzman Castillo,
M. Rayner, S. Capewell (Liverpool and Oxford, GB)
09:06 Intake of plant sterols from natural sources and risk of cardiovascular disease in the EPIC-NL population 577
R.T. Ras, Y.T. Van Der Schouw, E.A. Trautwein, I. Sioen, G.W. Dalmeijer, I. Huybrechts, P.L. Zock, J.W.J. Beulens
(Vlaardingen and Utrecht, NL; Ghent, BE)
09:15 Controlled clinical study on the effect of a patented combination of berberine, red yeast rice and orthosiphon on lipids
and borderline high blood pressure versus diet alone in metabolic syndrome 578
E. Manzato, C. Benvenuti (Padova and Monza, IT)
09:24 Total antioxidant capacity of diet and all-cause mortality in healthy elderly of the MOLI-SANI project 579
S. Costanzo, A. Di Castelnuovo, M. Persichillo, F. Zito, V. Krogh, M. Serani, N. Pellegrini, M.B. Donati, G. De Gaetano,
L. Iacoviello (Pozzilli, Isernia, Milano, Rome and Parma, IT)
09:33 Which health professionals are most at risk for cardiovascular disease? Or Do Not Be a Manager 580
E. Sovova, E. Sovova, M. Nakladalova, M. Sovova, M. Kaletova (Olomouc, CZ)
09:42 Socio-economic trends in CHD mortality in Denmark 1991-2007 581
A.M. Joensen, T. Joergensen, M.O.aherty, A. Borglykke, E.I.B. Prescott, S. Capewell (Aalborg, Glostrup and Copenhagen,
DK; Liverpool, GB)
09:51 Frequency of cardiovascular diseases and risk factors treated in France according to social deprivation and residence
in an overseas territory 582
P. Tuppin, P. Ricci-Renaud, C. De Peretti, A. Fagot-Campagna, N. Danchin (Paris, FR)
Exercise is Medicine quite some obstacles to overcome!
Joint Session with Sports Medicine and Exercise Therapists
Chairpersons: B. Bjarnason-Wehrens (Cologne, DE); P. Doherty (York, GB)
08:30 Look AHEAD for lifestyle changes in diabetics - are our efforts in vain? 583
M. Wilhelm (Bern, CH)
08:52 Impaired lipolysis in response to exercise in the obese another insurmountable problem? 584
D.R.M.J. Hansen (Hasselt, BE)
09:15 How to motivate patients for a long-term healthy lifestyle: the main task for the exercise therapists. 585
J.M. Kleinert (Cologne, DE)
09:37 Patient coaching - possible tools and new concepts. 586
A. Hoffmann (Basel, CH)
52
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
10:00 - 11:00 SPECIAL SESSION BRUSSELS
EACPR Join us!
The Fred Epstein Memorial Lecture
Chairpersons: G.S. Tell (Bergen, NO); E. Prescott (Copenhagen, DK)
11:00 CVD Prevention: what is behind the screen? 587
T.A. Gaziano (Boston, US)
11:00 - 12:00 SPECIAL SESSION BRUSSELS
Lessons from the past
Chairpersons: J. De Sutter (Gent, BE); U. Corra (Veruno, IT)
11:00 Chronicle of a defective heart valve prosthesis. 588
Y. Van der Graaf (Utrecht, NL)
11:30 Atherosclerosis across 4000 years of human history: the Horus study. 589
G.S. Thomas (Long Beach, US)
Lack of individual motivation a killer of cardiovascular prevention
Chairpersons: H. McGee (Dublin, IE); S. Hoefer (Innsbruck, AT)
11:00 Barriers and promoters of the individual motivation-consequences on rehabilitation success and patients prognosis. 590
S. Hoefer (Innsbruck, AT)
11:20 How to evaluate motivation and the potential to adhere lifestyle changes? 591
G. Kok (Maastricht, NL)
11:40 The smoker, the obese, the sedentary and the depressed patient different strategies to generate motivation? 592
M.E. Cupples (Belfast, GB)
Exercise intensity revisited
Chairpersons: V. Adams (Leipzig, DE); A. Mezzani (Veruno, IT)
Exercise training is an adjunct treatment modality to improve patients cardiovascular health. Whereas traditionally moderate endurance
exercise training has been implemented already since two decades, there is a clear and strong trend to explore higher exercise intensities,
especially in interval format. This session includes a translational introduction as well as the current focus of exploring the benets of high
intensity interval training in specic patient groups.
11:00 Lessons from sportive rats. 593
O.J. Kemi (Glasgow, GB)
11:20 High intensity exercise in coronary artery disease: proven concept? 594
L.E.M. Vanhees (Leuven, BE)
11:40 Pushing heart failure patients: is it time yet? 595
C. Heinrich (Munich, DE)

10:00 Welcome Address S. Gielen
10:10 Finance report U. Landmesser
10:20 Vote on Constitutional Changes P. Dendale
10:30 2014-2016 Elections results Executive Board D. Wood, I Graham
10:40 The future of EACPR A. Pelliccia
10:50 AOB & Questions
53
European Association for
Cardiovascular Prevention
and Rehabilitation
EACPR
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Research after your PhD: network opportunities
Chairpersons: D.E. Grobbee (Utrecht, NL); I. Vaartjes (Utrecht, NL)
This session is a network for researchers in the rst 6 years after their PhD
The Networking brunch permits reseachers to meet their peers who are in the same stage of careers. It will allow attendees to explore
any potential collaboration and partnership. The Networking Brunch is kindly offered by the Dutch Heart Foundation.
11:00 Opening: Representative from the Dutch Heart Foundation 596
M.C.M. Senten (The Hague, NL)
11:05 What can the EACPR do for you and what can you do for the EACPR? 597
11:15 Collaboration: the key to successful research. 598
S. Capewell (Liverpool, GB)
11:30 Networking brunch. 599

12:15 - 13:00 SPECIAL EVENT AMSTERDAM
Closing Ceremony
Chairpersons: A. Pelliccia (Rome, IT); S. Gielen (Halle, DE)
Welcome Address
Young Investigator Awards
J. De Sutter (Gent, BE); D.E. Grobbee (Utrecht, NL)
Poster Prizes
J. De Sutter (Gent, BE); D.E. Grobbee (Utrecht, NL)
European Journal of Preventive Cardiology Highly cited award
D.E. Grobbee (Utrecht, NL)
Welcome to EuroPRevent 2015
Closing
A. Pelliccia (Rome, IT)
54
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Poster Session 4
Posters to be on display from 08:30 to12:30
Presenter must be by the poster between10:00 - 11:00 for posters viewing time and discussant interventions.
Your poster must be removed between 12:30 - 13:00
Group 1 Prevention and Epidemiology hosted by J. Perk (Oskarshamn, SE) P600
Comparison of body mass index, waist circumference and epicardial adipose tissue for assessment of metabolic impairment in
children and adolescents P601
I. Schusterova, F.H. Leenen, M. Kuchta, J. Saligova (Kosice, SK; Ottawa, CA)
Revisiting the relationship between body mass index, obesity and cardiovascular risk P602
S.K. Malyutina, G. Simonova, V. Gafarov, Y.U. Nikitin, E. Veryovkin (Novosibirsk, RU)
Association between Obesity and Short sleeping hour in Korean Young Adults P603
S.Y. Jang, E.Y. Ju, D.K. Kim, S.W. Park (Seoul, KR)
The Systematic COronary Risk Evaluation (SCORE) in the prediction of subclinical atherosclerosis in overweight adults P604
L.I. Graur, L. Mihalache, C. Grosu, O. Nita, D.S. Popescu, A. Gherasim, M. Graur (Iasi, RO)
Visceral obesity and risk factors of cardiovascular diseases in men with professional stress P605
N.V. Pyrikova, I.V. Osipova, A.G. Zalzman, I.V. Kalinina, O.N. Antropova (Barnaul, RU)
Prevalence of weight excess in a young student population P606
J.F. Kerr Saraiva, D.J.B. Saraiva, L.A.M. Cesar, A. Timerman, A. Avezum, J.R.Z. Mendes, C.C. Magalhaes (Sao Paulo, BR)
Preclinical atherosclerosis and metabolic syndrome increase cardio and cerebro-vascular events in a 20-years follow up P607
S. Novo, F. Guarneri, A. Peritore, R.L. Trovato, D. Di Lisi, G. Novo (Palermo, IT)
Study of risk factors and left ventricular mass and function in normotensive offsprings of hypertensive parents P608
S. Bansal, A. Dua, D. Gulati (New Delhi, IN)
Control of cardiovascular risk factors with ursodeoxycholic acid and indapamide in postpreeclamptic nursing mothers: results
from a randomized, case-control 1-year study P609
I.R. Gaisin, A.S. Iskchakova, L.V. Shilina (Izhevsk, RU)
Arterial stiffness in children with essential hypertension and white coat hypertension P610
A. Jurko, I. Tonhajzerova, T. Jurko, Z. Visnovcova, M. Mestanik, A. Jurko (Martin, SK)
Ambulatory hypotensive effect of physical training: a reappraisal through a meta-analysis of selected moderators P611
P. Sosner, T. Guiraud, V. Gremeaux, D. Arvisais, L. Bosquet (Poitiers, Toulouse and Dijon, FR; Montreal, CA)
Group 2 Prevention and Epidemiology hosted by J. De Sutter (Gent, BE) P612
Epidemiology of arterial hypertension in working population of Chelyabinsk region in 2002-2007 P613
S.L. Levashov Sergey, M.R. Redkina Marina, A.G. Gorbunova Anastasia, E.G. Volkova (Chelyabinsk, RU)
Atherosclerosis in patients with prediabetes and type 2 diabetes is associated with more signicant microcirculation
abnormalities W614
V.M. Shyshko, T.V. Mokhort, E.E. Konstantinova, N.L. Tsapaeva (Minsk, BY)
Is it possible to prevention of acute myocardial infarction in patients with purulent complications of type 2 diabetes? P615
E. Shalaeva, A. Shalaeva, B. Babajanov, B. Janabaev, A. Bababekov (Tashkent, UZ)
Diagnostic and prognostic signicance of Tissue Doppler parameters, derived deformation parameters and blood pressure
pattern in asymptomatic type 2 diabetic patients P616
A. Stevanovic, M. Dekleva (Belgrade, RS)
The observational HDL hypothesis: a useful therapeutic target? A meta-analysis of 117,411 patients in Randomised Controlled Trials P617
D. Keene, C. Price, M. Shun-Shin, D. Francis (London, GB)
Subjects with low HDL-cholesterol reported higher Cardiovascular Disease (CVD) risk than subjects with high LDL-cholesterol:
The Attica study, 5-year follow-up (2001-2006). P618
N. Georgousopoulou, D. Panagiotakos, C. Pitsavos, C. Chrysochoou, I. Skoumas, C. Stefanadis (Athens, GR)
Association between postprandial triglycerides and coronary artery disease detected by coronary computed tomography
angiography P619
H.L. Staniak, W.S. Filho, M. Miname, I.M. Bensenor, P.A. Lotufo, R. Sharovsky, C.E. Rochitte, M.S. Bittencourt, R.D. Santos
(So Paulo, BR)
55
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
The effects of a low-carbohydrate-high-fat diet on the triad of atherogenic dyslipidaemia P620
E. Rostrup, J.E. Nordrehaug (Bergen, NO)
Tobacco use in middle-schools students in the north-east region of Greece. P621
T. Kyratzoglou, E. Foukarakis (Athens, GR)
Varenicline for smoking cessation in coronary patients: a cardiac rehabilitation program experience. P622
R. Dalmau Gonzalez-Gallarza, A. Castro Conde, S. Del Prado, I. Ponz, S.O. Rosillo, A.M. Iniesta, D. Gemma, M.J. Fernandez Aguita,
G. Alonso, J.L. Lopez Sendon (Madrid and Albacete, ES)
Group 3 Prevention and Epidemiology hosted by P. Leeson (Oxford, GB) P623
Smoking increases insuline resistance in patients with acute coronary syndrome P624
R. Dalmau, A. Castro, S. Del Prado, I. Ponz, M.J. Fernandez, G. Alonso, A.M. Iniesta, N. Montoro, F. De Torres, J.L. Lopez Sendon
Smoking behaviour amongst hospital staff and patients at St Vincents Hospital, Melbourne W625
M.A. Rahman, A. Wilson, R. Sanders, D. Castle, K. Daws, D.R. Thompson, C.F. Ski, S. Matthews, C. Wright, L. Worrall-Carter
(Melbourne, AU)
Diagnosis of chronic obstructive pulmonary disease in patients with coronary diseases who participated in cardiac
rehabilitation program P626
M. Andjic (Belgrade, RS)
Risk factor awareness in a coronary population and the association with health-related quality of life outcomes P627
D. De Smedt, E. Clays, L. Annemans, K. Kotseva, D. De Bacquer (Ghent, BE; London, GB)
The ability of music to prevent pain and anxiety during invasive cardiology procedures: a randomized control study P628
A. Dritsas, I. Dimtsia, I.D. Laoutaris, G. Poulos, T. Maounis (Athens, GR)
Verication of the SCORE model for cardiovascular death risk in the Polish population P629
W. Piotrowski, M. Polakowska (Warsaw, PL)
Data mining approach for in-hospital mortality prediction of patients presented with STEMI after primary PCI P630
M. Sladojevic, S. Tadic, K. Pavlovic, N. Cemerlic-Adjic, T. Popov, M. Petrovic, B. Vujin, S. Sladojevic (Novi Sad, RS)
Markers of iron metabolism and metabolic syndrome in swiss adults P631
N. Kilani, G. Waeber, P. Vollenweider, P. Marques-Vidal (Lausanne, CH)
Intergenerational differences in cardiovascular risk factor levels in Switzerland P632
C. Pommier, G. Waeber, G. Vollenweider, P. Marques-Vidal (Lausanne, CH)
Prognostic value of serial measurements of matrix metalloproteinase-9 in arterial hypertension patients after ischemic stroke P633
A. Berezin, O. Lisovaya (Zaporozhye, UA)
Cardiovascular risk in women with arterial hypertension and subclinical hypothyroidism P634
M. Gvozdyk, O. Mitchenko (Kyiv, UA)
Estimating Shannon ECG entropy in overriding risk for VT in arrhythmogenic right ventricular dysplasia P635
I. Vranic (Belgrade, RS)
Cardiac function after living kidney donation P637
B. Hewing, F. Knebel, H. Dreger, G. Baumann, K. Budde, F. Halleck (Berlin, DE)
ICEBERG, does carotid ultrasound provide additional risk information in some low Framingham risk score patients? P638
M. Matangi, D.W. Armstrong, D. Brouillard, U. Jurt, A.M. Johri (Kingston, CA)
Primary prevention of cardiovascular disease: are we targeting the right patients ? P639
K. Selby, D. Nanchen, P. Marquez-Vidal, R. Auer, B. Gencer, C.M. Matter, T.F. Luscher, S. Windecker, F. Mach, N. Rodondi
(Lausanne, Geneva, Zurich and Bern, CH)
Abnormal blood pressure rise post mild exercise and abnormal B-type natriuretic peptide (BNP) or NT pro-BNP are markers for
early cardiovascular disease risk stratication in asymptomatic subjects P640
M. El Shahawy, M. Entcheva, A. Sabatini (Sarasota, US; Florence, IT)
Cardiovascular risk and it relation to hormonal status in perimenopausal P641
A. Isayeva, A.V. Martynenko, T.A. Struk, O.A. Beloded (Kharkiv, UA)
Reticard study. follow up to a year of a cohort of patients with chronic ischemic heart disease and retinopathy (hypertensive /
atheroesclerotic / diabetic). P642
J. Piqueras Flores, M. Marina Breysse, I. Lopez Mesa, H. Estero Serrano De La Cruz, M.T. Lopez Lluva, A. Moreno Arciniegas,
N. Pinilla Echeverri, F. Lozano Ruiz Poveda, J. Benezet Mazuecos, I. Sanchez Perez (Ciudad Real, ES)
Incidence and severity of alterations in calcium phosphorus metabolism in patients with multiple cardiovascular risk factors and
high framingham score. P643
V.D. Martire, M.V. Martire, E.R. Pis Diez, D.O. Portillo (La Plata, Buenos Aires., AR)
Risk factors of cardiovascular diseases among patients and physicians of Ukraine P644
O.M. Barna, I.M. Gorbas, A.Y. Bazylevych, H.V. Svitlyk, M.O. Harbar (Kyiv and Lviv, UA)
Cardiovascular risk factors are associated with subclinical atherosclerosis in healthy individuals - A DanRisk substudy. P645
R. Ramanathan, J.J. Sidelmann, I.S. Bjerrum, A.C.P. Diederichsen, J. Jespersen, J.B. Gram, N.P.R. Sand (Esbjerg, Hillerod and
Odense, DK)
56
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 5 Prevention and Epidemiology hosted by K. Kamiya (Sagamihara, JP) P646
Novel cardiovascular biomarkers in women with a history of early preeclampsia. P647
J.T. Drost, A.H.E.M. Maas, S. Holewijn, L. Joosten, J. Van Eyck, J. De Graaf, Y.T. Van Der Schouw (Zwolle, Nijmege and Utrecht, NL)
Coronary calcium score and severity of atherosclerotic disease in a elderly population in a university hospital in Brazil P648
N.H. Lopes, L.F.E.G. Luis Fernando Escobar Guzman, S.S.A. Solange De Sousa Andrade, M.C.B. Marcela Cibien Baratella,
C.E.R. Carlos Eduardo Rochitte, C.H.N. Cesar Higa Nomura, H.P. Humberto Pierri (Sao Paulo, BR)
Chronic obstructive pulmonary disease in the prognosis of patients with heart failure: attention towards its prevention P649
S. Petrovic-Nagorni, S. Ciric-Zdravkovic, D. Stanojevic, L. Todorovic, M. Pavlovic, Z. Perisic, E. Dimitrijevic, T. Kostic, S. Dakic (Nis, RS)
Effects up-titration of beta-blocker dose on uric acid levels in chronic heart failure: results from CIBIS ELD study P650
S. Apostolovic, D. Stanojevic, M. Pavlovic, R. Jankovic-Tomasevic, S. Salinger-Martinovic, D. Djordjevic-Radojkovic, E. Tahirovic,
G. Gelbrich, L. Musial-Bright, H.D. Dungen (Nis, RS; Berlin and Leipzig, DE)
Sudden cardiac death in ukraine: ecological aspects of the problems P651
T. Solomenchuk, D.D. Zerbino (Lviv, UA)
B-type natriuretic peptide elevation is more frequent in HIV+ patients compared to the general population P652
N. Reinsch, L. Eisele, T. Neumann, V. Holzendorf, N. Brockmeyer, D. Schadendorf, R. Erbel, S. Moebus, K.H. Joeckel, S. Esser
(Essen, Leipzig and Bochum, DE)
Gender differences of coronary intervention for patients with acute coronary syndrome admitted at a major metropolitan
hospital in Melbourne, Australia W653
M.A. Rahman, A. Macisaac, E. Scruth, L. Worrall-Carter (Melbourne, AU; California, US)
Group 6 Prevention and Epidemiology hosted by D.E. Grobbee (Utrecht, NL) P654
The effect of morning or evening use of a xed-dose combination pill (polypill) on LDL-cholesterol, ambulatory blood pressure
and adherence in patients with cardiovascular disease P655
M. Lafeber, D.E. Grobbee, I.M. Schrover, S. Thom, R. Webster, A. Rodgers, F.L.J. Visseren, M.L. Bots, W. Spiering (Utrecht, NL;
London, GB; Sydney, AU)
Impact of non-fulllment with dietary-pharmacological objectives for the evolution and complications of carotid disease. P656
V.D. Martire, E.R. Pis Diez, D.O. Portillo (La Plata, Buenos Aires., AR)
Patient delay in patients suspected of TIA P657
L.S. Dolmans, K.A. Van Son, A.A. Vermeulen, M.E.L. Bartelink, L.J. Kappelle, A.W. Hoes, F.H. Rutten (Utrecht, NL)
Time for patient-centered health checks? W658
P.E. Korhonen, S. Jarvenpaa, H. Kautiainen, P. Mantyselka (Turku, nekoski, Helsinki and Kuopio, FI)
prevalence of long QT interval in the spanish population older than forty years. results from the OFRECE study P659
P. Awamleh Garcia, C. Graupner, S. Del Castillo, J. Serrano, J.J. Gomez-Doblas, J. Muniz, J.J. Alonso, E. Roig (Madrid, Malaga,
A Corua and Barcelona, ES)
VCG Sophie software as patented tool in risk detection of sudden cardiac dying P660
I. Vranic (Belgrade, RS)
Atorvastatin likewise EPA and DHA exhibit acute antiarrhythmic effects and facilitate termination of ventricular brillation in
hypertriglyceridemic rats. P661
N. Tribulova, T. Benova, C. Viczenczova, V. Knezl (Bratislava, SK)
Effectiveness of Omega 3 PUFAs in Preventing Sudden Death and Fatal Arrhythmias in Coronary Artery Disease P662
M.B. De Guzman, M.F. Ramirez, S. Simon (Manila, PH)
prevalence of inferior early repolarization pattern in spanish population older than forty years. results from the OFRECE study P663
P. Awamleh Garcia, R. Jimenez, A. Curcio, R. Cristobal, J.J. Gomez-Doblas, J. Muniz, J.J. Alonso, E. Roig (Madrid, Malaga,
New biomarkers of vascular aging P664
A.S. Kruglikova, I.D. Strazhesko, O.N. Tkacheva, D.U. Akasheva, E.V. Plokhova, V.S. Pyhtina, E.N. Dudinskaya, N.V. Sharashkina,
O.U. Isaykina, S.A. Boytsov (Moscow, RU)
Group 7 Prevention and Epidemiology hosted by S. Gielen (Halle, DE) P665
Prenatal diagnosis of complete AV- block in neonates and fetuses as best way to prevent heart failure Single centre experience P666
R. Bejiqi, R.R. Retkoceri, N.B. Bejiqi (Prishtina, XK)
Prevention of Stroke in Patients with Atrial Fibrillation: From Standards to Practice P667
E. Serdechnaya, S. Urieva (Arkhangelsk, RU)
prevalence of spontaneous type 1 and type 2 brugada electrocardiographic patterns in spanish population older than forty
years. results from the OFRECE study P668
P. Awamleh Garcia, C. Graupner, J. Serrano, P. Talavera, J.J. Gomez-Doblas, J. Muniz, J.J. Alonso, E. Roig (Madrid, Malaga,
Parental History of Stroke and Coronary Heart Disease and Incident Atrial Fibrillation According to Hypertension in a General
Urban Population: The Suita Study P669
Y. Kokubo, T. Kobayashi, M. Watanabe, K. Kusano, S. Kamakura, K. Kawanishi, Y. Miyamoto (Suita, JP)
Estimating participation factors in a cardiovascular assessment program for general practice patients and job center clients P670
D. Guertler, J. Braatz, F. Weymar, C. Meyer, U. John, J. Freyer-Adam, S.B. Felix, M. Doerr, S. Ulbricht (partner site Greifswald and
Greifswald, DE)
57
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Cardiorespiratory tness and self-reported physical activity in apparently healthy general practice patients W671
J. Braatz, D. Guertler, F. Weymar, C. Meyer, U. John, J. Freyer-Adam, S.B. Felix, M. Doerr, S. Kaczmarek, S. Ulbricht (Greifswald, DE)
Physical activity (PA), blood pressure (BP). Heart rate (HR) and Body mass index (BMI) in primary school students P672
E. Venturini, C. Marabotti, R. Testa (Cecina (LI), IT)
Doctor, tell me what car you drive and I tell you how healthy you are: Correlations between self-reported horsepower of cars
of Austrian physicians and health aspects: results from the TISPLA Study. P673
D. Niederseer, B. Steger, D. Neunhaeuserer, H.P. Colvin, C. Dankl, J. Rieder, J. Niebauer, C. Datz (Oberndorf, Innsbruck and
Salzburg, AT)
Self-reported physical activity in a multi-ethnic cohort: preliminary ndings of the healthy life in suriname study P674
S.M. Baldew, A. Jarbandhan, V. Cornelissen, J. Toelsie, G. Oehlers, L. Vanhees (Leuven, BE; Paramaribo, SR)
Group 8 Rehabilitation & Implementation hosted by H.K. Rasmusen (Copenhagen, DK) P675
Eighteen months of mediterranean diet counseling and high intensity interval training improved and maintained body
composition, cardiometabolic and exercise parameters in obese patients. P676
M. Gayda, G. Lapierre, T. Leandro, M. Juneau, V. Guilbeault, E. Latour, A. Nigam (Montreal, CA)
Statins in the increased risk of diabetes P677
R. Cadenas Chamorro, D. Iglesias, A. Garcia, E. Martinez, M. Larrondo, I. Hortelano, J. De Juan, B. Paredes, O. Salvador, I. Plaza
(Madrid, ES)
Inuence of dry red wine on glucose, HbA1c BP levels in patients with Diabetes Type 2 P678
R. Durgaryan, G.O.H.A.R. Babayan (Yerevan, AM)
Gender differences in the approach of smoking cessation in patients with ischemic heart disease. P679
F. De Torres Alba, R. Dalmau Gonzalez Gallarza, S. Del Prado Diaz, I. Ponz De Antonio, S. Rosillo Rodriguez, D. Gemma, A. Iniesta
Manjavacas, N. Montoro Lopez, A. Castro Conde, J.L. Lopez-Sendon (Madrid, ES)
Impact of a cardiac rehabilitation program on cardiovascular risk factor prole . P680
A. Ramirez Moreno, M. Noureddine-Lopez, J.R. Siles-Rubio, J.C. Salas-Serantes, J. Munoz-Bellido, L. Inigo-Garcia, P. Chinchurreta,
L. Fernandez-Lopez, F.J. Martinez-Garcia, R. Bravo-Marques (Estepona and Marbella, ES)
Intensive lifestyle program combining mediterranean diet counseling and high intensity interval training improves glycemic
control, cardiometabolic and tness parameters in obese patients. P681
M. Gayda, G. Marquis Gravel, M. Juneau, V. Guilbeault, E. Latour, A. Nigam (Montreal, CA)
Achievement of lipid goals in very high risk patients after a cardiac rehabilitation program P682
D. Iglesias Del Valle, A. Garcia, E. Martinez, M. Agudo, M. Larrondo, I. Hortelano, A. Berjillos, R. Cadenas, M.B. Paredes, I. Plaza
Optimal education of educators of adults with Coronary Heart Disease: Health professionals' views W683
M.H. Svavarsdottir, A. Steinsbekk, A.K. Sigurdardottir (Trondheim, NO; Akureyri, IS)
Improvement in exercise tolerance after cardiac rehabilitation in post acute ST elevation myocardial infarction survivors
received different modes of revascularization in Hong Kong P685
C.C. Tam, R. Chan, L. Li, K.B. Lam, Y.Y. Ho, Y.M. Fong, K.L. Wong, A. Wong, A. Yung, S. Lee (Hong Kong, HK)
Effectiveness of inpatient cardiac rehabilitation in patients with coronary artery disease after coronary revascularization P686
E. Milinaviciene, J. Skibarkiene, D. Zigmantiene (Kaunas and Virsuziglis, LT)
The inuences of the intensity of a six-month trial of cardiac rehabilitation on changes in resting heart rate in patients suffering
from ischemic heart disease P687
D. Kalka, Z.A. Domagala, J. Gebala, A. Rakowska, J. Wojcieszczyk, P. Koleda, M. Syrycki, K. Womperski, L. Rusiecki, W. Pilecki
(Wroclaw and Glucholazy, PL)
Characteristics and evolution of young patients with severe left ventricular dysfunction after an acute coronary syndrome P688
J. Caro Codon, F. De Torres Alba, Z. Blazquez Bermejo, I. Ponz De Antonio, R. Dalmau Gonzalez-Gallarza, A. Castro Conde,
S.O. Rosillo Rodriguez, D. Gemma, S. Del Prado Diaz, J.L. Lopez Sendon (Madrid, ES)
Undertreatment for lifestyle change therapy during cardiac rehabilitation: inuence of anxiety and depression symptoms P689
M.M. Van Engen-Verheul, H.M.C. Kemps, R.A. Kraaijenhagen, N.F. De Keizer, N.B. Peek (Amsterdam, Veldhoven and Utrecht, NL)
Weight changes and cardiovascular risk factors control in overweight and obese patients after an acute coronary syndrome:
results from a Swiss prospective multicenter cohort P690
P. Meyer, B. Gencer, F. Sittarame, R. Auer, L. Raber, H. Saner, C.M. Matter, T.F. Luescher, N. Rodondi, F. Mach (Geneva, Bern and
Zurich, CH; San Francisco, US)
Effect of cardiac rehabilitation in the rate of cardiovascular events in patients with ischemic heart disease P691
E. Otero Chulian, P. Fernandez Garcia, P. Sanchez Millan, M. Pajares Vinardell, L. Gheroghe, E. Chueca Gonzalez, M. Fernandez
Garcia, R. Del Pozo Contreras, R. Vazquez Garcia (Cadiz, ES)
Benecial effects of enhanced external counterpulsation therapy in patients with angina pectoris and congestive heart failure P692
T. Tak, H. Ramsey, D. Haberman, C. Cagin (La Crosse, US)
Effect of cardiac rehabilitation program on oscillatory ventilation pattern in heart failure patients P693
F. Yamauchi, H. Adachi, J. Tomono, S. Oshima (Maebashi, JP)
Burden of ischemic mitral regurgitation on severe left ventricular dysfunction in patients following a cardiac rehabilitation program P694
I. Ponz De Antonio, M.J. Fernandez Anguita, S. Del Prado Diaz, R. Dalmau Gonzalez-Gallarza, A. Castro Conde, J.L. Lopez Sendon
58
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 10 Rehabilitation & Implementation hosted by M.E. Cupples (Belfast, GB) P695
Cardiopulmonary exercise testing in patients with pulmonary hypertension: distinct prole of results compared to heart failure P696
S. Katano, A. Hashimoto, T. Fujito, E. Iwamoto, T. Neki, M. Katayose, K. Tsuchihashi, T. Miura (Sapporo, JP)
Analysis of physiotherapy needs of bedridden patients admitted in cardiology rehabilitation after acute event P697
A. Mazza, A. Maestri, F. Camera, P. Longoni, M. Ceresa, A. Gualco, C. Opasich, S. Priori (Pavia, IT)
Preliminary ndings of healthy life in suriname (HeLiSur) study: the self-reported risk prole of stroke patients P698
A.V. Jarbandhan, S.M. Baldew, G.P. Oehlers, F. Diemer, J. Toelsie, H.E.J. Veeger, L. Vanhees (Leuven, BE; Paramaribo, SR;
Amsterdam, NL)
Evaluation of health benets and safety of early comprehensive cardiac rehabilitation in patients with an implantable
cardioverter-debrillator (ICD) P699
J. Smialek, J.M. Majewski (Krakow, PL)
Predictores of performance, centile curves and normative data in incremental shutle walk test in cardiac patients at entry in
cardiac rehabilitation P700
F.M. Fonseca Cardoso, M. Almodhy, G. Pepera, G.R.H. Sandercock (Colchester, GB; Sterea Hellas, GR)
Feasibility of an outpatient cardiac rehabilitation program in primary care. The Norwegian Ullevaal model. P701
B.B. Nilsson, P. Lunde, E. Jarstad (Oslo and Bergen, NO)
Right ventricle disfunction predicts lower exercise tolerance in elderly patients undergoing cardiac rehabilitation after CABG. P702
G. Caminiti, V.D.antoni, R. Giorgi, J. Murugesan, D. Battaglia, M. Volterrani (Rome, IT)
Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac
rehabilitation: preliminary results of the FIT@Home study P703
J.J. Kraal, N. Peek, M.E. Van Den Akker-Van Marle, H.M.C. Kemps (Amsterdam, Leiden and Veldhoven, NL)
Utilizing community tness center for cardiac rehabilitation - the First trial in Japan P704
Y. Matsuo, R.F. Funada, N.T. Takama, N.K. Koitabashi, M.K. Kurabayashi, K.S. Shirakura (Maebashi, JP)
Impact of training methods and patient characteristics on exercise capacity during inpatient cardiac rehabilitation P705
H. Voeller, A. Salzwedel, R. Reibis, S. Kaminski, H. Buhlert, K. Wegscheider (Ruedersdorf, Potsdam and Hamburg, DE)
Skeletal muscle oxygen saturation improves after high intensity interval training in patients with chronic heart failure P706
V.M. Niemeijer, R.F. Spee, P.F.F. Wijn, H.M.C. Kemps (Veldhoven, NL)
Benets of in -hospital cardiac rehabilitation program following cardiac surgery: Exercise training and supervised mobilization P707
I. Burazor, M. Lazovic (Belgrade, RS)
Myocardial performance in breast cancer survivors athletes P708
L. Stefani, I. Corsani, V. Di Tante, G. Innocenti, G. Galanti (Florence, IT)
Group 11 "Sports Cardiology" hosted by To be announced P709
Upper limits and clinical correlates of blood pressure response to exercise in Olympic athletes P710
S. Caselli, B. Di Giacinto, R. Assorgi, F. Quattrini, R. Ciardo, F. Di Paolo, C. Pisicchio, A. Spataro, A. Pelliccia (Rome, IT)
Correlation between blood pressure and left ventricular mass in elite professional male athletes P711
M. Zdravkovic, S. Mazic, T. Acimovic, M. Djelic, M. Antic, I. Nedeljkovic, M. Dekleva (Belgrade, RS)
The ventilatory inefciency coefcient is a reproducible and feasible exercise parameter in chronic heart failure P712
M. Nicolaije, V.M. Niemeijer, R.F. Spee, H.M.C. Kemps (Veldhoven, NL)
Gender differences of the autonomic nervous system in endurance athletes: A study in elite Norwegian, Russian and Swiss
cross-country skiers P713
D. Schaefer, L. Trachsel, F. Schaufelberger, G.F. Gjerdalen, E.E. Solberg, M. Khokhlova, V. Badtieva, T. Radtke, H. Saner, M. Wilhelm
(Bern, CH; Oslo, NO; Moscow, RU)
sports-related sudden death in Germany - preliminary data from a nation-wide registry P714
P. Bohm, T. Meyer (Saarbrcken, DE)
Dynamic changes in left atrial reservoir, conduit, and active volumes in top-level athletes during the season P715
F.D.ascenzi, A. Pelliccia, B.M. Natali, M. Cameli, M. Lisi, M. Focardi, D. Corrado, M. Bonifazi, S. Mondillo (Siena, Rome and Padua, IT)
Prevalence and clinical signicance of inferior T-wave inversions in competitive athletes P716
H. Dores, A. Malhotra, N. Sheikh, H. Dhutia, L. Millar, A. Merghani, R.C. Narain, M. Papadakis, S. Sharma (Lisbon, PT; London, GB)
Correlation between resting heart rate and early left ventricular remodeling in preadolescent athletes P717
M. Zdravkovic, S. Mazic, S. Prijic, V. Vukomanovic, S. Krotin, S. Dimkovic, G. Koracevic, D. Lovic, S. Radovanovic, J. Saric
(Belgrade and Nis, RS)
Is there an association between different morphological BAV patterns and LV dimensions in athletes from different kinds of
sports ? P718
L. Stefani, G. Innocenti, R. Mercuri, G. Galanti (Florence, IT)
59
T
h
u
r
s
d
a
y
F
r
i
d
a
y
S
a
t
u
r
d
a
y
Group 12 "Exercise and Translational Science" hosted by To be announced P719
Active video games for physical activity promotion in obese youth: possibilities and risks P720
B. Boehm, H. Boehm, R. Oberhoffer, C.P. Bauer (Munich, Aschau im Chiemgau and Gaissach, Bad Tlz, DE)
Restricted blood ow training - affordable method for cardiac rehabilitation P721
Y. Matsuo, T.N. Nakjima, K.F. Fukumura, T.Y. Yasuda, Y.S. Sato, R.F. Funada, T.N. Takama, N.K. Koitabashi, M.S. Kurabayashi, K.S.
Shirakura (Maebashi and Tokyo, JP; Battaramulla, LK)
Effect of high intensity interval training on exercise haemodynamics in patients with chronic heart failure P722
R. Spee, V.M. Niemeijer, P.F.F. Wijn, P.A.F. Doevendans, H.M. Kemps (Veldhoven, Eindhoven and Utrecht, NL)
Endothelial function as measured by peripheral arterial tonometry is not related to body composition, exercise capacity and
insulin sensitivity in overweight patients with coronary artery disease P723
A. Jurs, L.R. Pedersen, R.H. Olsen, S.B. Haugaard, E. Prescott (Copenhagen, DK)
Heart rate response after the onset of exercise is associated with arrhythmic events in ARVC patients P724
S. Castelletti, B. Mist, S. Jenkins, P. Syrris, W.J. Mckenna, A. Pantazis (London, GB)
Six minutes walking test and energy activity expenditure in cardiac rehabilitation programs after cardiac surgery P725
F. Maslowsky, R.F.E. Pedretti, S. Sarzi Braga, R. Tramarin (Tradate and Cernusco, IT)
Use of pulsed magnetic eld in the treatment of arterial obliterative disease P726
L. Gaspar, I. Gasparova, P. Gavornik (Bratislava, SK)
60
Exercise & Translational Science
Exercise training: exploring new horizons .......................................................................................................................................................................................................................................... Page 25
Exercise intensity revisited .................................................................................................................................................................................................................................................................................... Page 53
Latest scientic news on exercise rehabilitation in heart failure ................................................................................................................................................................................. Page 37
Modern management of patients with diabetes: from screening to cardiac rehabilitation
Joint Session with the Japanese Society of Cardiac Rehabilation ............................................................................................................................................................ Page 39
Poster Session
Poster session 1 .................................................................................................................................................................................................................................................................................................................. Page 27
Poster Session 2.................................................................................................................................................................................................................................................................................................................. Page 40
Prevention and Epidemiology
2013 ESH/ESC Guidelines on Hypertension ....................................................................................................................................................................................................................................... Page 21
Around the world in 90 minutes .................................................................................................................................................................................................................................................................... Page 33
Biomechanical factors in cardiovascular disease
Joint Session with the ESC Working Group on Atherosclerosis and Vascular Biology ................................................................................................. Page 26
Erectile dysfunction: From the quality of life to the prediction of cardiovascular events
Joint Session with the ESC Working Group on Peripheral Circulation ................................................................................................................................................ Page 24
Global Forum on CVD Prevention in Clinical Practice ........................................................................................................................................................................................................... Page 34
HDL: Still important in cardiovascular prevention?
Mobile App Interactive Session ............................................................................................................................................................................................................................................................... Page 33
Hot debates in nutrition and globesity ................................................................................................................................................................................................................................................... Page 35
Hot topics in hypertension
Joint Session with the ESC Working Group on Hypertension ....................................................................................................................................................................... Page 34
How to detect early cardiovascular disease? Options and pitfalls of different methods
Mobile App Interactive Session ................................................................................................................................................................................................................................................................. Page 37
Imaging of subclinical atherosclerosis in cardiovascular disease prevention: show me the evidence ............................................................................. Page 38
Innovation in design and interpretation of research: Clinical trials ....................................................................................................................................................................... Page 22
Innovation in design and interpretation of research: Meta-analysis .................................................................................................................................................................... Page 22
Innovation in design and interpretation of research: Prediction research .................................................................................................................................................... Page 22
Innovation in design and interpretation of research: study design ........................................................................................................................................................................ Page 22
Lessons from the past ................................................................................................................................................................................................................................................................................................ Page 53
Prediction is difcult especially when its about the future ................................................................................................................................................................................................ Page 24
Rapid Fire Abstracts Session II: Diabetes, Nutrition and SES............................................................................................................................................................................................ Page 52
The Heart - Lung interaction in Preventive Cardiology ......................................................................................................................................................................................................... Page 38
2
(Lp-PLA
2
) testing in risk management of cardiovascular disease events
Sponsored by diaDexus Inc. ........................................................................................................................................................................................................................................................................ Page 36
Treating ACS patients beyond the stent : current evidence & future directions
Sponsored by AstraZeneca ............................................................................................................................................................................................................................................................................ Page 36
Whats new in hypertension: treatment in specic clinical conditions ................................................................................................................................................................ Page 22
Young Investigator Award II - Prevention & Epidemiology and Sports Cardiology ............................................................................................................................. Page 39
List of Sessions
61
Rehabilitation and Implementation
Drawing on expertise from nurses and AHPs for cardiovascular prevention
Joint Session with the Council on Cardiovascular Nursing and Allied Professions .............................................................................................................. Page 51
e-Health and telemedicine in cardiovascular prevention and rehabilitation ................................................................................................................................................. Page 51
Exercise is Medicine - quite some obstacles to overcome!
Joint Session with Sports Medicine and Exercise Therapists ........................................................................................................................................................................... Page 52
Sponsored by SERVIER ........................................................................................................................................................................................................................................................................................ Page 36
Hot topics preventive cardiology .................................................................................................................................................................................................................................................................. Page 37
Is there a scientic basis for the vocational advice during cardiac rehabilitation? ................................................................................................................................. Page 24
Lack of individual motivation a killer of cardiovascular prevention ......................................................................................................................................................................... Page 53
Rapid Fire Abstract Session I: Exercise, Rehabilitation and Other .............................................................................................................................................................................. Page 25
Renal denervation: a novel approach to treatment of hypertension
Joint Session with the ESC Working Group on Hypertension. ....................................................................................................................................................................... Page 35
Tailoring antiplatelet drugs: focus on special populations
Joint Session with the ESC Working Group on Thrombosis ............................................................................................................................................................................... Page 34
Young Investigator Award I - Cardiac Rehabilitation and EBTR ................................................................................................................................................................................... Page 37
Special Event
Closing Ceremony ........................................................................................................................................................................................................................................................................................................... Page 54
EACPR General Assembly ........................................................................................................................................................................................................................................................................................ Page 53
Inaugural Session .............................................................................................................................................................................................................................................................................................................. Page 01
Special Session
Cardiovascular risk management in primary care: dilemmas in following the guidelines
Joint session with the Dutch and Belgian Working Group on Primary Care .............................................................................................................................. Page 34
Cardiovascular risk management part II: secondary prevention pitfalls
Joint session with the Dutch and Belgian Working Groups on Preventive Cardiology. .............................................................................................. Page 35
Guidelines on preventive cardiology: minor or major differences across the Atlantic?
Joint session with the American Heart Association ...................................................................................................................................................................................................... Page 38
Joint Session with the Council on Primary Care ............................................................................................................................................................................................................................ Page 39
Management of cardiovascular risk in non-cardiac surgery ............................................................................................................................................................................................ Page 23
Research after your PhD: network opportunities ........................................................................................................................................................................................................................ Page 54
The Country of the Month project: creating an interactive prevention network .................................................................................................................................... Page 23
The Fred Epstein Memorial Lecture ............................................................................................................................................................................................................................................................. Page 53
The year in Cardiology: The best from our prime Journals.
Joint Session between the European Heart Journal and the European Journal of Preventive Cardiology. ..................................... Page 25
Sports Cardiology
Conundrums in sports cardiology.................................................................................................................................................................................................................................................................. Page 24
Emerging concepts in sports cardiology ............................................................................................................................................................................................................................................... Page 33
How to practice sports cardiology ............................................................................................................................................................................................................................................................... Page 23
How to train heart failure patients with cardiac devices? What should we know about the effect of devices to exercise? .................. Page 23
Sports cardiology in practice ................................................................................................................................................................................................................................................................................ Page 51
62
A
Abreu A.: 23
Adams V.: 37*, 39, 53
B
Barna O.: 35
Benzer W.: 23
Biff A.: 51
Bjarnason-Wehrens B.: 52
Bots M.: 37
Brguljan J.: 21
C
Carre F.: 33
Cifkova R.: 34
Coca A.: 35
Corra U.: 39*, 53
Corrado D.: 24
D
Davos C.: 24
De Sutter J.: 37*, 53
Dendale P.: 51
Doherty P.: 25, 52
E
Elegeert I.: 35
Evans P.: 26
F
Fagard R.: 34
Fitzsimons D.: 51
G
Giannuzzi P.: 37, 39
Gielen S.: 34, 36, 37, 51, 54
Gohlke H.: 38
Graham I.M.: 33
Greco E.: 38
Grobbee D.E.: 23, 25, 33, 39, 52, 54
Guazzi M.: 25, 39*
Gupta S.: 35
H
Halcox J.: 37*
Halle M.: 33, 37
Hambrecht R.: 37
Hewing B.: 37
Hobbs R.: 39
Hoefer I.: 26
Hoefer S.: 53
Husted S.: 34
K
Kahan T.: 21
Kamiya K.: 39
Kimura Y.: 39
Kjeldsen S.E.: 35
Konings K.: 34
L
Landmesser U.: 25
Leeson P.: 33
Logstrup S.: 38
Lovic D.: 21
M
Mancia G.: 21
McGee H.: 53
Mendis S.: 34
Mezzani A.: 53
Moons C.: 24
N
Nathoe H.: 23
Niebauer J.: 51
Nixdorff U.: 36, 38
P
Panico S.: 36
Panhuyzen-Goedkoop N.M.: 24
Pelliccia A.: 33, 37, 54
Perk J.: 34, 38
Piepoli M.F.: 23, 25
Prescott E.: 39*, 52, 53
R
Rocca B.: 34
S
Saner H.: 51
Sans Menendez S.: 24
Schmid J-P.: 37*
Sharma S.: 23
Sinnaeve P.R.: 36
T
Tell G.S.: 37*, 53
Tokgozoglu L.: 21
U
Urhausen A.: 38
V
Vaartjes I.: 54
van Buuren F.: 23
Vanhees L.: 37
Vanuzzo D.: 39*
Vigorito C.: 24
Viigimaa M.: 24
Vlachopoulos C.: 24
Voors A.: 36
W
Wittekoek J.: 35
List of Chairpersons and Judges*
Name / Page(s) number
63
A
Abreu A.: P151, P403
Adachi H.: 294
Adamopoulos S.: 268
Adams V.: 214
Ajjan R.: 262
Andersen K.: 27
Appelman J.E.A.: 246
Aveyard P.: 302
B
Back M.: 74
Barna O.: P490, P76
Beattie S.: 11
Biff A.: 564, P543
Boethius G.: 281
Bots M.: 286
Boudrez H.: 280
C
Capewell S.: 238, 598, P87
Chowdhury R.: 40
Christensen K. L.: 2
Cifkova R.: 242, 4
Coca A.: 223
Corra U.: 51
Corrado D.: 566
Cosentino F.: 56
Cupples M.E.: 592, P695
D
Davos C.H.: P530
De Backer G.: 284, 35
de Koning H. J.: 288
De Sutter J.: P612
Dempster M.: 42
Dendale P.: P362, P457
Dennison C.: 572
Duengen H.D.: 270
E
Edelmann F.: 270
Elegeert I.: 247
Evans P.: 75
F
Fache W.: 258
Fagard R.: 221, 261
Franco Duran O. H.: 5
Frederix I. :562
G
Gambassi G.: 234
Gaziano T. A.: 587, 283
Ghiadoni L.: 45
Giallauria F.: 21
Gielen S.: 230, 249, 597, P665
Gohlke H.: 25, 285
Graham I. M.: 232, 282, 29, P98
Greco E.: P372
Grobbee D.E.: 60, P654
Groenwold R.: 18
Guazzi M.: P426
Gyberg V.: 260
H
Halcox J.P.J.: P200
Halle M.: 50
Hansen D.R.M.J.: 584
Hanssen H.: 264
Heinrich C.: 595
Henkin Y.: 28
Hewing B.: P163
Hoefer I.: 73
Hoefer S.: 590
Hoffmann A.: 586
Hollander M.: 226
Huijbers E.: 228
Husted S.: 236
J
Jacobsen J.C.: 18
Jennings C. S.: 569
Jennings S.: 25
Joergensen T.: 239, P435
Jourdain P.: 252
K
Kahan T.: 17, 243
Kamiya K.: P339, P646
Kavousi M.: 37, 61
Kemi O. J.: 593
Kengne A.P.: 208
Kiessling A.: 26
Kjeldsen S. E.: 16
Kleinert J.M.: 585
Koehler F.: 561
Kok G.: 591
Kraaijenhagen R.: 28
L
Landmesser U.: 213, 250, 55
Lazaridis A.: 47
Leeson P.: 267, P623
Lorenz M.: 287
M
Mancia G.: 3
Mant J. W.: 304
Marques-Vidal P.: P446
Marsh T.: 240
Mayer-Berger W. J.: 43
McKee G.: 571
Meijer R.: 266
Mendes M.: 269, 41
Mendis S.: 209, 229
Mezzani A.: P553
Monserrat L.: 32
Moons K.G.M.: 61
Mosterd A.: 216
N
Nathoe H. M.:13
Nawrot T.: 44
Niebauer J.: 218, P189
Nilsson P. M.: 14
Nixdorff U.: 257, P131, P306
P
Papadakis M.: 217
Parati G.: 1, 244
Perk J.: 231, 24, P600
Peters R. J. G.: 560
Piepoli M. F.: 20
Pistono M.: 19
Pogosova N.: 210
Prescott E.: P142, P351
R
Rasmusen H. K.: 7, P675
Reiner Z.: 263
Reitsma J.B.: 40
Rocca B.: 237
Rubinstein A.: 211
Rutten F. H.: 279
Ryden L.: 233, 292
S
Saner H.: P468
Schmid J.-P.: 256, P175
Schmied C.: 59
Scholte Op Reimer W. J. M.: 570
Seidell J.: 241
Senten M.C.M.: 596
Sharma S.: 30
Sheikh N.: 6
Siegbahn A.: 235
Sinnaeve P. R.: 254
Solberg E. E.: 8
Sone H.: 209, 293
Stehouwer C.D.A.: 265
T
Taddei S.: 57
Taylor C.: 303
Tell G. S.: P317
Thomas G. S.: 589
To be announced: 58, 212, 215
Tsioufs C.: 245
Tuomilehto J.: 291
U
Uiterwaal C.S.: 5
Ural D.: 27
V
van Buuren F.: P416
Van den Brekel K.: 227
Van der Graaf Y.: 588
Van Herwaarden J.: 12
Vanhees L. E. M.: 53, 594
Vanuzzo D.: 36, P328
Velthuis B. K.: 565
Verheugt F.W.A.: 255
Vigorito C.: P380, P520
Viigimaa M.: 26
Vlachopoulos C.: 46
Volpe M.: 222
Voors A. A.: 251, 253
W
Weber C.: 72
Wilhelm M.: 583
Willemsen D.: 563
Wittekoek J.: 248
Wuerzner G.: 15
Z
Zaidi S. T. A.: 31
List of Speakers
Name / Index number
64
A
Aamot I.L.: P556
Abaravicius J.-A.: P81
Abaraviciute L.: P81
Abazaj A.: P85
Abd Rahman E.: P359
Abdel Rahman T. M.: P475
Abdel Wahab M. A. K.: P342, P475
Abdelhameed A.: P201
Abdennbi K.: P413
Abe T.M.O.: P102
Abeytua Jimenez M.: P519
Abildstroem S.: P112
Abildstrom S.Z.: P350
Abirova E.S.: P108
Abreu A.: P179, P397, P534
Acimovic T.: 10, P711
Adachi H.: P531, P693
Adami P.E.: P190, P192, 195
Adams V.: P398, P557
Adamson A.: P390
Adamuz C.: 295
Adamuz Ruiz M. C.: P422
Adsett J.: P415
Agnoletti D.: P413
Agnoli C.: P341
Agudo M.: P682
Aguirre-Marco P.C.: P532
Aidietiene S.: P307, P81
Akasheva D.: P334
Akasheva D.U.: 574, P664
Akashi Y.J.: P147
Akhmedova E.: P349, P450, P467
Aksenova T.: P382
Akturk I.F.: P343
Al Nemri M.: P518
Alabakovska S.: P449
Alarcon J. A.: P387
Albert A.: P164
Albert I.: P164
Alders T.: P521
Aleksandrov A.A.: P318
Aleksentseva A.: P314
Aleman Sanchez J.J.: P482
Alexiev A.: P114
Al-Hashemi M.: P460
Alloni M.: P170
Almodhy M.: P527, P700
Alonso Deniz G.: P169
Alonso G.: 48, P323, P622, P624
Alonso J.J.: P659, P663, P668
Altenberger J.: P414
Alterini B.: P442
Aluma T.: P140
Alvarez Gomez J.: P90
Alves T.: P397
Alvino F.: 568, P425
Alyasova P.A.: P108
Amah G.: P413
Amin A. E. H.: P320
Ammar W. A. A.: P320
Amore M.: P538
Amrat H.: P518
Ana Djordjevic Dikic A.D.D.: P352
Andersen K.: P503
Anderssen S.: P412
Andjic M.: P626
Andonov S.: P384
Andreev D.A.: P405
Andreeva G.F.: P78
Andrei V.: P425
Annemans L.: P627
Antic M.: 10, P711
Antonio Di Patria A.D.P.: P363
Antonius C.C.F.: P440
Antonoulas A.: P166
Antropova O.: P314
Antropova O.N.: P605
Anwar E.: 576
Apostolovic S.: P650
Arandjelovic A.: P523
Araujo A.: 48, P323
Arbulo B.: P515
Arefnia B.: P364
Arkhipova N.V.: P537
Armstrong D.: P489
Armstrong D.W.: 289, P354, P638
Arnesen H.: P412
Arnold J.M.O.: P485
Arranz H.: 48, P323
Arrazola X.: P387
Arshad K.: P359
Arvigo L.: P437
Arvisais D.: P611
Ashikaga K.: P147
Ashok Kumar D.: P554
Ashour A.: P518
Assorgi R.: P548, P710
Attalah W.: P358
Auer R.: P639, P690
Ausheva A.: P313, P480
Autore C.: 65
Avezum A.: P103, P325, P455, P606,
P95
Avila Lopez J.C.: P90
Avogaro A.: P383
Awamleh Garcia P.: P659, P663, P668
Ayub S.: P430
Azevedo A.: 70
B
Bababekov A.: P615
Babajanov B.: P615
Babayan G.: P678
Babovic P.: P384
Bacal F.: P406, P430
Backholer B.: P377
Backx F.J.G.: P193
Bacova B.: 224, P136, P444
Badtieva V.: P713
Bagyura Z.: P365, P493
Baibata D.E.: P458
Baird L.: P375
Bairey Merz N.: P129
Baker J.: P124
Balaceanu B.: P79
Balaceanu L.A.: P400, P79
Balakhonova T.V.: P357
Balanova Y.: P327, P349, P450, P467
Baldasseroni S.: 273
Baldew S.M.: P674, P698
Balouchi A.: P484
Banerjee T.: P167
Banovic M.: P205, P432
Bansal S.: P608
Bara P.: P119
Baranova E.: P438
Barbarash O.L.: P537
Barna O.M.: P644
Barrera J.: P387
Barron A. J.: P434
Bartelink M.E.L.: P657
Bartos D.: P400
Bartsch P.: 52
Barucci R.: 273
Bassle E.R.: 277
Battaglia D.: P702
Battakova Z.: P110
Bauer C.P.: P720
Bauer M.: P470
Baumann G.: P637
Bautista P.K.: P144
Bayomi S.: P358
Bazhenova E.: P438
Bazylevych A.Y.: P644
Beckers P.J.: 54
Behr E.: P497
Bejiqi N.B.: P666
Bejiqi R.: P666
Bele S.: P85
Beleslin B.: P205, P432
Bellotto F.: 23, P383
Beloded O.A.: P641
Belohoubek J.: P125
Belvederi Murri M.: P538
Benaim C.: P542
Benczur B.: P494
Benezet J.: P394
Benezet Mazuecos J.: P642
Bennett K.: P329
Benova B.: P136
Benova T.: 224, P444, P661
Bensenor I.M.: P619
Benvenuti C.: 578
Benzer W.: P167, P534
Berenyi I.: 67
Berezin A.: P204, P633
Berg S.K.: 68, P203
Berger J.: P521
Bergman Markovic B.: P451
Berjillos A.: P184, P682
Berkinbaev S.: P110
Berlutti G.: P190
Bernardi M.: P192
Berntsen S.: P197, P420, P547, P551
Berrino F.: P559
Bertelsen J. B.: P173
Bertini I.: P442
Bertolin F.: 66
Beskow B.: P121
Besportochny D.: P417, P418
Besson D.: P525, P536
Beulens J.W.J.: 577, P340, P499
Biagioli M.: P442
Bijnens B.: 297, P198
Bilato C.: P383
Bilyk A.: P488
Birch K.: P544
Bittencourt M.S.: P619
Bjarnason-Wehrens B.: 52, P181
Bjerrum I.S.: P645
Bjorndal B.B.: P472
Blankoff I.: 69
Blazquez Bermejo Z.: P172, P688
Blokstra A.: P443
Boanta F.: P145
Bobby Z.: P554
Bocchi E.: P406, P430
Bocchi E.A.: 274, P441
Bochkareva E.V.: P139
Bocicor A.E.: P344
Bocskei R.: P494
Bodak P.: P346
Bodak V.: P111, P346
Bodini B.D.: P105
Boehm B.: P199, P720
Boehm H.: P720
Boersma E.: P517
Boffa M.M.: P336
Bohm P.: P714
Bohov P.: P472
Bolzani V.: P155
Bonaccio M.: P321
Bonet Alvarez M.: P481
Bongers B.C.: P206
Bonifazi M.: 568, P425, P715
Bonne K.: P521
Boonman-De Winter L.J. M.: P133
Booth S.: P499
Borg J.: P336
Borglykke A.: 581, P112
Bosch Peligero E.: P481
Bosquet L.: P536, P611
Bots M.L.: 290, P431, P443, P655
Bottio T.: 23
Bouslenko Z.: 66
Bovet P.: 300
Bowen T.S.: P557
Boyarinova M.A.: 225, P445
Boytsov S.: P334, P477
Boytsov S.A.: 574, P357, P664
Braatz J.: P670, P671
Braber T.L.: P193
Brailova N.: P334
Brailova N. V.: 574
Brajkovic M.: P436
Bralic Lang V.: P451
Bramer W.M.: P144
Brand A.V.: P405
Branko Beleslin B.B.: P352
Brattelid T.: P472
Bravo-Marques F.J.: P522
Bravo-Marques R.: P680
Breda J.: 299
Briand S.: P398
Briganti C.: P190
Brimas G.: P307
Brismar K.: P448
Brockmeyer N.: P652
Brodmann M.: P364
Bromley H.: 576, P373
Brotons B.: 297
Brotons D.: P198
Brouillard D.: 289, P354, P489, P638
Brown M.: 299, P498
Brozaitiene J.: P161, P185
Brubaker P.H.: 272
Brugada R.: 297, P198
Brugnera R.: P439
Bruthans J.: P125
Bruyndonckx L.: 277
Bucci M.: P338
Buckmaster R.: P512
Budde K.: P637
Buhler R.P.: P171
Buhlert H.: P705
Bunevicius R.: P161
Burazeri G.: P135
Burazor I.: P707
Burgisser C.: 273
Burlaka A.P.: P429
Buskermolen G.: P535
Buys R.: 276, P533
Buzo C. G.: P102
List of Authors
Name / Page(s) number
65
Byrkjeland R.: P412
Byrne E.: P375, P377
C
Cabrera De Leon A.: P482
Cabrera Sierra M.: P368, P528
Cadenas Chamorro R.: P677
Cadenas R.: P682
Caetano F.: 49
Cafka M.: P135, P85
Cagin C.: P692
Caglar I.: P343
Cakerri L.: P85
Calvo Bonacho E.: P368, P528
Camacho-Azkargorta I.: 62
Cameli M.: 568, P715
Camera F.: P697
Caminiti G.: P702
Campos Moreira De Almeida I.: 49
Cano R.: P515
Capewell S.: 576, 581, P373
Carlos Eduardo Rochitte C.E.R.: P648
Caro Codon J.: P172, P688
Carre F.: P550
Caruana E.J.: P336
Caruso A.: 278
Casanova C.: P515
Caselli S.: 567, 65, P548, P710
Casillas J.M.: P410, P525, P536, P542
Castelletti S.: P724
Castillo Martin J.: P519
Castillo Martinez L.: P90
Castle D.: P625
Castro A.: 48, P323, P624
Castro Conde A.: P107, P169, P172,
P183, P622, P679, P688, P694
Castro R.: P430
Castro R. E.: P406
Catalina-Romero C.: P528
Catrina S.B.: P448
Catrinoiu D.: P453
Cattozzo A.: P207
Cechet R.: P177
Celic V.: P202
Cemerlic-Adjic N.: P630
Ceresa M.: P697
Certik M.: P444
Cesana F.: P170
Cesana G.: P322, P462, P91
Cesar Higa Nomura C.H.N.: P648
Cesar L.A.M.: P103, P325, P455, P606,
P95
Chambless L.E.: P462
Chan R.: P685
Chandra N.: 219
Chen P.-C.: 300
Cherkasova O.G.: P117
Chernikch E.A.: P401
Chernova A.: P369
Chinchurreta P.: P680
Chiodini P.: P559
Chmara M.: P454
Choi D.: P466
Chong T.: P524
Choudhury S.R.: P459
Chowdhury R.: P144
Christensen B.: P173
Christensen K.L.: P173
Chrysohoou C.: P118, P618
Chu S.H.: P104
Chueca Gonzalez E.: P691
Chukaeva I.: P324
Chytilova E.: P428
Ciardo R.: P710
Cifkova R.: P125
Ciolac E.: P430
Ciolac E. G.: P406
Cipollone F.: P338
Ciric-Zdravkovic S.: P649
Civantos S.: P308, P465
Claes N.: 69
Clays E.: P378, P627
Cleland C.L.: P508
Coats A.J.S.: 22
Coeckelberghs E.: 276, 54, P533
Coelho H.: 49
Colombo C.: P105
Colvin H.P.: P673
Coman I.: P376
Comazzi F.: 66, P155
Compostella L.: 23, P383
Conraads V.: 54
Conraads V.M.: 277
Cornelissen V.: 276, P674
Cornelissen V.A.: 54, P533
Corra U.C.: P155
Corrado D.: P715
Corrado E.: P80
Corsani I.: P708
Corsi L.: P192
Cortes Arcas M.V.: P368
Costanzo S.: 579, P321
Couto Comba P.: P482
Cox A.: P419
Cox A.T.: P375, P377
Cramer M.J.: P133
Cristobal R.: P663
Crowley J.: P411
Cruz Ferreira R.: P179, P397
Cruz L.G.B.: 274, P441
Cubattoli L.: P146
Culasso F.: P190
Cupples M.E.: P508
Curci V.: 568
Curcio A.: P663
D
Da Silva R.I.: P177
Daal H.: 271
Dakic S.: P649
Dalla Pozza R.: P82
Dalla Vecchia L.: P424
Dalmau Gonzalez-Gallarza R.: P107,
P169, P172, P183, P622, P679, P688,
P694
Dalmau R.: 48, P323, P624
Dalmeijer G. W.: P140, P499, 577
Daly K.: P411
Danchin N.: 582, P315
Dankl C.: P673
Dantoni V.: P702
Danylova A.V.: P117
Darweesh A. F.: P342
Darweesh S.K.L.: P144
Das S.: P469
Dascenzi F.: 568, P425, P715
Datz C.: P673
Daviglus M.L.: 298, P506
Davletov K.: P110
Davoli M.: 70
Davos C.: P534
Dawood F.: P524
Daws K.: P625
De Backer G.: 575, P128, P378
De Bacquer D.: 575, P128, P378, P627
De Blasiis E.: P190
De Curtis A.: P341
De Gaetano G.: 579, P321, P341
De Graaf J.: P647
De Guchtenaere A.: 277
De Guzman M.B.: P662
De Jong P.A.: P340, P499
De Juan J.: P184, P677
De Keizer N.F.: P689
De Koning E.: P100
De Koning H.J.: P123
De La Chica J.A.: P162, P174, P402
De La Cuesta P.: P387
De Lima J.B.: P171
De Luca G.: P345
De Lucia C.: 278
De Maeyer C.: 54
De Marco D.: P338
De Mora M.: P162, P402
De Mora M.A.: P174
De Mutsert R.: P100
De Peretti C.: 582, P315
De Roia G.: P186
De Roos A.: P100
De Smedt D.: P627
De Smet P.: P378
De Torres Alba F.: P172, P679, P688
De Torres F.: P624
De Vries S.I.: P206
De Wit N.: P138, P366
De Wit N.J.: P143
Deev A.: P327
Deev A.D.: P141
Dekleva M.: 10, P523, P616, P711
Del Castillo S.: P659
Del Pozo Contreras R.: P691
Del Prado Diaz S.: P172, P183, P679,
P688, P694
Del Prado S.: 48, P323, P622, P624
Deleanu D.: P376
Deley G.: P536
Deligiannis A.: P176
Deljanin - Ilic M.: P132
Deljanin Ilic M.: P384, P511
Della Mattia A.: P396
Demuth I.: P94
Den Heijer M.: P100
Denchev S.: P114
Dendale P.: P521, P534
Dernarova L.: P505
Desposito V.: 278
De-Torres Alba F.: P169
Devito F.: P383
Dhutia H.: 219, 296, 33, 34, 9, P419,
P423, P497, P549, P716
Di Castelnuovo A.: 579, P321
Di Castelnuovo A. F.: P341
Di Giacinto B.: P190, P548, P710
Di Lisi D.: P607
Di Paolo F.: 65, P195, P548, P710
Di Stolfo G.: P345
Di Tante V.: P708
Diaconu C.C.: P400, P79
Diaconu E.: P79
Diaz Anton B.: P107
Diaz Buschmann I.: P519
Diaz Nuila Alcazar M.: P481
Dibra A.: P119
Didigova R.: P349
Diederichsen A.C.P.: P645
Diemer F.: P698
Diez Alonso L.A.: P368
Dikur O.N.: P405
Dillenburg A.: P540
Dima F.: P91
Dimitrijevic E.: P649
Dimitros E.: P176
Dimkovic S.: P717
Dimtsia I.: P628
Dinca-Panaitescu S.: P145
Divajeva D.: 299
Djelic M.: 10, P202, P711
Djordjevic-Dikic A.: P205, P432
Djordjevic-Radojkovic D.: P650
Dobric M.: P205, P432
Doenst T.: P557
Doerr M.: P670, P671
Doevendans P.A.F.: P722
Doevendans P.A.F.M.: P193
Doimo S.: P396
Doko A.: P85
Doletsky A.A.: P405
Dolmans L.S.: P657
Domagala Z.A.: P483, P687
Donati M.B.: 579, P321, P341
Donfrancesco C.: P148, P322, P462,
P91
Donnelly M.: P508
Donova T.: P116
Doolub G.: P137
Dorea E.L.: 274, P441
Dores H.: 296, 33, 34, P549, P716
Dorynska A.: 64
Doyle F.: P512
Dragana Bacic D.B.: P352
Dreger H.: P637
Dritsas A.: P628
Drost J.T.: P647
Drozdova E.: P318
Dua A.: P608
Dubova G.: P488
Dubrovskaya O.B.: P445
Dudinskaya E.: P334
Dudinskaya E. N.: 574, P664
Dulfer K.: P152, P392
Dumanova F.: P349
Dungen H.D.: P650
Dunleavy E.: P106
Duoneliene I.: P185
Durgaryan R.: P678
Duval M.: P413
Dzenkeviciute V.: P307, P81, P97
E
Eason S.: P99
Ebbing M.: 38, P126, P353
Edell-Gustafsson U.: P390
Egeland G.: 38, P126
Egland G.: P353
Eisele L.: P652
Eivindson G.: P420, P547
Eivindson G.E.: P197, P551
Ejdeback J.: P390
El Baz N.: P331
El Shahawy M.: P316, P640
El Shahawy O.: P316
Elkin S.: P434
Elmenhorst J.: P199, P474, P92
Elramly M. Z. R.: P320
Entcheva M.: P316, P640
Erbel R.: P470, P652
Eriksson J.: P367
Erina A.M.: 225
Erjavec T.: P333
Ermachkova L.: P84
Ermini G.: P538
Erne P.: P83
Erturk M.: P343
Esaulenko I.A.: P117
Eser P.: P165
Espagnac C.: P410
Espinoza Castillo A.: P90
Esser S.: P652
Estero Serrano De La Cruz H.: P394,
P642
Evtushenko V.: P178
Exposito-Tirado J.A.: P408, P539
F
Facciorusso A.: P345
Fagot-Campagna A.: 582, P315
Fahey T.: P329
Fanelli M.: P345
66
Facciorusso A.: P345
Fagot-Campagna A.: 582, P315
Fahey T.: P329
Fanelli M.: P345
Fanelli R.: P345
Farmakis D.: 70
Farrag A. A. F.: P320
Fattirolli F.: 273
Federico F.: P195
Fedina N.: P417, P418
Felix S.B.: P670, P671
Fernades-Silva M.M.: 274, P441
Fernandes-Silva M.: P406
Fernandez Aguita M.J.: P622
Fernandez Anguita M.: 48, P169, P323,
P183
Fernandez Anguita M.J.: P694
Fernandez Garcia M.: P691
Fernandez Garcia P.: P691
Fernandez M.D.: P360
Fernandez M.J.: P624
Fernandez Olmo M.R.: P408, P539
Fernandez-Labandera C.: P528
Fernandez-Lopez L.: P522, P680
Fernandez-Meseguer A.: P368
Fernando S.: P99
Ferrario M.M.: P322, P462, P91
Ferretto S.: P383
Ferrieres J.: 70
Fijalkowski M.: P454
Filcescu V.: P145
Filho W.S.: P619
Filipovsky J.: P125
Finkova E.P.: P117
Fitzsimons D: P518
Flaherty G.: P411
Flores Clotet R.: P481
Focardi M.: 568, P715
Fondinho C.: P179
Fong Y.M.: P685
Fonseca Cardoso F.M.: P700
Formisano P.: 278
Forsey J.: P433
Foukarakis E.: P621
Franchi F.: P146
Francini S.: 273
Francis D.: P617
Francis D.P.: P434
Franco A.: P190
Franco O.H.: P144, P500
Franke R.: P483
Fras Z.: P127, P355, P386
Frederiksen M.: P513
Frederix I.: P521
Freyer-Adam J.: P670, P671
Frigerio L.: P170
Fruend A.: P86
Frysak Z.: P96
Fu L.J.: P524
Fujito T.: P696
Fukumura K.F.: P188, P721
Funada R.F.: P188, P704, P721
G
Gaber R.: P358
Gabriel L.: P356
Gafarov V.: P602
Gagey S.: P413
Gaida S.: P488
Gaisin I.R.: P401, P609
Gaita D.: P376, P534
Galanti G.: P207, P555, P708, P718
Galanti L.: P356
Galeone D.: P148
Galijan V.: P436
Galimova A.A.: P401
Gallagher J.: P512
Gallozzi C.: P192
Galovcova M.: P125
Galvao A.: P121
Gambaryan M. H.: P141
Ganzetti G.S.: P472
Gao M.: P129
Gao W.: P374
Garcia A.: P184, P515, P677, P682
Garcia Martin E. P.: P107
Garcia Romero A.: P519
Garcia-Margallo M.T.: P368
Gasimov Z.: P101
Gaspar L.: P726
Gasparova I.: P726
Gati S.: P194
Gatterer H.: P207
Gattone M.: P155
Gavornik P.: P726
Gavrilova N.: P477
Gayda M.: P154, P456, P676, P681
Gazimzyanova A.S.: P401
Gebala J.: P483, P687
Gelbrich G.: P650
Geleijnse M.L.: P517
Gelesz E.: 67
Gelziniene V.: P185
Gemma D.: P169, P172, P622, P679,
P688
Gencer B.: P639, P690
Gensini G.F.: P442
Gentile M.: P559
Georgiopoulos D.: P89
Georgousopoulou N.: P618
Gerosa G.: 23
Ghani S.: 219
Gharipour M.: P484
Ghati S.: P549
Gherasim A.: P604
Gheroghe L.: P691
Giallauria F.: 22, P559
Giambanco S.: P437
Giammichele G.: P338
Giampaoli S.: P148, P322, P462, P91
Gianassi M.: P555
Gianfagna F.: P462
Giannattasio C.: P170
Giannuzzi P.: 66, P155
Gianturco L.: P105
Gianturco V.: P105
Giga V.: P205, P432
Gilis-Januszewski J.: P86
Gil-Rey E.: P187
Gimaev R.H.: P496
Giordano A.: P155
Giorgi R.: P702
Giupponi L.: P170
Giverts I.Y.U.: P405
Gjerdalen G.F.: P713
Gjestvang F.T.: P197, P420, P547
Gjestvang F.T.G.: P551
Gjyli L.: P134
Glaser S.: P557
Glasius Tischer S.: P196, P552
Glatz L.: P540
Gnedina A.A.: P405
Goda A.: P135, P309
Goethals M.: 69
Goethals P.: 69
Goetschalckx K.: 54
Gogol C.: P181
Golovskoy B.: P84
Golubovic M.: P384
Gomez Mariscal E.: P107
Gomez Martinez M.: P90
Gomez-Doblas J.J.: P659, P663, P668
Gonseth S.: 300
Gonzalez A.: P465
Gonzalez Caceres J.A.: P492
Gonzalez Garcia A.: P394
Gonzalez Gomez A.: P308
Gonzalez-Quintela A.: P528
Gopal Krushna P.: P554
Gorbas I.M.: P644
Gorbunov V.: P382
Gorbunova Anastasia A.G.: P613
Gospodinova M.: P114
Govc Erzen J.: P127
Graeni C.: P421
Graham I.: P130, P329
Gram J.B.: P645
Grange M.: P149
Graupner C.: P659, P668
Graur L.I.: P604
Graur M.: P604
Graversen P. L.: P112
Grayson T.: P473
Grazioli G.: 297, P198
Gremeaux V.: P410, P536, P542, P611
Gremeaux V.G.: P525
Greve J.: P406
Grimaldi G.: 278
Grimm Blenk C.: P167
Grobbee D.E.: P655
Grosu C.: P604
Grubisic M.: P129
Gruchala M.: 71, P454
Grunze M.: P398
Gualco A.: P697
Guardiola-Sabater M.: P532
Guarneri F.: P607, P80
Guasch E.: 297, P198
Gubelmann C.: 300
Guerrero-Marquez F.: P408
Guertler D.: P670, P671
Guessous I.: P149
Guglielmo M.: P437
Guijarro G.: P465
Guijarros G.: P308
Guilbeault V.: P154, P676, P681
Guimaraes G.: P430
Guimaraes G. V.: P406
Guimaraes G.V.: 274, P441
Guindo Soldevila J.: P481
Guiraud T.: P529, P611
Guiti C.: P413
Gulati D.: P608
Guliev Z.: P310
Gumanova N.G.: P108
Gupta S. K.: P469
Gureckyte J.: P307
Gusakovskaya L.: P153, P510
Gutierrez Gonzalez F.: P368
Guzman Castillo M.: 576
Gvozdyk M.: P634
Gyberg V.: 575, P128, P448
H
Haberman D.: P692
Hackl G.: P364
Hafner F.: P364
Hakkinen U.: 70
Halle M.: P379
Halleck F.: P637
Haller U.: P414
Halvorsen B.B.: P472
Hambraeus K.: P471
Hannequin A.: P542
Hannon B.: P512
Hansen D.: P521
Hansen P.R.: P350
Hansen T.B.: 68
Hansen V. B.: P160
Hanssen H.: P379
Harbar M.O.: P644
Harrington J.M.: P312
Harrison K.: P375, P377
Harshfeld E.: P144
Hashimoto A.: P696
Haslev V.P.: P160
Hassager C.: 68
Haugaard S.B.: 275, P168, P180, P723
Hawkes C.: P373
Hayami D.: P154
Heinonen I.: P504
Held C.: P503
Helders P.J.M.: P206
Helis L.: P122, P348
Hendriks E.J.E.: P340
Henkin Y.: P130
Herbert K.: P495
Herget-Rosenthal S.: P150
Herich L.: P409
Hernandez Afonso J.S.: P482
Hernandez De La Pena C.: P519
Hernandez Jimenez V.: P308, P465,
P476
Hernandez M.D.: 48, P323
Herrero F.: P187
Hewing B.: P637
Hickey A.: P415
Hillebrand S.: P100
Hingley L.: P498
Hirvensalo M.: P504
Ho S.L.: P524
Ho Y.Y.: P685
Hobzova M.: P337
Hoes A.W.: P133, P431, P657
Hofman A.: P440, P500
Hofmann R.: P181
Holdgaard A.: P513
Holewijn S.: P647
Hollander M.: P143
Holm S.: P472
Holtermann A.: P378
Holzendorf V.: P652
Hong G.R.: P466
Hoogeveen A.: 220
Hoogsteen J.: 220
Horina A.: P364
Horstkotte D.: P86
Hortelano I.: P184, P677, P682
Hossain S.: P86
Hourrier G.: P356
Howlett J.: P485
Hoymans V.Y.: 277
Hu X.: P442
Huck L.P.: P102
Hueppe P.: P470
Hughes A.D.: P434
Hulsegge G.: 298, P506
Humberto Pierri H.P.: P648
Humphries K.H.: P129
Hunter R.F.: P508
Hutchinson K.: P106
Huupponen R.: P504
Huxley R.: 573, P447
Huybrechts I.: 577
I
Iacoviello L.: 579, P321, P341
Iakovleva A.: P478
Iancu O.C.: P458
Ibrahim A. M.: P475
Ibrahim Z.: P359
Igland J.: 38, P126, P353
Iglesias Bolanos P.: P308
Iglesias D.: P677
Iglesias Del Valle D.: P184, P515, P682
Iglesias P.: P465
Ignaszewski A.: P485
Ijkema R.: P123
67
Ilic S.: P384, P511
Ilic V.: P132, P384
Iliuta L.: P491
Illyes M.: P494
Incampo E.: P425
Iniesta A.M.: P622, P624
Iniesta Manjavacas A.: P679
Inigo-Garcia L.: P522, P680
Innocenti G.: P708, P718
Ionescu S.G.: P458
Ippolito R.: P148
Isayeva A.: P641
Isaykina O. Y.: 574
Isaykina O.U.: P664
Isaza-Arana S.: P408, P539
Iskchakova A.S.: P609
Ismail J.: P359
Issa J.S.: P102
Issa V.: P430
Ivana Paunovic I.P.: P352
Ivanova R.: P114
Iwamoto E.: P696
Izadnegahdar M.: P129
J
Jackson M.: P473
Jakaite R.: P97
Jakubseviciene E.: P407
Jakumaite V.: P185
Janabaev B.: P615
Jang S. Y.: P464, P603
Jankovic-Tomasevic R.: P650
Jarbandhan A.: P674
Jarbandhan A. V.: P698
Jarrah M.O.H.A.M.D.: P518
Jarstad E.: P701
Jarvenpaa S.: P658
Jaspers M.: P395
Jayo-Montoya J.A.: 272
Jelena Kostic J.K.: P352
Jelena Stepanovic J.S.: P352
Jenkins S.: P724
Jennings C.: 575, P128
Jespersen J.: P645
Jespersen L.: P112, P350
Jimenez R.: P663
Joeckel K.H.: P652
Joeckel K.-H.: P470
Joensen A. M.: 581
Joergensen T.: 581
Johansen P.P.: P203
Johansson A.: P390
John U.: P670, P671
Johnsen S.P.: P173
Johri A.M.: 289, P354, P638
Jonasson M.R.: P385
Jonsdottir S.: P385
Joosten L.: P647
Joussain C.: P410, P525, P542
Ju E.Y.: P464, P603
Jug B.: P127, P355, P386
Jukema J.W.: P100
Jula A.: P504
Jumari J.: P524
Juneau M.: P154, P456, P676, P681
Jurado Roman A.: P107
Jurio-Iriarte B.: 62
Jurko A.: P610, P610
Jurko T.: P610
Jurs A.: 275, P168, P180, P723
Jurt U.: 289, P354, P489, P638
K
Kaan A.: P485
Kabili S.: P309
Kaczmarek S.: P671
Kaelsch H.: P470
Kahonen M.: P504
Kaiser-Nielsen L. V.: P552
Kaletova M.: 580
Kalinina A.M.: P141
Kalinina I.V.: P605
Kalka D.: P483, P687
Kaltsatou A.: P176
Kamakura S.: P669
Kamasova M.: P337
Kaminski S.: P705
Kang S.M.: P466
Kanstrup H.: P173
Kanters J.: P196
Kappelle L.J.: P657
Kapustina A.: P327
Kara K.: P470
Karakaya O.: P343
Karamnova N.: P370
Karasek D.: P96
Karlsen T.: P130, P556
Karoff M.: P181
Karpov R.: P156
Karpov R.S.: P157
Karpov Y.A.: P357
Karpova A.: P313, P480
Kasim S.: P359
Kasiulevicius V.: P97
Kassner U.: P94
Katano S.: P696
Katayose M.: P696
Kautiainen H.: P658
Kaveshnikov V.: P77
Kawanishi K.: P669
Kaygorodova E.: P487
Kazukauskiene N.: P185
Keane E.: P312
Kearney P.M.: P312
Kee F.: P508
Keene D.: P617
Kelleher C.C.: P312
Kemps H. M. C.: P535, P703, P706
Kemps H.M.: P182, P722
Kemps H.M.C.: 220, P393, P689, P712
Kenny R.A.: P329
Kerr Saraiva J. F.: P103, P325, P455,
P606, P95
Kervio G.: P550
Khaitovych N.V.: P429
Khalaf H.: P496
Khalil A.: P544
Khamedova M.: P77
Khir R.I.Z.M.Y.: P359
Khokhlova M.: P713
Khosravi A.: P484
Khosravi Z.: P484
Khovaeva Y.: P84
Kida K.: P147
Kiefte-De Jong J.C.: P500
Kiessling A.: P471
Kilani N.: P113, P631
Kim D.K.: P464, P603
Kim G.: P361
Kim H.C.: P104
Kim I.V.: P139
Kiseleva I.: P417, P418
Kishko N.: P505
Kisko A.: P505
Kiss L.: P493
Kiss L. Z.: P365
Kittel F.: P378
Klausriegler S.: P414
Kleut M.: P202
Knebel F.: P637
Knezl V.: 224, P661
Knoerzer W.: P540
Kobayashi T.: P669
Kober L.: 68
Kocic G.: P511
Koepp U.: P197, P420, P547, P551
Kogias Y.: P166
Kogler B.: P414
Koitabashi N.K.: P188, P704, P721
Kokubo Y.: P669
Kokurina E.V.: P139
Koleda P.: P687
Kolek V.: P337
Kolesova E.P.: 225, P445
Kologrivova I.: P156
Komarova I.: P324
Komkov D. S.: P332
Komoliatova V.: P417, P418
Konradi A.O.: 225, P445
Konstantinova E.E.: P614
Kontsevaya A.: P370
Koopman C.: P443
Koracevic G.: P717
Korhonen P.E.: P658
Koshelskaya O.: P156
Koshelskaya O.A.: P157
Kostic T.: P649
Kosuta D.: P355
Kotseva K.: 575, P128, P627
Kouidi E.: P176
Koval O.: P488
Kovrigina M.: P450
Kozachok M.M.: P429
Kozela M.: 64
Kraaijenhagen R.: P366, P395
Kraaijenhagen R.A.: P689
Kraal J. J.: P703
Kraenkel N.: P398
Kravthenko A.: P324
Krawczyk M.: P326
Kremzer A.: P204
Krestjyaninov M.: P496
Krishnadath I.S.K.K.: P440
Kristjansson H.: P385
Kristjansson K.: P385
Krogh V.: 579
Krotin M.: P436
Krotin S.: P717
Krstic M.: P132
Kruglikova A.: P334
Kruglikova A.S.: P664
Kruuse Rasmusen H.: P513, P552
Kubilius R.: P407
Kuchta M.: P601
Kukharchuk V.V.: P357
Kukharenko S.: P318
Kukreja R.: P136
Kulieva O.: P318
Kulikov V.: P314
Kumar N.: P497
Kura B.: P136
Kurabayashi M.K.: P188, P704
Kurabayashi M.S.: P721
Kursakov A.: P480
Kusano K.: P669
Kushakova T.: P324
Kuzmina E.R.: P405
Kyratzoglou T.: P621
L
Labandeiro J.: P397
Labrunee M.: P529
Labudovic D.: P449
Lackner T.: 63
Lacroix S.: P456
Laerum Sibilitz K.: 68
Lafeber M.: P655
Lalonge J.: P456
Laloux P.: P356
Lam K.B.: P685
Lammel C.: P379
Landmesser U.: P398
Langenbeck B.: P150
Langenbeck M.: P150
Lanzano R.: P192
Laoutaris I. D.: P628
Lapierre G.: P676
Laroche D.: P410, P525
Larrondo M.: P184, P677, P682
Latour E.: P154, P676, P681
Laucevicius A.: P97
Laurent Y.: P525, P542
Lavado M.: P387
Lazaj J.: P135
Lazaro Gomez C.: P519
Lazovic M.: P707
Leandro T.: P676
Lebedeva E.V.: P516
Leblanc M.-H.: P485
Lee M.K.: P129
Lee S.: P685
Lee S.H.: P466
Lee W.J.: P104
Leeder S.: P459
Leenen F.H.: P601
Lehmann N.: P470
Lehtimaki T.: P504
Leinan I.M.: P556
Leitao-Marques A.: 49
Leite Alves R.: P526
Leivas J.: P121
Lelyavina T.: P404
Leone A.: P442
Leosco D.: 278
Leppert J.: P311
Leskosek B.L.: P127
Levashov Sergey S.L.: P613
Lewalle H.: P356
Li L.: P685
Lian X.Q.: P191
Lidegaard M.: P378
Lim C.W.: P359
Lima Santos P.C.J.: P102
Limon J.: P454
Linchak R. M.: P332
Linke A.: P557
Liontou C.: P118
Lisi M.: 568, P715
Lisovaya O.: P633
Listopad O.: P438
Lisulov-Popovic D.: P436
Liu P.: P485
Livi U.: 23
Llorens Leon R.: P482
Lloyd Williams F.: 576, P373
Lo Noce C.: P148
Lo Presti M.: P437
Lochen M.L.: P507
Loforte A.: 23
Loison J.L.: P356
Loktionova E.B.: P537
Longoni P.: P697
Lonobile T.: 278
Lopes N. H.: P102, P648
Lopez Lluva M.T.: P394, P476, P642
Lopez Mesa I.: P394, P642
Lopez Sendon J.L.: 48, P172, P183,
P323, P622, P624, P688, P694
Lopez-Lozano A.: P408, P539
Lopez-Sendon J.L.: P169, P679
Lotufo P.A.: P619
Louw M.: P106
Lovic D.: P717
Low G.H.: P524
Lozano Ruiz Poveda F.: P394, P642
Lubinskaya E.: P399
Luchinat C.: P442
Lucini D.: P424
68
Lucy J.: P473
Luescher T. F.: P398, P690
Luis Fernando Escobar Guzman
L.F.E.G.: P648
Lukyanov S.: P382
Lum Y. C.: P330
Lunde P.: P701
Luscher T.F.: P639
Lydsdottir R.: P385
M
Maan A.C.: P100
Maas A.H.E.M.: P647
Macaione F.: P80
Macartney M.: P498
Mach F.: P639, P690
Macias I.: P360
Macisaac A.: P653
Macneill B.: P411
Madanmohan T.: P554
Madruga F.: P387
Maerz W.: P94
Maestri A.: P697
Magalhaes C.C.: P103, P325, P455,
P606, P95
Maggio D.: P186
Magnussen C.G.: P504
Mahabadi A.A.: P470
Mahmood M.A.: P459
Maindal H.T.: P160
Mairesse G. H.: 69
Mairinger I.: P414
Majerus P.: P356
Majewski J.M.: P699
Majstorovic A.: P202
Makarov L.: P417, P418
Maksimov N.I.: P401
Maldonado-Martin S.: 272, 62, P187
Malev E.: P361
Malev E.G.: P445
Malhotra A.: 219, 296, 33, 34, 9, P419,
P423, P497, P549, P716
Mali W.P.T.M.: P193, P340
Malmberg K.: P448, P93
Malyutina S.: P310
Malyutina S. K.: P463, P602
Mamedov M.: P349, P450, P467
Mancas S.: P458
Mancia G.: P462
Mancini M.: P559
Mangge H.: P364
Mangner N.: P557
Manhylova T.: P88
Mantas Y.: P166
Mantyselka P.: P658
Manzato E.: 578
Manzini S.: P472
Maounis T.: P628
Marabotti C.: P672
Maras P.: P396
Marcantonio P.: P338
Marcassa C.: P155
Marcela Cibien Baratella M.C.B.: P648
Marchiori G.: P485
Marczulin J.: P326
Maresca G.: P336
Maresca L.: P559
Marina Breysse M.: P394, P476, P642
Marinescu C.: P376
Marini C.: P192
Marinoni T.: P439
Markava I.: P122, P348
Marko C.: 63
Maron B.J.: 567
Maron M.: 567
Marques-Sule E.: P159
Marques-Vidal P.: 300, P113, P149,
P631, P632, P639
Marquis-Gravel G.: P154, P681
Marrugat J.: 70
Marsh T.I.M.: 299
Martinez E.: P184, P515, P677, P682
Martinez N.E.: P515
Martinez Rubio A.: P481
Martinez-Garcia F.: P522
Martinez-Garcia F.J.: P680
Martinez-Martinez A.: P408, P539
Martin-Penato A.: P184
Martire M.V.: P643
Martire V.D.: P502, P643, P656
Marti-Soler H.: 300
Martyanova I.: P318
Martynenko A.V.: P641
Marzovenko I.: P388
Mascherini G.: P207, P555
Maslowsky F.: P439, P725
Masnaghetti S. E.: P439
Mason J.: P106
Mastroianno S.: P345
Matangi M.: 289, P354, P489, P638
Matata B.: P473
Matelot D.: P550
Mateva L.: P114
Matoulek M.: P428
Matsuo Y.: P188, P704, P721
Matter C.M.: P639, P690
Matthews S.: P625
Mattiello A.: P322, P559
Matullo G.: P341
Maucec Zakotnik J.: P127
Mavrovouniotis F.: P176
Mayen-Chacon A.: P149
Mayer Jr 0.: P125
Mayet J.: P434
Mayordomo Gomez S.: P107
Mazic S.: 10, P202, P523, P711, P717
Mazilu L.: P453
Mazoteras Munoz V.: P476
Mazza A.: P697
Mc Gee H.: P534
Mcadam B.: P512
Mcgill R.: 576
Mckee G.: P541
Mckenna W.J.: P724
Mclennan P.: P498
Mcshane J.: P473
Meani P.: P170
Meisinger C.: 70
Mellbin L.: 575
Mellbin L.G.: P448, P93
Mellor G.: P423, P497
Mellwig K.P.: P86
Menchetti M.: P538
Mendes J.R.Z.: P103, P325, P455,
P606, P95
Meniconi C.: 568
Mercuri R.: P718
Merghani A.: 219, 296, 33, 34, 9, P419,
P423, P497, P549, P716
Merkely B.: P365, P493
Mestanik M.: P610
Metaxas T.H.: P176
Metelskaya V.: P477
Meyer C.: P670, P671
Meyer P.: P690
Meyer T.: P714
Mezzetti A.: P338
Miadzvedzeva A.: P122, P348
Micallef S.: P336
Micklewright D.: P460
Mickuviene N.: P185
Middel L.J.: P331
Midttun O.: P335
Miguel Gutierrez A.: P107
Mihalache L.: P604
Mike Garcia P.: P90
Milanova M.: P116
Milinaviciene E.: P407, P686
Millar L.: 296, 33, 34, 9, P419, P423,
P497, P549, P716
Millasseau S.: P413
Miller F.: P433
Miller L.: 219
Miname M.: P619
Minetti E.: P555
Mirolyubova O.: P478
Miroshnichenko A.: P314
Misiowiec W.: 64
Mist B.: P724
Mitchell G.: P456
Mitchell R.: P124
Mitchenko O.: P634
Mitu F.: P376
Miura T.: P696
Miyamoto Y.: P669
Moebius-Winkler S.: P398
Moebus S.: P470, P652
Moehlenkamp S.: P470
Moellenberg M. E.: P86
Moguchaya E.V.: 225, P445
Moiseenko N.: P84
Mokhort T.V.: P614
Mokryk I.: P488
Molchanova O.: P78
Molchko O.: P427
Molina Martin De Nicolas J.: P107
Molteni M.: P170
Mondillo S.: 568, P425, P715
Monereo Megias S.: P308
Monereo S.: P465
Montereggi A.: P442
Montesanti D.: 65
Montoro Lopez N.: P679
Montoro N.: P624
Mooney M.: P541
Morard M.D.: P536
Mora-Robles J.: P162, P174, P402
Moreau C.: P542
Moreira E.M.: P144
Moreno Arciniegas A.: P642
Moreno G.: P186
Moreno Reig A.L.: P476
Morino Y.M.: P188
Morisset C.: P410, P525
Morseth B.: P507
Moscato F.: 63
Moser D.K.: P541
Mosterd A.: P193
Mota P.: 49
Mp G.: P469
Mudge A.M.: P415
Mueller J.: P199, P558
Mueller R.: 63, P414
Muniz J.: P659, P663, P668
Munoz-Bellido J.: P522, P680
Murphy C.: P329
Murugesan J.: P702
Musial-Bright L.: P650
Musnelli M.: P472
Mussi C.: P538
Musumeci B.: 65
Muzichin O.: P488
Myers J.: 9
Myftiu S.: P134
N
Nagle A.: P415
Nagorna N.: P488
Nakajima T.N.: P188
Nakjima T.N.: P721
Nakladalova M.: 580
Nanchen D.: P639
Narain R.: 219, 296, 33, 34, 9, P419,
P423, P497, P549
Narain R.C.: P716
Nash P.: P411
Nasman P.: P93
Natali B.M.: P425, P715
Nathoe H.M.: P193
Navarro Valle R.I.: P368
Naydenov S.: P116
Nechwatal R. M.: P540
Nedeljkovic I.: 10, P202, P205, P432,
P711
Nedeljkovic M.: P205, P432
Negoescu R. M.: P145
Neki T.: P696
Neovius M.: P503
Nery R.M.: P171
Netz H.: P82
Neumann T.: P652
Neunhaeuserer D.: P673
Nicholas C.Y.C.: P359
Nicolaije M.: P712
Niebauer J.: P673
Niederseer D.: P673
Niemeijer V. M.: P535, P706
Niemeijer V.M.: P712, P722
Nigam A.: P154, P456, P676, P681
Nikitin Y.U.: P463, P602
Nikolaeva O.: P399
Nikolic - Pavlovic I.: P132
Nikulina S. Y.U.: P369
Nil M.: P165
Nilsson B.B.: P701
Nilsson G.: P311
Nilsson L.: P471
Nita O.: P604
Njerve I.U.: P412
Nocci M.: P146
Nogueira M.: P179, P397
Noman De Alencar M.: P526
Nonka T.G.: P516
Nordrehaug J.E.: P620
Norelius M.: 39
Norhammar A.: P93
Notara V.: P166
Noureddine-Lopez M.: P522, P680
Novack O.: P488
Novikov V.E.: P108
Novo G.: P437, P607, P80
Novo S.: P437, P607, P80
Novotny D.: P96
Nozadze D.N.: P357
Nunez Cortes A.: P519
Nunez S.: P482
Nygaard O.K.: P335
Nygard O.: P126, P353
O
Obbens P.R.: P392
Obeid J.: P206
Oberhoffer R.: P199, P474, P558, P720,
P82, P92
Obrien F.: P541
Odonnell S.: P541
Oehlers G.: P674
Oehlers G.P.: P698
Ofaherty M.: 576, 581, P373
Ofaz E.: P343
Oh J.: P466
Oleinikov V.: P153, P510
Oliva Morera J.C.: P481
Oliveira E.: P397
Oliveira Lima M.M.: P526
Olivencia L.: P360
Olsen R. H.: 275
Olsen R.H.: P168, P180, P723
69
Omelchenko M.: P361
Oneill B.R.E.N.D.A.: P518
Opasich C.: P697
Orsag J.: P96
Orton L.: 576, P373
Oshima S.: P531, P693
Osipova I.: P314
Osipova I.V.: P605
Ossola M.: P155
Ostojic M.: P432
Ostojic M.C.: P205
Otero Chulian E.: P691
Otman Fernandez Concepcion O.F.C.:
P492
Oudkerk M.: P123
Oxborough D.: P544
Ozemek C.: 272
Ozerova I.: P334
P
Pace-Moore G.: P336
Pacini A.: P555
Paganelli C.: P338
Pagani M.: P424
Pagnottella M.: P338
Pajak A.: 64
Pajares Vinardell M.: P691
Pajuelo C.: 297, P198
Pallante R.: 273
Palmieri L.: P148, P322, P462, P91
Panagiotakos D.: P166, P618
Panaitescu E.: P491
Pandian N.G.: 567, 65, P548
Panhuyzen-Goedkoop N. M.: P545,
P546
Panico S.: P322, P341, P559, P91
Panikian-Latifyan M.: P347
Pantaleo P.: P442
Pantazis A.: P724
Pantic I.: P202
Panzeri F.: P170
Papadakis M.: 219, 296, 33, 34, 9, P194,
P419, P423, P497, P549, P716
Papamichael N.: P194
Papasavvas T.: P460
Paraschiv B.: P400, P79
Paredes B.: P677
Paredes M.B.: P682
Parepa I. R.: P453
Parisi V.: 278
Park S.: P466
Park S.W.: P464, P603
Park Y.R.: P104
Parolini C.: P472
Parpia S.: 219
Passaretti F.: 278
Pathak A.: P529
Pattyn N.: 54
Paulitch F.: P102
Paulsen G.: P420, P547, P551
Paulsenn G.: P197
Pavli E.: P119
Pavlovic K.: P630
Pavlovic M.: P649, P650
Pavlovic R.: P511
Pedersen E.K.R.: P335
Pedersen L.R.: 275, P168, P180, P723
Pedersen P.U.: P203
Pedersen S.S.: P331
Pedretti R.F.E.: P439, P725
Peek N.: P182, P395, P703
Peek N.B.: P393, P689
Peeters R.: 276
Pell J.P.: P124
Pellegrini N.: 579
Pelliccia A.: 567, 65, P190, P192, P195,
P548, P710, P715
Pena A.: P350
Pender N.: P512
Peoples G.: P498
Pepera G.: P527, P700
Peraro M.: P439
Pera-Rojas C.: P522
Pereira A. C.: P102
Pereira Nunes M.C.: P526
Pereira-Da-Silva T.: P179, P397
Perez A.: P387
Perisic Z.: P649
Peritore A.: P607, P80
Perk J.: 39, P130, P471
Peroz J.: P413
Perry I.J.: P312
Persichillo M.: 579, P321
Peters S.A.E.: 290, 573, P447
Petlin K.: P178
Petrela E.: P119, P85
Petris A.: P376
Petrova J.: P114
Petrovic D.: P384
Petrovic M.: P630
Petrovic-Nagorni S.: P649
Petrulioniene Z.: P307, P81, P97
Philippi A.: P167
Pieles G. E.: P433
Piepoli M.: P538
Piepoli M.F.: 22
Pierri H.: P102
Pikhtina V.: P334
Pilecki W.: P483, P687
Pilot M.: P483
Pilotto L.: P91
Pimentel P.: P121
Pimienta R.: P482
Pinilla Echeverri N.: P394, P476, P642
Piotrowski W.: P629
Piqueras Flores J.: P394, P476, P642
Piras A.: P538
Pis Diez E. R.: P502, P643, P656
Pisicchio C.: 65, P195, P548, P710
Pitsavos C.: P118, P166, P618
Piwonska A.: P461
Piwonski J.: P461
Plaza I.: P184, P515, P677, P682
Plokhova E. V.: P334, P664
Pogorelova O.A.: P357
Pogosova N.: P313, P480
Pokrajac R.: P436
Polakowska M.: P629
Polgar L.: P365
Poltavskaya M.G.: P405
Pomeshkina S.: P537
Pommier C.: P632
Ponz De Antonio I.: P169, P172, P183,
P679, P688, P694
Ponz I.: 48, P323, P622, P624
Popescu D.S.: P604
Popov S.: P487
Popov T.: P630
Portillo D. O.: P502, P643, P656
Portugal G.: P179
Posca F.: P170
Possemiers N.: 54
Potaskalova V. S.: P429
Poulos G.: P628
Poulsen R.: P513
Prado Diaz S.: P169
Prakken N.H.J.: P193
Pratesi A.: 273
Pratt G.: P375, P377
Pravati P.: P554
Prescott E.: 275, P112, P168, P180,
P196, P350, P513, P552, P723
Prescott E.I.B.: 581
Price C.: P617
Prieto E.: P184
Prijic S.: P717
Prior L.: P508
Priori S.: P697
Pukrop J.: P150
Puronaite R.: P97
Pyhtina V.S.: P664
Pyrikova N.V.: P605
Q
Qirko S.: P119
Quattrini F.: P548, P710
Quattrini F.M.: P195
Querol-Fuentes F.: P159
Quevedo K.: P187
Quka A.: P134
Qvist I.: P173
R
Raber L.: P690
Rac Albu M.: P491
Radchenko G.: P388
Radosinska J.: 224
Radovanovic D.: P83
Radovanovic S.: P717
Radtke T.: P165, P421, P713
Rahman M.: P459
Rahman M.A.: P459, P625, P653
Rahman M.T.: P319
Raitakari O.T.: P504
Rakowska A.: P483, P687
Ramanathan R.: P645
Ramanujam P.: P433
Ramet J.: 277
Ramirez M.F.: P662
Ramirez Moreno A.: P522, P680
Ramkumar T.: P554
Ramsey H.: P692
Rapin A.: P542
Ras R.T.: 577
Rasmusen H.K.: P196
Rasmussen F.: P503
Rauch B.: P534
Ray P. C.: P469
Rayner M.: 576, P373
Razin V.A.: P496
Redkina Marina M.R.: P613
Reed M.: P194
Refsgaard J.: P173
Reibis R.: P705
Reinsch N.: P652
Rengers A.: P366
Rengo G.: 278
Rensen P.C.N.: P100
Reparaz J.: P387
Repin A.N.: P516
Resnik M.: P186
Retkoceri R.R.: P666
Rhee Y.: P104
Ricci-Renaud P.: 582, P315
Riccobono S.: P170
Richter D.: P89
Ridard C.: P550
Riding N.: P422
Riding N.R.: 295
Riebandt J.: 63
Rieder J.: P673
Rieder R.: P414
Rienks R.: P193
Rinkuniene E.: P97
Rio P.: P179, P397
Ritsinger V.: P93
Rivera R.: P360
Rocandio M.: P387
Rocca E.: 297, P198
Rocha M.O.C.: P526
Rochev Y.: P106
Rochitte C.E.: P619
Rodgers A.: P655
Rodondi N.: P639, P690
Rodriguez Cordoba P.: P90
Rodriguez Esteban M. T.: P482
Roig E.: P659, P663, P668
Roitenburd D.: P186
Roldan Jimenez M.A.: P162, P174, P402
Roman Degano I.: 70
Rombopoulos G.: P89
Rosenblad A.: P311
Rosendaal F.R.: P100
Rosillo Rodriguez S.: P169, P679
Rosillo Rodriguez S.O.: P172, P688
Rosillo S.O.: P622
Rostrup E.: P620
Rotar O.P.: 225, P445
Rroji M.: P135
Rrugia A.: P85
Rubio Alonso B.: P107
Ruescas-Nicolau M.A.: P159, P532
Ruffa R.M.: P186
Ruilope L.M.: P528
Ruiz-Moraga M.: P528
Runev N.: P116
Rusiecki L.: P687
Russo A.: P345
Russo N.: 23, P383
Russo O.: P148
Rutten F.H.: P133, P143, P657
Rutten G.: P133
Ruzov V.I.: P496
Ryabikov A.: P310, P463
Ryden L.: 575, P128, P448, P93
Rynkiewicz A.: P454
S
Saavedra Falero J.: P308
Saavedra J.: P465
Sabatini A.: P640
Sacerdote C.: P341
Sadeghi M.: P484
Salame K.: P396
Salas-Serantes J.C.: P680
Saligova J.: P601
Salinger-Martinovic S.: P650
Salvador O.: P677
Salzwedel A.: P409, P705
Samura B.: P486
San Vicente J.: P387
Sanchez Millan P.: P691
Sanchez Perez I.: P394, P642
Sanchez-Chaparro M.A.: P528
Sand N.P.R.: P645
Sandercock G.: P527
Sandercock G.R.H.: P700
Sanders R.: P625
Saner H.: P165, P690, P713
Sani G.: 23
Santalo Corcoy M.: P481
Santoro T.: P345
Santos N.: P179, P397
Santos R.D.: P619
Santovito D.: P338
Sanyal A.: P495
Sanz M.: 297, P198
Sanz Martin C.: P368
Sapoka V.: P81
Sapozhnikova I.: P452
Saraiva D.J.B.: P103, P325, P455, P606,
P95
Saric J.: P436, P717
Saric S.: P384
Sarrafzadegan N.: P484
Sarzi Braga S.: P439, P725
Sato Y.S.: P188, P721
Sayers M.: P99
70
Scavee C.: 69
Schadendorf D.: P652
Schaefer D.: P165, P421, P713
Schakhmatov S.: P310
Schartum-Hansen H.: P335
Schaufelberger F.: P713
Schembri-Wismayer P.: P336
Schepers D.: P533
Schima H.: 63
Schmid J.-P.: P534
Schmidt-Trucksaess A.: P421
Schnell F.: P550
Schnell O.: 575
Scholl J.: 290
Schrepper A.: P557
Schroeder E.: P356
Schrover I.M.: P655
Schuler G.: P557
Schuler G. C.: P398
Schusterova I.: P601
Schwenkglenks M.: P83
Scolletta S.: P146
Scott D.: P508
Scruth E.: P653
Sec P.: P444
Sedlak T.: P129
See J. H. J.: P330
Seferi S.: P135
Seidlerova J.: P125
Seifert R.: P335
Seinost G.: P364
Seiti J.: P135
Selby K.: P639
Seliuk M.N.: P429
Seliuk O.V.: P429
Seljefot I.: P412
Semegen-Bodak K.H.: P111, P346
Semenova A.E.: P357
Senard J.M.: P529
Senthil Kumar S.: P554
Serafni M.: 579
Serdechnaya E.: P667
Serebryakova V.: P77
Sergatskaya N.: P153, P510
Sergienko I.V.: P357
Sergienko T.N.: P516
Serrano J.: P659, P668
Setzu T.: 23, P383
Shakhmatov S.: P463
Shalaeva A.: P615
Shalaeva E.: P615
Shalnova S.: P327
Shalnova S.A.: P141
Shamsheva D.: P381
Sharashkina N.V.: 574, P664
Sharif F.: P411
Sharka I.: P134
Sharma R.: P194
Sharma S.: 219, 296, 33, 34, 9, P194,
P375, P377, P419, P423, P497, P549,
P716
Sharovsky R.: P619
Sharvadze G.: P467
Shatskaya O.: P318
Shaw M.: P473
Sheikh N.: 296, 33, 34, 9, P194, P419,
P423, P549, P716
Shelley E.: P329
Shilina L.V.: P609
Shirakura K.S.: P704, P721
Shirka E.: P309
Shlyakhto E.V.: 225, P404, P445
Shulman V. A.: P369
Shun-Shin M.: P617
Shvedka O.: P488
Shyshko V.: P122, P348
Shyshko V.M.: P614
Sidelmann J.J.: P645
Siegrist M.: P379
Sigurdardottir A.K.: P683
Siles-Rubio J.R.: P522, P680
Silva J.: 49
Silva S.: P179, P397
Silveira A.D.: P171, P177
Silveira Costa H.: P526
Simon A.: 67, P534
Simon S.: P662
Simoni L.: P309
Simonova G.: P602
Simonovic D.: P511
Sinagra G.: P396
Sioen I.: 577
Siren R.: P367
Sitges M.: 297, P198
Sitnikova M.Y.U.: P404
Sittarame F.: P690
Siva A.: 296
Ski C.F.: P625
Skibarkiene J.: P686
Skoumas I.: P618
Skoumas J.: P118
Skreckova G.: P505
Skripnikova I.A.: P108
Sladojevic M.: P630
Sladojevic S.: P630
Slater P.A.U.L.: P518
Slavik L.: P96
Slezak J.: P136
Sljivic A.: P202
Smaradottir M.I.: P448, P93
Smeets J.L.R.M.: P545, P546
Smialek J.: P699
Smit H.A.: 298, P506
Smyshlyaev K.: P178
Snoer M.: 275
Sobiczewski W.: 71
Sokolov A.: P487
Sokolova T.V.: P401
Solange De Sousa Andrade S.S.A.:
P648
Solberg E.E.: P713
Soler I.: P515
Solheim S.: P412
Solntsev V.N.: P445
Solomenchuk T.: P111, P115, P346,
P651
Solyanik Y.: P318
Soos P.: P365, P493
Sosner P.: P456, P611
Soto Martinez Y.: P90
Sova M.: P337
Sovova E.: 580, 580, P337
Sovova M.: 580, P337
Spataro A.: 567, 65, P192, P548, P710
Spee R.: P722
Spee R. F.: P535, P706, P712
Spiering W.: P655
Spronk A.: P152
Spurrier N.: P459
Squeo M.R.: P192, P195
Stam H.J.: P158, P514, P517
Staniak H.L.: P619
Stanisz J.: P483
Staniute M.: P161, P185
Stankev M.D.S.: P347
Stanojevic D.: P649, P650
Stavropodis P.: P166
Steenaard R.: P517
Stefanadis C.: P118, P166, P618
Stefani L.: P207, P555, P708, P718
Steger B.: P673
Steimann L.: P94
Stein A.: P121
Stein R.: P171, P177
Steinhagen-Thiessen E.: P94
Steinsbekk A.: P683
Stella D.: P105
Stepanovic J.: P205, P432
Stevanovic A.: P523, P616
Stigter M.: P138
Stoickov M.: P384
Stoickov V.: P384
Stojanov V.: P205
Stoylen A.: P556
Straessler E.: P398
Strandt G.: P409
Strazhesko I.: P334
Strazhesko I.D.: 574, P664
Strazzullo P.: P148
Stringhini S.: 300
Struk T.A.: P641
Stuart A.G.: P433
Stuhr H.: 52
Subirana I.: 70
Subirats E.: 297, P198
Suceveanu A.: P453
Suceveanu A. I.: P453
Sugar V.: 271
Sulo E.: P126, P353
Sulo G.: P126, P353
Sulo S.: 38
Sunamura M.: P152, P158, P389, P392,
P514, P517
Sundstrom J.: P503
Suslova T.: P156
Sutera M.R.: P437
Suzic Lazic J.: P202, P523
Suzic S.: P202
Suzuki N.: P147
Svavarsdottir M.H.: P683
Svennberg L.: P471
Svet A.V.: P405
Svingen G. F. T.: P335
Svitlyk H.V.: P644
Swenne C.A.: P100
Sygnowska E.: P371, P461
Sylwina-Krauz E.: P483
Syrkin A.L.: P405
Syrris P.: P724
Syrycki M.: P687
Szafraniec K.: 64
Szakacs Xantus T.O.: P344
Szelid Z.: P365
Szelid Z.S.: P493
Szenczi O.: P365, P493
T
Tadic S.: P630
Taglieri C.: 66
Tahirovic E.: P650
Tak T.: P692
Takama N.T.: P188, P704
Takama T.N.: P721
Takken T.: P206
Talaie M.: P484
Talavera P.: P668
Tam C.C.: P685
Tammelin T.: P504
Tan S.C.: P524
Tan S.W.: P524
Tanghe A.R.: 277
Tardif J.-C.: P456
Targett S.: P422
Tarlovskaya E.I.: P452
Tarlovski A.K.: P452
Tarro Genta F.: 66
Taszner M.: P454
Tatar R.: P344
Tatu-Chitoiu G. P.: P376
Taurozzi S.: P186
Tavares A.: P430
Tavares A. C.: P406
Taylor R. S.: 271
Taylor Robinson D.: 576, P373
Tecuceanu R.: P376
Teferici D.: P119
Teixeira P.: P179
Tejero C.: P515
Tell G.S.: 38, P126, P353
Tenori L.: P442
Ter Hoeve N.: P152, P158, P389, P392,
P514, P517
Teramoto K.: P147
Tesic M.: P432
Testa R.: P672
Thilaganathan B.: P194
Thom S.: P655
Thompson D.R.: P625
Thygesen L.C.: 68
Tidu M.: 66
Tilea I.: P344
Timerman A.: P103, P325, P606, P95
Timoracka K.: P125
Ting P.: P524
Tiringer I.: 67
Tkacheva O.: P334
Tkacheva O. N.: 574, P664
Tobin C.: P489
Todorovic L.: P649
Toelsie J.: P440, P674, P698
Toguzova Z.: P450
Tomashevskaya Y.: P510
Tomono J.: P531, P693
Tonhajzerova I.: P610
Topi G.: P144, P538
Topor-Madry R.: 64
Toran C.: P465
Tordi N.: P410
Torre M.: 70
Torres-Llergo J.: P408, P539
Torrisi L.: P190
Tosheska Trajkovska K.: P449
Traa S.C.J.: P393
Trachsel L.: P421, P713
Tramarin R.: P725
Tranquilli C.: P190, P192
Trautwein E.A.: 577
Traversi E.: P424
Tribulova N.: 224, P136, P444, P661
Tripi F.: P538
Trovato R.L.: P607
Trubacheva I.: P77
Tsai D.: 300
Tsapaeva N.L.: P614
Tsarenok S.: P382
Tsonev S.V.: P116
Tsuchihashi K.: P696
Tuhomiletho J.: 575
Tuka V.: P428
Tulloh R.M.R.: P433
Tully M.A.: P508
Tumino R.: P341
Tundidor M.E.: P195
Tuohy S.: P411
Tuppin P.: 582, P315
Turhan Caglar F.N.: P343
Turiel M.: P105
Turlyun T.S.: P117
Tursi V.: 23
Tynelius P.: P503
Tyshchenko I.V.: P117
U
Ueland P.M.: P335
Ugurchieva Z.: P349
Uhlemann M.: P398
Uiterwaal C.S.P.M.: P140
Uitterlinden A.G.: P500
71
Ulbricht S.: P670, P671
Ungan I.: P343
Urazalina S.Z.: P357
Urbano Moral J.A.: 567
Urieva S.: P667
Usenko N.: P488
Utens E.M.W.J.: P152, P392
V
Vaartjes C.H.: P431
Vaartjes I.: P443
Vadas R.: P365, P493
Vagovicova P.: P125
Vakhrusheva Y.U.: P478
Valcarcel Paz D.: P481
Valdivielso P.: P528
Vallejo-Carmona J.: P408, P539
Van Aerde M.A.: P123
Van Ballegooijen M.: P123
Van Buuren F.: P86
Van Buuren S.: P206
Van Craenenbroeck E.M.: 54
Van De Sande D.A.J.P.: 220
Van Den Akker-Van Marle M. E.: P703
Van Den Berg H.J.: P517
Van Den Berg-Emons H.J.G.: P158,
P389, P514
Van Den Brekel K.: P138, P366
Van Den Hooven E.H.: P144
Van Der Aalst C.M.: P123
Van Der Graaf Y.: P340
Van Der Schouw Y.T.: 298, 577, P140,
P340, P499, P506, P647
Van Dijk J.P.: P331
Van Dis I.: P443
Van Domburg R.T.: P152, P158, P389,
P392, P514, P517
Van Driessche N.: P521
Van Engen-Verheul M. M.: P689
Van Eyck J.: P647
Van Geffen M.E.: P158, P389, P514
Van Helvoirt M.: 277
Van Herck K.: P378
Van Son K.A.: P657
Van Stel H.F.: P133
Vandekerckhove Y.: 69
Vanek J.: P125
Vanhanen H.: P367
Vanhees L.: 276, 54, P533, P674, P698
Vannucchi S.: P322
Vanuzzo D.: P148, P322, P91
Varakin Y.Y.: P139
Varounis C.: P89
Vasiliauskas D.: P407
Vassallo A.M.: P336
Vaverkova H.: P96
Vazquez Garcia R.: P691
Veeger H.E.J.: P698
Velasquez Aguilar C.: P90
Velicka L.: P407
Velthuis B.K.: P193
Venturini E.: P672
Verdile L.: 65, P195
Veress G.: 67
Verga S.: P437
Vergara Castaneda A.: P90
Vermeulen A.A.: P657
Veronesi G.: P322, P462, P91
Verschuren W.M.M.: 298, P443, P506
Veryovkin E.: P310, P602
Vettore E.: P383
Viczenczova C.: 224, P136, P444, P661
Vigorito C.: 22, P559
Viikari J.S.A.: P504
Vijgen J.: 69
Vik R.: P472
Ville N.: P550
Villelabeitia K.: P519
Visnovcova Z.: P610
Visseren F.L.J.: P655
Vissers D.K.: 277
Vitale E.: P338
Vitelli A.: P559
Vitezova A.: P500
Vitlianova K.: P116
Vizcarra R.: P186
Voeller H.: P705
Vojislav Giga V.G.: P352
Volkova E.G.: P613
Vollenweider G.: P632
Vollenweider P.: P113, P149, P631
Voller H.: P409
Vollset S.E.: P126, P353
Volterrani M.: P702
Voortman T.: P144
Vordos Z.: P176
Voronina E.: P463
Voronova M.A.: P401
Vosbergen S.: P395
Vranic I.: P635, P660
Vrbovsek S.: P127
Vrints C.J.: 277
Vromen T.: P182
Vujin B.: P630
Vukcevic M.: P436
Vukomanovic V.: P717
W
Waeber G.: P113, P149, P631, P632
Walker M.: P419, P423
Wallner K.: P414
Wang L.S.: P191
Wang X.: P431
Wasag B.: P454
Waskiewicz A.: P371
Watanabe M.: P669
Webber L.: 299
Weberruss H.: P82
Webster R.: P655
Wegrzyn A.: P454
Wegscheider K.: P409, P705
Wensel R.: P434
Werner S.: P557
Weymar F.: P670, P671
Widimsky J.: P428
Wiggers J.M.R.: P395
Wijn P. F. F.: P535, P706
Wijn P.F.F.: P722
Wijnhoven T.: 299
Wilhelm M.: P165, P421, P713
Willemsen D.: 52
Williams C.A.: P433
Wilms M.: P558
Wilson A.: P625
Wilson D.: P375, P377
Wilson M.: P422
Wilson M.G.: 295
Wimmer G.: P364
Windecker S.: P639
Wirtwein M.: 71
Witassek F.: P83
Wojcieszczyk J.: P687
Wojtyniak B.: 300
Wolfshaut-Wolak R.: 64
Womperski K.: P483, P687
Wong A.: P685
Wong K.L.: P685
Wood D.: P128
Woodward M.: 573, P447
Workowski A.: 52
Worrall-Carter L.: P625, P653
Wright C.: P625
Wuehle-Demuth M.: P94
Wynia K.: P331
X
Xhafaj M.: P134
Xhelili E.: 63
Y
Yadrikhinskaya M.: P318
Yamauchi F.: P693
Yang F.: P431
Yarovaya E.: P477
Yasuda T.S.: P188
Yasuda T.Y.: P721
Yasyukevich N.: P463
Yevdokimova A.: P467
Yin C.: P136
Yip F.Y.: P524
Yoshida S.: P531
Youm Y.S.: P104
Youn J.C.: P466
Yung A.: P685
Z
Zaidi A.: P194
Zainal Abidin A.I.Z.A.: P359
Zalzman A.G.: P605
Zamora Ramirez M.A.: P368
Zanetidou S.: P538
Zanini M.: P171
Zapletalova J.: P337
Zauner H.: P414
Zauner P.: P167
Zdravkovic M.: 10, P436, P711, P717
Zdrojewski T.: 300, P326, P461
Zelinka T.: P428
Zeman M.: 224
Zemtsovsky E.: P361
Zen Jurancic M.: P333
Zerbino D.D.: P651
Zhao W.: P374
Zigmantiene D.: P407, P686
Zillikens M.C.: P500
Zimpfer D.: 63
Zito A.: P383
Zito F.: 579
Zlobina M.: P487
Zock P.L.: 577
Zombolos S.: P166
Zucchetti C.: P121
Zwisler A.-D.: 68, P534
72

Save by registering before 31 May
www.escardio.org/ESC2014
Discover the Scientific Programme
www.escardio.org/ESC2014programme
5 days of scientific Sessions 150 CV Topics
30 000 healthcare professionals from
140 countries 11 400+ abstracts submitted
500 expert sessions 200 exhibiting companies
& all year long on ESC Congress 365
Bring your Prevention & Rehabilitation
congress experience full circle by
participating in ESC Congresss 2014
In Village 8, you will find the latest evidence, updates
and controversies in prevention, rehabilitation, sports,
nursing & allied professional practice.
Sessions not to miss:

Global Focus on Prevention

Guidelines in Daily Practice

Spotlight sessions
For more information visit the ESC stand C1

Eacpr: European Association For Cardiovascular Prevention and Rehabilitation

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Eacpr: European Association For Cardiovascular Prevention and Rehabilitation

Uploaded by

Copyright:

Available Formats

European Association for

You might also like